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ABSTRACT 
Flavocytochroine b2 (in) from baker's yeast catalyses the two 
electron oxidation of L(+)lactate to pyruvate and subsequent 
reduction of cytochrome c. The enzyme is a tetramer of identical 
subunits, each of which consists of two functionally distinct 
domains; a flavodehydrogenase domain containing flavin 
mononucleotide (FMN) and a cytochrome domain containing protoheme 
Ix. 
The work in this thesis describes the investigation of the roles 
of specific amino acid residues, carried out through the kinetic and 
spectroscopic characterisation of site-directed mutant forms of b2. 
Tyr143 is an active site residue which lies between the 
flavodehydrogenase and cytochrome domains of b2. Its role in the 
catalytic cycle was examined by replacement of this residue with 
phenylalanine. The most significant effect of this mutation was a 
change in the rate-limiting step of catalysis. In the wild-type 
enzyme, this is abstraction of the lactate C2-H. In the mutant 
enzyme, interdomain electron transfer between the flavin and heme 
prosthetic groups is now the slowest step. The rate of heme 
reduction by lactate, determined using the stopped-flow method, is 
decreased by > 20-fold from 445 ± 50 s in the wild type enzyme to 
21 ± 2 s- ' in the mutant enzyme. Decreases in kinetic isotope 
effects seen with [2- 2H]lactate for the mutant enzyme compared to 
the wild-type, both for flavin and for heme reduction, also provide 
support for a change in the nature of the rate-limiting step. Other 
kinetic parameters are all consistent with the mutation having a 
dramatic effect on interdomain electron transfer. It therefore 
V 
appears that Tyr143 plays a key role in facilitating electron 
transfer between the flavin and hemé groups. 
Further studies on the role of Tyr143 were carried out by 
replacing this residue with glutamine. Kinetic results show that the 
enzyme is a poor lactate dehydrogenase. Furthermore, the lactate K?1 
has increased by > 100-fold from 0.5mM in the wild-type enzyme to 
-
65mM in the mutant enzyme. These and other kinetic results suggest 
that lactate to flavin electron transfer is the slowest step in 
catalysis, due to conformational effects at the active site. This is 
consistent with circular dichroism studies which show that a 
significant flavin/aromatic residue interaction has been lost. 
Two other interdomain residues, Phe325 and Tyr97, were 
investigated by substitution with alanine and tyrosine respectively. 
Although kinetic results indicate that Tyr97 is not of great 
functional significance, it is shown that Phe325 contributes towards 
domain/domain integrity and recognition. 
The roles of key active site residues Arg376, Lys349, His373 and 
Asp282 in catalysis were investigated by replacement with lysine, 
arginine, glutamine and asparagine respectively. Arg376 is 
considered to be largely responsible for substrate binding at the 
active site. The steady-state kinetic results for the R376K mutant 
enzyme show that the lactate Km has increased by -100-fold, 
consistent with the proposed role for Arg376 in catalysis. The 
flavin prosthetic group dissociates from this enzyme, showing 
that Arg 376 is also important in preserving the integrity of the 
active site. The other three mutant enzymes possess only residual 
activity. 
A steady-state kinetic study with various substrates and 
vi 
inhibitors was carried out to examine the specificity of the active 
sites of several site-directed mutant forms of b2. This study showed 
that long chain 2-hydroxyacids such as 2-hydroxyoctanoate and 2-
hydroxycaproate bind more effectively to the WT and mutant enzymes 
than does lactate. The substrate specificity of the F325A mutant 
enzyme has altered somewhat as it is almost as efficient a 2-
hydroxyoctanoate dehydrogenase as it is a lactate dehydrogenase. 
Oxalate inhibition of the mutant enzyme in which Tyr143 has been 
replaced by phenylalanine is considerably weaker than that observed 
with the 1fF enzyme. As oxalate is considered to be a transition 
state analogue of b2, this suggests that Tyr143 is important in 
transition state stabilisation. 
The heme group of bz is axially ligated by two histidine 
residues. To investigate the flow of electrons through the heme, one 
of these histidines, His43, was replaced with methionine. Although 
heme incorporation is low (5%), the UV/visible spectrum of the 
mutant enzyme shows that high-spin heme iron has been generated. 
This heme iron is capable of binding exogenous uganda such as 
carbon monoxide. There is no evidence of methionine ligation. The 
mutant enzyme functions as a fairly efficient lactate dehydrogenase 
and ferricyanide reductase, but is a poor cytochrome c reductase. 
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ABBREVIATIONS AND UNITS 
Both the single and three letter codes have been used to denote 
amino acids:- 
AMINO ACID THREE LETTER ONE LETTER 
ABBREVIATION SYMBOL 
Alanine Ala A 
Arginine Arg R 
Asparagine Asn N 
Aspartic acid Asp D 
Glutamine Gin Q 
Glutamic acid Giu E 
Histidine His H 
Lysine Lys K 
Methionine Met M 
Phenylalanine Phe F 
Proline Pro P 
Serine Ser S 
Tyrosine Tyr Y 
The following noRenclature has been adopted in referring to 
flavocytochro.e in (in):- 
Wild-type in is abbreviated to WT-in 
Y143F-l2, for example, denotes a site-directed mutant form of in in 
which the tyrosine (Y) at position 143 in the amino-acid sequence 
has been substituted with phenylalanine (F). 
Kinetic paraaeters: - 
Km 	Michaelis constant 
kcat 	 the enzyme turnover number 
V.ax 	 limiting value for reaction rate 
Ki 	the inhibitor constant 
K8 	dissociation constant of the enzyme substrate complex 
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When referring to oligonucleotides, the following abbreviations are 
used: - 
A, Adenine; T, Thymine; C, Cytosine; G, Guanine. 
Other abbreviations include:- 
ATP adenosine-5 '-triphosphate 
CD circular dichroism 
DNA deoxyribonucleic acid 
E.coli Escherichia coli 
EDTA ethylenediaminetetraaceticac id 
FMN flavin mononucleotide 
H. anomala Hansenula anomala 
lactate L- [2 -1 H]lactate (unless otherwise stated) 
PMSF phenylmethylsulphonylf luoride 
S. cerevisiae Saccharomyces cerevisiae 
SDS-PAGE Sodium Dodecyl Suiphate-Polyacrylamide Gel 
Electrophoresis 
Abbreviations of units are of a standard for.:- 
Da 	 dalton units 	 V 	 volt(s) 
g 	 grain(s) 	 K 	 kelvin(s) 
1 	 litre(s) 	 ohm(s) 
s 	 second(s) 	 A 	 angstrom(s) 
Other unit abbreviations include:- 
first order rate constant 
M 1 8 1 	 second order rate constant 
W 1 cm 1 	molar extinction coefficient 
p.s.i. 	 pounds per square inch 
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Flavocytochrome b2 (L(+)lactate : cytochrome c oxidoreductase) 
catalyses the two electron oxidation of L(+)lactate to pyruvate and 
subsequent transfer of electrons to cytochrome c [1]. The enzyme is 
believed to have evolved as the result of a fusion between two 
genes [21, one coding for a flavin mononucleotide binding 
dehydrogenase and another coding for a b-type cytochrome, a 
combination which pairs one of nature's most versatile catalysts 
with one of its most effective electron transfer vehicles. 
Flavoproteins are able to catalyse a wide range of redox 
processes by various chemical mechanisms. The cof actor of 
a flavoprotein is either flavin mononucleotide (FMN) or flavin 
adenine dinucleotide (FAD) (Figure 1.1). These are the 
coenzymatically active forms of riboflavin (vitamin B2). The 
sidechain functions do not participate in catalysis but play an 
important role in anchoring the group at the active site. 
Flavins are able to exist in three spectrally distinguishable 
oxidation states. The oxidised and reduced forms are yellow and 
colourless respectively whereas the one electron reduced form (the 
semiquinone) is blue or red depending whether the radical exists on 
Ni or N5. The redox active part of the flavin is the 7,8-
dimethylisoalloxazine nucleus [3]. Since C=N fragments in the 
oxidised flavin are comparable to isolated carbonyls, nucleophilic 
addition is possible at C4a, N5, ClOa as well as C6 and C8. Most 
strong nucleophiles appear to add to positions C4a or N5. 
Cytochromes form a diverse group of proteins, all of which 
contain protoheme IX (Figure 1.2) or one of its derivatives. They 
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function in electron transport and are found in most forms of life. 
The initial classification of cytochromes was made by Keilin who 
designated them into three groups, a, b, or c, depending on the 
relative positions of their a, 13 and Soret bands in the visible 
spectrum [4]. This is essentially a reflection of the nature of the 
substituted side chains in the porphyrin ring. Cytochromes are 
one electron acceptors and function by alternation of the heme iron 
between the ferric and ferrous redox states. 
1.2 	ISOLATION AND PURIFICATION OF FLAVOCYTOCHROME in 
Flavocytochrome in (in) from the yeast Saccharomyces cerevisiae, 
was first isolated by Bach et al. in 1942 [5] and identified as a 
b-type cytochrome (containing protoheme IX). The enzyme was 
further purified and crystallized 12 years later by Appleby and 
Morton [1] who revealed the existence of a second prosthetic 
group, flavin mononucleotide, present in a 1 : 1 ratio to the heme. 
The crystallized in (termed type 1) was found to contain - 5% DNA [6] 
which could be removed by dialysis at high ionic strength [6,7] or 
chromatography on DEAE-cellulose [8]. The resulting DNA-free in was 
termed type 2. 
A comparison of the kinetic properties of in before and after 
crystallization was not favourable [9,10]. Both the Kn for lactate 
and the electrophoretic mobility of the enzyme were increased after 
crystallization, as were the number of electrophoretic bands. The 
latter effect indicated that cleavage of the enzyme had occurred (a 
similar effect was observed with non-crystallized enzyme which had 
been stored over a period of time [91) and indeed Lederer and Simon 
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[11] found that the crystallized enzyme consisted of two main 
polypeptide fragments of molecular weight 36 kDa and 21 kDa, termed 
a and 13 respectively. It was suggested that this modification of the 
enzyme was necessary for crystallization to take place under the 
reported conditions and that the changes were due to the action of a 
proteolytic enzyme [9]. This was verified by the discovery that b2 
degradation could be inhibited by PMSF [12], a known protease 
inhibitor and, furthermore, the enzyme did not crystallize when PMSF 
was used at all stages during purification [13]. The enzyme 
purified in this manner was termed t intact' or physiological in 
after it was shown to consist of one single polypeptide chain of 
approximate molecular weight 57 kDa [13]. The crystalline enzyme 
was correspondingly labelled as the t c leaved form of W.  
Although high purity of the intact enzyme could be achieved through 
the use of hydroxyapatite and sepharose chromatography columns, the 
yield of protein from 1kg of dry yeast was only about ]umol [14]. A 
breakthrough in the efforts to achieve increased yields was made 
in 1989 by Black et al. [15] with the high level expression ( - 5%) of 
in in E.coli. Yields of in were estimated to be between 500 and 
1000-fold more than from the same wet weight of yeast. 
1.3 	LOCATION AND FUNCTION 
in is located in the intermembrane space of yeast mitochondria 
[16]. It is synthesised in the cytoplasm and transported through the 
outer membrane into the intermembrane space. Part of the polypeptide 
chain penetrates the inner membrane and is proteolytically cleaved 
leaving an insoluble, membrane bound intermediate. This is further 
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cleaved to form the soluble mature protein which is subsequently 
released into the intermembrane space [17,181. Here in catalyses the 
two electron oxidation of L(+)lactate to pyruvate and subsequent 
transfer of electrons to cytochrome c, also located in the 
intermembrane space. 
Figure 1.3 shows the postulated oxidation pathways of L(+)lactate 
in yeast mitochondria [19]. In the presence of antimycin, route B, 
the main electron transport chain is blocked. However, route A, 
involving in, cytochrome c and cytochrome c oxidase, bypasses this 
segment of the respiratory chain and enables the continuing 
respiration of yeast, albeit with a greatly lowered yield of ATP. 
1.4 	STRUCTURE 
1.4.1 OVERALL STRUCTURE 
in is a tetramer (Figure 1.4A) of molecular weight 230 kDa 
[20,21], with each subunit comprising a single polypeptide chain of 
511 amino acids. The X-ray crystal structure of in, determined to 
2.4A resolution [22,23] shows that the subunit is composed of two 
functionally distinct domains; a cytochrome domain (residues 1-100) 
and a flavin binding domain (101-511) (Figure 1.5). The four flavin 
binding domains pack together around the molecular 4-fold axis 
and form an ellipsoidal disc of approximately bOA across and 60A 
deep. The cytochrome domains are positioned on the outer edge of 
this disc and protrude from above its mid plane (Figure 1.4B). 
Although in possesses local 4-fold symmetry, it is located on a 
crystallographic 2-fold axis. In subunit 2, the cytochrome domain 
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The oxidation pathways of L(+)lactate in yeast mitochondria as 
determined by Pajot and Claisse [19]. Route A, involving 1,2, 
cytochrome c and cytochrouie c oxidase, enables yeast to respire on 
L(+)lactate if the main route (B) is blocked, for, example, by 
antimycin. 
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View of the bz tetramer down the 4-fold axis of symmetry. The dashed 
lines in subunits b and d represent the two cytochrome domains which 
are disordered in the structure. 
B. 
PROTOHEME IX 
A side view of Figure 1.4A, perpendicular to the above, with the 
disordered cytochrome domains omitted. 
FIGURE 1.5 
THE BACKBONE STRUCTURE OF THE b2 SUBUNIT 
The cytochrome doaain is shown in red with the flavin binding doRain 
in green. 
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is disordered and a molecule of pyruvate is found bound at the 
active site in the flavin binding domain. This disorder is 
consistent with movement of the cytochrome domain about a hinge, 
thought to encompass residues 89-103, linking the two domains. 
Mobility of the cytochrome domain relative to that of the flavin was 
first suggested by Gervais et al. [24,25] and later confirmed in a 
solution study of NMR linewidths [26]. The flavin binding domains of 
the two subunits are mainly ordered and are very similar in 
structure. The pyruvate molecule in subunit 2 is assumed to have 
been formed upon oxidation of lactate present in the crystallization 
buffer by turnover of the crystalline enzyme under anaerobic 
conditions [22]. 
1.4.2 THE CYTOCHROME DOMAIN 
The cytochrome domain is composed of a 6-stranded mixed 13 
sheet, surrounded by a helix on one side and two pairs of 
antiparallel helices on the other (Figure 1.6) [22,23]. The latter 
four helices form a hydrophobic pocket containing the heme which 
is located near the interface of the two domains. The heme is bound 
non-covalently and is axially ligated by two histidine residues, 
His43 and His66. The two heme propionates extend towards the flavin 
and form hydrogen bonds with two tyrosine residues, 97 and 143 [22]. 
The cytochrome domain can be isolated, by tryptic hydrolysis of b, 
as a' cytochrome polypeptide of molecular weight 11 kDa, known as the 
b2 core [27]. The gene encoding the cytochrome domain (from residues 
6-100) has been independently expressed in E.coli [28]. 
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FIGURE 1.6 
A REPRESENTATION OF THE b2 CYTOCUROME DOMAIN [221. 
The cylinders and arrows represent the helices and B-strands 
respectively. 
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1.4.3 THE FLAVIN BINDING DOMAIN 
The main structural feature of the flavin binding domain is a 
parallel 138 as barrel contained within residues 191-465 [22,23]. In 
addition, there are 4 short 13 strands and 8 helices outwith the 
barrel (Figure 1.7). The flavin is bound non-covalently at the C-
terminal end of the central 13 barrel and has very little exposure to 
solvent, the only exposed atoms being C4a, N5 and C5a and, to a 
lesser extent, one of the phosphate oxygen atoms. All of the 
hydrogen bonded or polar interactions of the flavin with the protein 
involve atoms which are located on 6 out of the 8 principal 13 
strands. The flavin ring is slightly bent, with an angle of 172 
between the two planes, and is almost coplanar to the heme. The 
shortest distance between the two is 9.7A, between the flavin N5 and 
the edge of the porphyrin ring. 
A region of disorder encompassing residues 301-311 is apparent in 
the crystal structure [23]. This segment corresponds to the main 
protease sensitive region observed in the cleaved enzyme. In 
subunit 1, residues 312-316, in addition to residues 301-311, are 
disordered. The final 25 residues of the flavin domain comprise an 
extended C-terminal tail which wraps around the 4-fold axis and 
forms many intersubunit contacts. It was originally assumed that the 
tail was essential for conserving the tetrameric nature of the 
protein but construction of a mutant form of the enzyme, devoid of 
the final 23 residues proved otherwise [29]. Instead of the 
anticipated monomer, the mutant enzyme was found to be tetrameric 
and, during turnover, dissociation of the flavin prosthetic group 
was observed. It was concluded from these results that the tail was 
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FIGURE 1.7 
A TOPOLOGICAL REPRESENTATION OF THE b2 FLAVIN BINDING DOMAIN 122]. 
THP fl1nDnown I(Vfl 
N - TER? 
........... .... .. see........ esse• see...... 5S55e5 s...se...e . 
The 138 X8 structure is depicted by the numbered rectangles (helices) 
and the arrows (13-strands). The shaded rectangles and circles 
represent the helices outwith the barrel. 
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essential for preserving the structural inte' 
conformation around the flavin. The flavin 
cerevisiae cannot be isolated by proteolytic 
cytochrome domain. Recently however the gene 
has been successfully cloned, sequenced and 
(30]. 
rity of the protein 
domain of b2 from S. 
cleavage as can the 
encoding this region 
expressed in E.coli 
1.5 	THE CATALYTIC MECHANI SM 
1.5.1 GENERAL 
The physiological pathway of electron transfer in 1,2 	is 
unequivocally recognised as that shown below: 
BOUND LACTATE - FLAVIN - HEME - CYTOCHROME c 
The main rate-limiting step in catalysis is abstraction of the 
lactate C2-H as determined by deuterium kinetic isotope effect (KIE) 
studies [31]. In the steady state, the KIE value determined with 
ferricyanide as the electron acceptor is 3.8 [32]. Stopped-flow 
kinetic experiments in which flavin and heme reductions were 
monitored gave KIE values of 8 and 6 respectively showing that 
flavin to heme electron transfer was only partially rate limiting 
[32]. 
1.5.2 ELECTRON TRANSFER FROM LACTATE TO FLAVI N 
1.5.2.1 LACTATE OXIDATION : EVIDENCE FOR A CARBANION MECHANI SM 
The actual mode of lactate oxidation and subsequent electron 
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transfer to the flavin is a topic of much debate in the literature. 
Flavins can transfer electrons singly ,  and as pairs. Thus three 
possible mechanisms can be considered for the two electron 
oxidation of lactate to pyruvate: (i) homolytic cleavage of the C2-H 
bond (a radical mechanism); (ii) hydride transfer and (iii) proton 
transfer with the formation of a carbanion. Although not 
conclusively proven, the general body of consensus favours the 
carbanion mechanism. 
Part of the evidence for the formation of a carbanion 
intermediate in the catalytic mechanism of b2 is derived from the 
observation that some flavo-oxidases catalyse halide ion 
elimination from 3-halo substrates. For example, it was shown that 
D- and L-amino acid oxidases could catalyse the non-oxidative 
transformation of 13-chioroaniline and 2-amino-3-chlorobutyrate to 
pyruvate and 2-ketobutyrate respectively [33,34]. Similarly, the 
reaction of L(+)lactate oxidase with 13-chlorolactate produced 
pyruvate [35]. These results were interpreted in terms of a common 
mechanism whereby the initial step of C2-H abstraction resulted in 
the formation of a carbanion intermediate. In 172, initial 
experiments indicated that non-oxidative elimination of chloride 
from 13-chlorolactate did not occur [31] and it was suggested that 
the carbanion was oxidised too rapidly for chloride ion elimination 
to compete. Dehydrohalogenation did take place during the reaction 
of the oxidised enzyme with bromolactate but was difficult to 
observe due to the low efficiency compared to the normal oxidative 
reaction [36]. However, a study of the reverse reaction, starting 
with reduced enzyme and the halopyruvate, revealed that 
dehydrohalogenation did occur with both bromo and chiorolactate but 
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not with the fluoro compound [37]. Evaluation of the partition 
ratios for the reaction with bromolactate showed that in the forward 
reaction only 1 mole of pyruvate was formed for every 500 moles of 
bromopyruvate whereas in the reverse reaction the ratio was 1 : 2 
[37]. The proposed mechanism for halosubstrate oxidation or 
elimination via a carbanion intermediate is shown in Figure 1.8. 
Since abstraction of the 2-hydroxyacid C2-H is rate limiting in 
the forward reaction, the principle of microscopic reversibility 
requires that C-H bond formation is rate limiting in the reverse 
reaction. A deuterium KIE of 4.4 was duly obtained for the latter 
reaction, using L-[2- 2 H]lactate as the reducing substrate and 
monitoring the rate of bromopyruvate disappearance [38]. There is 
also an inverse isotope effect on bromide ion elimination (pyruvate 
formation), supporting the proposition of a carbanion intermediate 
against that of a hydride. If the elimination of bromide were 
occurring by a hydride mechanism, an isotope effect would have been 
expected for this step as well as for protonation. The observation 
of an inverse isotope effect was ascribed to a branched pathway with 
the carbanion intermediate partitioning between protonation (an 
isotope sensitive route) and elimination (an isotope insensitve 
route). 
The study of intermolecular hydrogen transfer catalysed by t72 
offered further evidence for a carbanion mechanism. Under 
transhydrogenation conditions, in functions as a flavodehydrogenase 
with the heme not participating in electron transfer [36]. The 
enzyme was incubated in the presence of DL-[2- 3H]lactate and 
halopyruvate and was found to catalyse an intermolecular tritium 
transfer from C2 of lactate to C2 of the keto substrate, with 
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FIGURE 1.8 
THE MECHANISM FOR HALOSUBSTRATE OXIDATION (ROUTE A ') OR ELIMINATIQN 
(ROUTE B) VIA A CARBANION INTERMEDIATE. 
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Abbreviations 
E, enzyme; S, substrate; B, active site base; F, flavin; X, halogen. 
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tritium also found in water [38]. If the halogen was bromine or 
chlorine, the pyruvate formed through elimination was labelled at 
C3. The specific amount of radioactivity found on pyruvate was 
five and six times lower than that on bromo and chlorolactate 
respectively but significantly higher than that incorporated into 
water [38]. These results were interpreted as arising from the 
ketonisation, partially on the enzyme and partially in the solvent, 
of an enol pyruvate intermediate formed during the 
dehydrohalogenation reaction [38,39]. Again, these results are 
consistent with a carbanion intermediate and argue against the 
hydride or radical mechanisms. 
Studies with the suicide inhibitior 2-hydroxy-3-butynoate also 
lend support for a carbanion mechanism in in [31,40]. This 
acetylenic substrate is an analogue of lactate and has been shown 
to inactivate several hydroxyacid-oxidising enzymes [41-43]. With 
in, no inactivation occurs under anaerobic conditions but in the 
presence of ferricyanide inactivation does occur as well as 
oxidation. The partition ratio between the two is 1 3200 [40]. 
The proposed mechanism for the inactivation reaction with 2-hydroxy-
3-butynoate is shown in Figure 1.9. After C2-H abstraction to form a 
carbanion, this intermediate can either be oxidised or undergoes 
isomerism to form the allenic carbanion which can then undergo 
nucleophilic attack on the flavin. A study of the reverse reaction 
with reduced enzyme and 2-keto-3-butynoate saw the latter reduced as 
well as inactivation of the enzyme. The partition ratio on this 
occasion was 5 : 1 indicating that protonation of the carbanion 
in the reverse reaction was slow [40]. It therefore appears that 
inactivation and the normal oxidative reaction occur from the same 
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FIGURE 1.9 
THE MECHANISM FOR ENZYME INACTIVATION, VIA A CARBANION INTERMEDIATE, 
BY 2–HYDROXY- 3–BUTYNOATE. 
B: Fog 	 RH Fog 	 RU Fito 





Inactivation occurs from a nucleophilic attack at the flavin N4 by 
the allenic anion, formed by resonance, to form a covalent adduct 
(Route B). Substrate oxidation occurs as in Route A. 
(E, enzyme; S, substrate; B, active site base; F, flavin.) 
{I] 
intermediate. Under anaerobic conditions, no inactivation takes 
place as the acetylenic carbanion is rapidly processed to the keto 
acid which dissociates immediately. With electron acceptors, the 
competition between oxidative processing of the carbanion and 
inactivation after isomerisation is not very efficient as the 
partition ratio is high. 
1.5.2.2 THE MODE OF ELECTRON TRANSFER TO THE FLAVIN 
If one assumes the presence of a carbanion intermediate the 
possibilities for transfer of electrons to the flavin may involve 
radical or covalent intermediates [441 as shown in Figure 1.10. The 
first possibility, Route 1, results in the formation of a 
covalent adduct due to nucleophilic attack by the carbanion at the 
flavin N5. Subsequent cleavage of the adduct, route 5, yields 
pyruvate and reduced flavin. Secondly, there could be one electron 
transfer to the flavin with subsequent coupling of the intermediate 
flavin and substrate radicals to form the covalent adduct (routes 2 
and 3) and finally there could be two one electron transfer steps to 
directly yield reduced flavin and pyruvate (route 4) [3]. The 
coupling of the radical pairs in route 3 would be expected to be 
fast thereby making differentiation beteen route 1 and routes 2 
plus 3 all but impossible. 
Although no intermediates have been detected in b2, two covalent 
intermediates were formed with L(+) lactate oxidase when glycolate 
was used as substrate [45]. With its physiological substrate however 
neither the biradical nor covalent intermediates were detected [46]. 
From analysis of the in crystal structure, it was considered that 
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FIGURE 1.10 
THE POSSIBLE MODES OF ELECTRON TRANSFER FROM THE SUBSTRATE 
CARBANION TO THE FLAVIN (FMN). 
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Route 1 involves nucleophil.ic attack at the flavin N5 to form a 
covalent intermediate. Routes 2 and 3 show formation of a radical 
pair followed by collapse to form a covalent intermediate. This 
intermediate is then fragmented to yield pyruvate and reduced flavin 
(route 5). The third alternative is formation of a radical pair 
followed by a second one electron transfer to give the same products 
(routes 2 and 4). 
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the pyruvate carbonyl was positioned too close to the anionic flavin 
N5 for there not to be a covalent adduct [3]. The formation of the 
adduct with L(+)lactate oxidase and glycolate was cited as evidence 
to substantiate this suggestion. 
A mechanism for the oxidation of L(+)lactate by b2 was proposed 
by Lederer and Mathews [39], based onthe active site configuration 
of subunit 2 in the crystal structure [22,23]. This mechanism 
(Figure 1.11) is assumed to proceed via a carbanion intermediate. 
The existence of a covalent intermediate is at present conjecture. 
The lactate molecule is considered to be bound and orientated by 
electrostatic and hydrogen bond interactions with Arg376 and by 
hydrogen bonding to Tyr143. The substrate C2-H is abstracted by the 
active site base His373 (the rate-limiting step [31]) with formation 
of a carbanion intermediate. The resultant imidazolium ion formed on 
residue 373 is stabilised by Asp282. The carbanion then collapses to 
form an assumed covalent intermediate which is stabilised by Lys349. 
The removal of the hydroxyl hydrogen was originally assumed to be 
catalysed by Tyr254. After the flavin is fully reduced to the 
hydroquinone, electrons are passed, one at a time to the heme with 
formation of a semiquinone intermediate. 
1.5.3 FLAVIN TO JIEME ELECTRON TRANSFER 
The use of the stopped-flow kinetics to investigate the rate of 
reduction of the flavin and heme prosthetic groups in In was 
initiated by Morton et al. [47]. These early studies were carried 
out on cleaved in and showed that electron transfer between the two 
groups was intramolecular as the first order rate constants for 
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FIGURE 1.11 
jjE MECHANISM OF L(+)LACTATE OXIDATION BY b2, BASED ON THE ORIGINAL 
PROPOSAL BY LEDERER AND MATHEWS 11391 .  
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The mechanism shows the reaction proceeding via a carbanion 
intermediate. k2/k-2 is the rate-limiting step in catalysis. The 
presence of a covalent adduct is at present conjecture. 
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flavin and heme reduction were independent of enzyme concentration. 
Rates of flavin and heme reduction were monitored at 470nm and 557nm 
respectively [48-50]. Difficulties were encountered with the choice 
of wavelength for flavin reduction as spectroscopic studies with the 
flavin-free enzyme revealed that at 470nm only around 50% of 
absorbance changes were due to the flavin [491. Even though 
allowances were made for the heme contribution the absorbance of the 
flavin-semiquinone, which is higher than the flavin-hydroquinone at 
this wavelength, was not taken into consideration. In the studies 
detailed in [51], Iwatsubo et al. began monitoring the flavin at 
438.5nm after determining this heme isosbestic point from absorbance 
spectra of oxidised and reduced de-flavo b. 
A thorough characterisation of intramolecular electron transfer 
was made by Capeillère-Blandin et al. [52], combining parallel EPR 
rapid freezing and stopped-flow kinetic studies. The heme isosbestic 
point for monitoring flavin reduction was redetermined as 438.3nm 
and it was demonstrated that absorbance coefficients for both the 
flavin-semiquinone and hydroquinone were the same at this 
wavelength. Absorbance changes at 438.3nm were therefore direct 
representations of variation in the amount of oxidised flavin (the 
ratio of the amount of oxidised flavin / total flavin). This study 
confirmed that, in the absence of an electron acceptor, the enzyme 
takes up three electrons per protomer, 2 by the flavin and 1 by 
the heme. Both flavin and heme reduction time courses were found to 
be the same and biphasic (120 ± 20s 1 , 5 ± 2s 1 and 125 ± 15s 1 , 5 ± 
2s_ 1 ). Phase 1 corresponded to 85% of the total absorbance change in 
flavin and heme reduction and lasted 35ms. Up to - 6mg fully reduced 
flavin was observed. From 6ms - 35ms, the percentages of accumulated 
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redox forms were; 80% reduced heme, up to 50% flavin-semiquinone 
and 25-35% flavin-hydroguinone. This phase corresponds to the 
distribution of two electrons per protomer and is followed by phase 
2. 
Phase 2 was considered to be too slow to be involved in the 
actual turnover of the enzyme and was ascribed to the entry of a 
third electron following interprotomer electron transfer between two 
flavin-semiquinones to generate two oxidised flavins per tetramer. 
(Phase 2 had been observed in a previous stopped-flow study but had 
been dismissed as a contribution from inactive enzyme [501). The 
rate-limiting step of this slow phase was ascribed to the result 
of a conformational change, possibly causing steric hindrance of 
the approaching lactate molecule. The possibility of the rate-
limiting step being dissociation of pyruvate from its complex 
with the flavin-hydroquinone, resulting from one lactate turnover 
per protomer , was discounted as this would also affect the turnover 
rate, contrary to all the available data. 
To rationalise the above results Capeillère-Blandin et al. [52] 
proposed the scheme shown in Figure 1.12 	(for simplicity, the 
enzyme is depicted as a dimer). 	Known kinetic rates were 
supplemented with those obtained through computer simulation [53]. 
The salient features of this model are: reversible flavin to heme 
electron transfer, reversible interprotomer electron transfer 
between flavins and, as previously stated, a conformational change 
as the rate-limiting step of phase 2. 
The Capeillère-Blandin model was based on kinetic data at 
saturating lactate concentrations. Pompon et al. [32,54] refined 
this model, based on their stopped-flow kinetic experiments with 
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FIGURE 1.12 
A SCHEME FOR ELECTRON TRANSFER IN in AS PROPOSED BY cApEILLgRE-
BLANDIN ET AL. 152531. 
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For simplicity, the enzyme is depicted as a dimer; After the 
transfer of two electron pairs to the enzyme, the hemes are reduced 
with subsequent formation of two flavin -semiquinones. Interprotomer 
electron transfer then occurs to form one flavin-hydroquinone and 
one oxidised flavin per dimer. To allow entry of the third electron 
(phase 2), thereby generating fully reduced in, a conformational 
change occurs (as shown by the rectangles). 




varying concentrations of L-[2- 1 H}1actate and L-[2- 2 H]lactate, which 
allowed much lower rates of electron entry. Differences between the 
two models were that in the former scheme the transfer of 
electrons from lactate to flavin was said to occur simultaneously 
for the two protomers in the dimer whereas in the Pompon model this 
was assumed to be random. The limiting step of phase 2 in the Pompon 
model was thought to be the rate of interprotomer electron transfer. 
This was proposed to take place not only between flavin pairs but 
also between heme pairs and from flavin to heme. In the light of the 
crystal structure however, the likelihood of electron transfer 
occurring between two hemes is slim due to the distances involved 
(52.8A) [23]. Also, the Kd of 30 am [55] was considered to be too 
small and it was suggested that the k-i of 2s in the Capeillère-
Blandin model should be in the region of 50-100s' [32]. 
Laser flash photolysis studies of the intact enzyme showed that 
intramolecular electron transfer was only observed in the presence 
of pyruvate even though favourable cofactor orientation and driving 
forces existed [56]. It was therefore proposed that intramolecular 
electron transfer was controlled by conformational changes of the 
protein induced by pyruvate binding. 
The Pompon study was useful in that it provided the first direct 
comparison of stopped-flow studies with the cleaved and intact 
enzymes [32]. Results suggested that proteolysis affected electron 
transfer steps up to and including flavin reduction but not 
intramolecular electron transfer. Deuterium kinetic isotope effects 
for flavin and heme reduction were 8 and 6 respectively for both 
forms of the enzyme. showing that flavin to heme electron transfer 
was only slightly rate limiting. The overall KIE value for the 
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reduction of ferricyanide was lower for the intact enzyme (3.8) than 
for the cleaved enzyme (4.9). 
1.6 	ELECTRON ACCEPTORS 
1.6.1 CYTOCHROME c• 
Bach et al. [57,58] were the first to observe that in could 
reduce cytochrome c, now considered to be its physiological 
acceptor. The b2 heme is the specific donor of electrons to 
cytochrome c [59]. In the steady state, the KIE for cytochrome c 
reduction is 2.3 [60], significantly lower than the value of 6 
observed for heme reduction in the stopped-flow and also lower than 
the value of 3.8 observed for ferricyanide reduction in the steady 
state [32]. 
In both the crystalline state and in solution, in forms a 
stable complex with cytochrome c. The first studies of a crystalline 
in / cytochrome c complex showed that its formation was pH dependent 
and was inhibited at high ionic strength [61]. The binding 
stoichiometry was 1 cytochrome c per in tetramer which was 
unexpected bearing in mind the symmetry and structure of in. Tegoni 
et al. [62], upon diffusing cytochrome c into crystals of intact in 
found a binding stoichionietry of 1 : 1 per in subunit at low ionic 
strength (10mM phosphate). Crystalline in was found to be capable of 
transferring electrons as it could reduce cytochrome c. Even when 
cytochrome c was bound, the time course of flavin reduction was 
unaffected showing that the substrate had free access to the active 
site. At high ionic strength (100mM phosphate) no accumulation of 
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cytochrome c occurred in the b2 crystals. 
Association of cytochrome c with b2 is assumed to occur through 
interactions of the positively charged lysine residues on cytochrome 
c with a negatively charged region on b2. Modifications of these 
lysines resulted in a slight decrease in the binding stoichiometry 
[63]. The most obvious congregation of negative charge in b2 is on 
the C-terminal tail. When the majority of these residues were 
deleted from the enzyme [29], the rate of cytochrome c reduction was 
found to have decreased significantly. An estimation of the Kti for 
cytochrome c binding to this mutant enzyme was over 60-fold higher 
than that for the WT enzyme. It was postulated that, in the tail-
deleted mutant enzyme, either the L I cytochrome c complex does 
not form and electron transfer is second order or that a complex 
does form but cytochrome c is not so well orientated for electron 
transfer. This is being probed with the construction of more mutant 
enzymes, deleting and changing various residues in the C-terminal 
tail of b2 [64]. 
The heme of cytochrome c was replaced with closed shell metals 
such as tin and zinc so as to ascertain the distance between the ly 
heme and that of cytochrome c [651. This was accomplished by 
studying the spectral overlap between the fluorescence of the 
cytochrome c derivatives and the absorbance of the b2 heme. 
The distance was estimated to be in the region of 18A. 
The rate of cytochrome c reduction is ionic strength dependent as 
shown in studies with H. anomala b2. It was also observed that the 
stoichiometry of cytochrome c binding to this enzyme was 1 : 1 per 
In heme [66] and that both the flavin and cytochrome domains could 
independently bind cytochrome c, the acceptor having a greater 
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affinity for the ulavin domain [67,681. 
1.6.2 FERRICYANIDE 
Ferricyanide is the most widely used electron acceptor in steady-
state kinetic studies on b2 and is considered to be able to accept 
electrons from both the flavin and heme prosthetic groups of b2. 
When the heme group is removed from in, electrons are not 
transferred to cytochrome c but the enzyme retains some of its 
ferricyanide reductase activity [59], estimated to be - 64% [691. 
This, coupled with the observation that the isolated flavin domain 
also reduces ferricyanide [67,30] implies that ferricyanide can 
accept electrons from either the flavin-semiquinone or 
hydroquinone. Reduction of the acceptor by the former is estimated 
to be 20-fold higher than by the latter [69]. The use of 
ferricyanide as the electron acceptor also has the added advantage 
that its rate of reduction by b2 is more or less independent of 
acceptor concentration over the range 0.2mM - 3mM. 
1.7 	Lrz FROM Hansenula an oaal a 
in has also been isolated from the yeast Hansenula anomala [70]. 
This protein of subunit molecular weight 56.2 kDa contains 500 amino 
acids and has a sequence identity of 60% with in from S. cerevisiae 
[71]. All the active site residues are conserved. The main 
structural differences between the two enzymes occur in the amino-
acid composition of the regions of S.cerevisiae corresponding to the 
two surface loops, one joining the flavin and heme binding domains 
(encompassing residues 89-103), the other forming a protease 
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sensitive region (300-312). These segments have charges of -1 and 
+4 respectively. In H. anoinala b2 these corresponding regions 
(residues 88-96 and residues 288-298) are not only shorter but are 
considerably more acidic. These changes may be responsible for 
observed differences in reactivity between the two enzymes. Kinetic 
studies on H. anomala L2 revealed that the rate-limiting step was 
different from that in S. cereviaiae l2. In the latter it is 
abstraction of the lactate C2-H, whereas flavin reduction is rate 
limiting in the former enzyme [72]. Overall, the molar activity of 
H. anomala b2 is several times greater than that from S. cerevisiae 
[73]. Unlike the latter enzyme, the cleaved form of b2 from H. 
anoinala is never observed during purification [74] even in the 
absence of PMSF [75]. Also, the flavodehydrogenase domain of H. 
anomala can be isolated following exposure to S. aureus V8 
protease [76]. This is purified as a tetramer of subunit molecular 
weight 39 kDa [77] and retains - 70% of the ferricyanide reductase 
activity of the intact enzyme. 
1.8 	A COMPARISON OF ha WITH RELATED ENZYMES 
The flavin and heme binding domains of b2 show structural 
homology with other FMN containing enzymes and cytochromes 
respectively. b2, along with L(+)lactate oxidase from Myobacterium 
smegmatis, spinach glycolate oxidase and long chain o-hydroxy 
acid oxidase comprise a family of FMN dependent enzymes which 
catalyse the oxidation of a-hydroxy acids and are believed to share 
mechanistic similarities [78]. They differ in that b2 is reoxidised 
by its cytochrome moiety whereas the other members' of the family 
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utilise oxygen as the electron acceptor. 
The amino acid sequence of lactate oxidase has recently been 
solved [79] allowing structural comparisons to be made with 
glycolate oxidase and b2. A sequence comparison of the three 
enzymes revealed 69 conserved residues. These include those which 
have been shown from analysis of the X-ray crystal structures of be  
[22,23] and glycolate oxidase [80,81] to be involved in the binding 
of FMN, substrate binding and catalysis. 
The cytochrome domain of b2 is homologous to microso.al 
cytochrome b5, a heme protein of 11 kDa which forms part of the 
electron transport chain in endoplasmic reticulum membranes [82). 
The two moieties are members of a family of bs like cytochromes 
which exhibit the same backbone folding and heme ligation. Others 
include the heme binding domains of both assimilatory nitrate 
reductase (a flavomolybdohemoprotein) [83] and the 
molybdohemoprotein 	sulphite oxidase 	[84,85] 	as well 	as 
mitochondrial and erythrocyte cytochrome b5 [86,87]. 
The following sections in this thesis detail the characterisation 
of various site-directed mutant forms of in, focussing on 
the roles of interdomain and active site residues. The effects of 
changing one of the heme axial ligands are also described. 
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CHAPTER 2 
THE ROLE OF TYR143 
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2.1 	INTRODUCTION 
In recent years, protein engineering has attained much prominence 
as an invaluable aid towards the understanding of enzyme structures 
and mechanisms. Through the cloning and expression of genes, large 
quantities of protein can be produced, thereby allowing experiments 
that were previously impractical to be carried out. These techniques 
are frequently used in conjunction with site-directed mutagenesis a 
technique, 	which is gradually superceeding that of chemical 
modification, 	that can allow the investigation of specific 
interactions in a protein. 
Successful protein engineering requires the fulfilment of three 
main criteria : a high resolution X-ray crystal structure; a means 
of altering the DNA encoding the protein and finally a good 
expression and purification system [1]. With b2, all of these 
conditions have been satisfied allowing site-directed mutagenesis to 
be employed as a means of studying the roles of various amino acid 
residues in the enzyme [2-4]. The majority of the residues probed 
have been those involved at the active site and those thought to be 
of importance in domain/domain interactions. 
A study of the crystal structure of b2 at 2.4A resolution [5,6] 
reveals that there are two crystallographically distinct subunits in 
the asymmetric unit. In subunit 1, the cytochrome and 
flavodehydrogenase domains are both ordered. In contrast, the 
cytochrome domain of subunit 2 is disordered and, in the 
flavodehydrogenase domain, a molecule of pyruvate is bound at the 
active site. Figure 2.1 shows a comparison of the active sites of 
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apparent dual role of Tyr143. In subunit 1, where the active site 
is occupied by a water molecule (W664), the tyrosine side chain 
forms a hydrogen bond (2.4A) to one of the heme propionates. In 
subunit 2 however the residue is hydrogen bonded (2.8A) to the 
pyruvate carboxylate. Furthermore, when the two active sites were 
superimposed [6], Tyr143 was found to be the moiety with the 
greatest deviation (r.m.s. deviation of 0.4R) between the matched 
subunits. It was therefore considered that Tyr143 might not only 
contribute to substrate binding but could also be involved in 
controlling electron transfer from both substrate to flavin and 
flavin to heme. 
To investigate the role of Tyr143, a mutant form of b2 was 
constructed by site-directed mutagenesis (Dr.M.T.Black). In this 
enzyme, termed Y143F-l2, the tyrosine was substituted with 
phenylalanine (Figure 2.2) so that the residue retained its aromatic 
character but was unable to form a hydrogen bond, either with the 
heme propionate in subunit 1 or with the pyruvate carboxylate in 
subunit 2. The results of a comprehensive kinetic comparison of the 
Y143F mutant enzyme with WT-b2 are presented in this chapter. (A 
preliminary kinetic characterisation of Y143F-l2 has previously been 
carried out [71). 
2.2 	EXPERIMENTAL 
2.2.1 CONSTRUCTION OF Y143F-l2 	(DR. M.T.BLACK) 
Y143F-l2 was generated by site-directed mutagenesis, using the 
double primer method [8], as described in [2] . The oligonucleotide 
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FIGURE 2.2 











used was (GTGGGCCTTCTATTCCT), synthesised on an Applied Biosystems 
model 380B DNA synthesiser. Both the WT and Y143F enzymes were 
expressed in E.coli as reported in [9]. Growth conditions were as 
described in Section 7.1.4. 
2.2.2 ENZYME PREPARATION 
The WT and Y143F enzymes were isolated from E.coli and purified 
as described in Section 7.6.3. The pure enzyme was stored under 
nitrogen, at 0-4 ° C, as a 70% ammonium sulphate precipitate until 
required. 
When pure, both enzymes exhibited a single band at Mr 57000 on 
an SDS-PAGE gel and also gave identical electronic absorption 
spectra (Figure 2.3). Enzyme concentrations were determined 
spectrophotometrically using published extinction coefficients [101. 
2.2.3 	KINETIC ANALYSIS 
All kinetic experiments, unless otherwise stated, were carried 
out at 25 ° C in Tris/HC1 pH 7.50. Buffer concentration was 0.01M in 
HC1 and the ionic strength adjusted to 0.1M with sodium chloride. 
Steady-state kinetic analyses involving the oxidation of 
L(+)lactate by b2 were carried out as described in Section 7.9, 
using either Pye-Unicam SP8-400 or Beckman DU-62 UV/visible 
spectrophotometers. Ferricyanide and cytochrome c were used as 
electron acceptors, reduction being monitored at 420nm and 550nm 
respectively [10,11]. Data were fitted to a linear least means 
squares program to determine kcat and Kn values. 
Stopped-flow kinetic measurements were accomplished as described 
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FIGURE 2.3 
THE UV/VISIBLE ABSORVFION SPECTRUM OF WT-bz. 
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in Section 7.10, using an Applied Photophysics SF.17MV stopped-flow 
spectrophotometer (dead time <. ims). Flavin and heme reductions were 
monitored at 438.3nm and 557nm respectively. A minimum of 5 runs 
were performed at each lactate concentration with the resulting 
traces being fitted to either double exponentials or, as with lob 
concentrations of lactate, single exponentials. 
Kinetic isotope effects were measured using L-[2- 2 H] and L-[2-'HJ 
lactate, the former synthesised and purified as described in Section 
7.8.2.1. 
2.2.4 REDOX POTENTIAL DETERMI NATION 
The midpoint potential of the Y143F-b2 heme group was determined 
spectrophotometrically as described in Section 7.11. The reaction 
was carried out under anaerobic conditions with platinum and Ag/AgCI 
as the working and reference electrodes respectively. 
2.3 	RESULTS AND DISCUSSION 
2.3.1 A COMPARISON OF THE STEADY-STATE KINETIC RESULTS FOR THE NT 
AND Y143F ENZYMES. 
The results of steady-state kinetic measurements on the WT and 
Y143F enzymes with L-[2-'H] and L-[2- 2 H] lactate as substrates and 
ferricyanide and cytochrome c as electron acceptors are presented in 
Table 2.1. Both enzymes exhibited typical saturation kinetics 
(examples are given for the Y143F enzyme in Figures 2.4 and 2.5). 
It is obvious from Table 2.1 that there are some significant 
kinetic differences between the WT and Y143F enzymes. For the WT 
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FIGURE 2.4 
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STEADY-STATE KINETIC PARAMETERS AND DEUTERIUM KINETIC ISOTOPE 








ACCEPTOR ['lILAC 	['lILAC 
	
['lILAC 	['lILAC 




0.49 + 0.05 	0.76 ± 0.06 
	




0.24 ± 0.04 	0.48 ± 0.10 
	
3.0 ± 0.5 




2.90 ± 0.23 	5.14 ± 1.10 
	









CYT.c 	cytochrome c; [ 1 H]LAC, L-[2-'H]lactate; [ 2H]LAC, L-[2- 
2 H] lactate. 
Experi.ental conditions 
All experiments were conducted at 25 ° C in Tris/HC1 buffer pH 7.50, 
I = 0.1M. The concentrations of ferricyanide used were 1mM (>90% 
saturating) with WT-b2 and 8mM (71% saturating) with Y143F-b. 
The cytochrome c concentration was 50uM for both enzymes ( - 90 % and 
>95% saturating for WT-b2 and Y143F-b2 respectively). 
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enzyme with L-[2-'H}lactate as substrate, the kcat values for 
ferricyanide and cytochrome c reduction are 400s 1 and 207s 1 
respectively. A comparison of the corresponding values for Y143F-172 
reveals that although the kcat for ferricyanide reduction is the 
same as for WT-b2, 400s 1 , the rate of cytochrome c reduction is 
only 22s 1 , over 9:-fold less than for WT-bz. The value of kcat 
obtained for ferricyanide reduction by the WT enzyme is 
approximately double that of cytochrome c reduction (see also 
[12,71). This is considered to be a reflection of the different 
pathways of electron transfer to the two acceptors [1,13]. Whereas 
ferricyanide can accept an electron from either the flavin or the in 
heme, cytochrome c can only accept an electron from the latter 
[14]. Consideration of this point leads to the following 
conclusions. As the rate constants for ferricyanide reduction by the 
two enzymes are the same, the decrease in kcat for cytochrome c 
reduction by the Y143F enzyme must be due to a drop in either (i) 
flavin to henie electron transfer or (ii) heme to cytochrome c 
electron transfer. 
The kinetic isotope effect (KIE) values for the two enzymes 
also differ. Previously reported values for the intact WT enzyme 
(with ferricyanide as the electron acceptor) are 3.8 and 4.2, [15,7] 
(although the latter value was obtained under the same experimental 
conditions reported here it was only calculated at one saturating 
lactate concentration). This is consistent with the main rate-
limiting step being abstraction of the lactate C2-H. These 
values compare favourably with that obtained here, 4.7 ± 0.4. The 
KIE value when cytochrome c was used as the electron acceptor is 3.0 
± 0.5, slightly higher than the previously reported value of 2.3 [7] 
52 
(again obtained at saturating lactate concentration only) indicating 
that at least one of the electron transfer steps occurring after 
abstraction of the lactate C2-H, is partially rate limiting. With 
the mutant enzyme, KIE values for the reduction of both acceptors 
are much lower than for WT-, having dropped from 4.7 to 2.0 with 
ferricyanide and from 3.0 to 1.7 with cytochrome c. This indicates 
that there has been a substantial change in the main rate-limiting 
step of enzymic catalysis. 
In the model proposed by Lederer and Mathews [16,13] based on 
the active site structure of b2, Tyr143, in conjunction with 
Arg376, plays an important role in the binding and orientation of 
lactate (see Figure 1.11). The results for the WT and Y143F enzymes 
however indicate that Tyr143 does not contribute significantly to 
the binding of lactate in the Michaelis complex (the lactate Kn has 
been shown to be very similar to the Kd for lactate in the WT enzyme 
[17]). With ferricyanide as the electron acceptor, the K?1 value for 
Y143F-b2 is approximately 6-fold higher than that for the WT enzyme 
(2.90mM and 0.49mM respectively). In terms of binding energy, this 
represents a loss of 4.3kJmol 1 . It is generally accepted that the 
removal of an amino acid side chain which forms a hydrogen bond with 
a charged group on the substrate decreases the binding energy by 
between 14.7kJmol 1 and 25.1 kJmol 1 [18]. The small change 
observed with the Y143F enzyme would seem to preclude the loss of a 
hydrogen bond in the Michaelis complex. It should be noted however 
that, as given in Table 2.1, the Ki with cytochrome c as the 
electron acceptor is the same for Y143F-l2 as it is for WT-b2. 
Since steady-state kinetic parameters such as KM represent a 
combination of kinetic steps, their interpretation is not always 
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straightforward. It is clear that in this case, Kn does not only 
reflect substrate binding but is dependent on the acceptor used. 
Another important difference between the two enzymes is the 
dependence of rate on the concentration of electron acceptor. This 
is most pronounced with ferricyanide. The apparent Ki values for 
ferricyanide and cytochrome c are shown in Table 2.2. With the 
Y143F enzyme, there is a marked ferricyanide concentration 
dependence up to - 8mM resulting in a KM of 3.3 ± 0.6mM (Figure 
2.6). This is much larger than the KM of 0.6mM previously reported 
[7] which was obtained only up to acceptor concentrations of 2mM 
and would account for the low value of kcat (140 ± 10s 1 ) and 
lactate KM (0.65mM) previously reported for the enzyme [7]. No 
ferricyanide concentration dependence above 0.1mM was observed for 
the WT enzyme which is in accordance with previously reported KM 
values of between 5iM and 200 1uM [19-22]. In several of the 
steady-state kinetic experiments with ferricyánide as the electron 
acceptor, double reciprocal plots were obtained yielding different 
values of KM, one at high and the other at low ferricyanide 
concentrations (Figure 2.7). It was not obvious if this was a real 
effect or a reflection of the difficulties and inaccuracies 
encountered when working with low concentrations of acceptor. If 
real, it could be interpreted as an indication of two different 
binding sites for ferricyanide on the Y143F enzyme. It is not at 
present known where on b2 ferricyanide associates but molecular 
modelling studies by Tegoni [23] suggest that one possible site is 
near the domain interface. If one examines the overall charge 
distribution on the enzyme there are no obvious 'clumps' of positive 
charge where ferricyanide might associate. This contrasts with the 
54 
TABLE 2.2 
KM VALUES FOR THE ELECTRON ACCEPTORS FERRICYANIDE AND CYTOCHROME c. 
ENZYME 	 ELECTRON ACCEPTOR 
FERRICYANIDE 	CYTOCHROME c 
KM(mM) 
WT 	 <<0.1 	 10±1 
Y143F 	 3.3 ± 0.6 	3.0 ± 0.5 
All experiments were carried out at 25 °C in Tris/HC1 buffer pH 7.50 
I = 0.1M. The concentration of L(+)lactate was maintained at 10mM 




THE FERRICYANIDE CONCENTRATION DEPENDENCE EXHIBITED BY Y143F-b2. 
(A) PLOT OF RATE AGAINST THE CONCENTRATION OF FERRICYANIDE. 
1' RATE (s'') 
0 	 2 	 4 	 6 	 8 
[FERRIcYMIDEI (103M) 
(B) DOUBLE RECIPROCAL PLOT OF THE ABOVE. 





V 	 08 	 16 	 24 	 3-2 
1/(FERRICYANIDEJ (10 -3 M- 1 ) 
56 
FIGURE 2.7 
THE BIPHASIC I  DOUBLE RECIPROCAL PLOT, OBTAINED WITH SOME DATA SETS, 
FOR THE FERRICYANIDE CONCENTRATION DEPENDENCE EXHIBITED BY Y143F-b. 
Sp 





U 	 09 	18 	27 	36 	4.5 
l/FFERRICYANLDEI (10 -3 M- ') 
57 
negatively charged tail region thought by some to accommodate 
cytochrome c binding [7]. 
The results of steady-state kinetic studies to investigate the 
effects of ionic strength on the ferricyanide concentration 
dependence are presented in Table 2.3. The ferricyanide Kit value 
decreases with decreasing ionic strength, consistent with an 
electrostatic interaction. Although the kcat value drops by 25% upon 
increasing I from 0.1M to 0.2M, there is no difference between the 
values obtained at 0.lM and 0.05M ionic strength. 
The steady-state efficiency of the WT and Y143F enzymes, as 
expressed by kcat/Kt, is shown in Table 2.4. The WT enzyme is 
marginally more efficient with cytochrome c as the electron acceptor 
than with ferricyanide (kcat/KM = 8.62 x 10 5 M 1s' and 8.16 x 
10 5M's 1 respectively), as would perhaps be expected considering 
that it is the physiological acceptor of the enzyme. With Y143F-b2 
the situation has been reversed, the enzyme being 30% more 
efficient with ferricyanide as the electron acceptor than with 
cytochrome c (1.38 x 10 5M 1 s 1 versus 0.96 x 10 5M's 1 ). With both 
electron acceptors, WT-b2 is a considerably more efficient enzyme 
than Y143F-b2 in the steady state. 
2.3.2 A COMPARISON OF THE STOPPED-FLOW KINETIC RESULTS FOR THE MT 
AND Y143F ENZYMES. 
Stopped-flow kinetic studies to investigate the reduction of both 
the flavin and heme groups of the WT and Y143F enzymes were carried 
out with L-[2-'H] and L-[2- 2H] lactate. At high concentrations of 
lactate, biphasic traces were observed for both flavin and heme 
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TABLE 2.3 
VARIATION OF THE FERRICYANIDE CONCENTRATION DEPENDENCE WITH IONIC 
STRENGTH FOR THE Y143F ENZYME. 
IONIC STRENGTH 	 KM 	 kcat 
(M) 	 (mM) (s-i) 
0.2 	 5.64 ± 1.06 	299 ± 29 
0.1 	 3.30 ± 0.57 	400 ± 29 
0.05 	 1.85 ± 0.17 	404 ± 15 
All experiments were carried out at 25 °C in Tris/HC1 buffer pH 
7.50, adjusted to the required ionic strength with sodium chloride. 
The concentration of L(+)lactate was 10mM throughout. 
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TABLE 2.4 
THE STEADY STATE EFFICIENCY OF THE WT AND Y143F ENZYMES, AS 
EXPRESSED BY kcat/KH, WITH L[2-'H} AND L[2- 2H]LACTATE AS 
SUBSTRATES AND FERRICYANIDE AND CYTOCHROME c AS ELECTRON ACCEPTORS. 
ENZYME 	ELECTRON 
	
10 	kcat/Ki (M's') 
ACCEPTOR L-[2-'H]LACTATE 	L-[2- 2 H]LACTATE 
WT 	FERRICYANIDE 
WT 	CYTOCHROME c 
Y143F 	FERRICYANIDE 
Y143F 	CYTOCHROME c 
8.16 ± 0.86 
8.62 ± 1.50 
1.38 ± 0.15 
0.96 ± 0.15 
1.13 ± 0.11 
1.46 ± 0.37 
0.38 ± 0.09 
0.18 ± 0.03 
All experiments were carried out at 25 ° C in Tris/HC1 buffer pH 7.50, 
I = 0.1M. The concentrations of ferricyanide used were 1mM and 8mM 
for the WT and Y143F enzymes respectively. The cytochrome c 
concentration was 50MM. 
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reduction (Figure 2.8), consistent with previously reported studies 
[15,24,25]. The fast phase, which constituted a minimum of 80% of 
the total absorbance change corresponds to the initial reduction of 
flavin and heme by one molecule of lactate. The slow phase is 
thought to correspond to the entry of the third electron [15,25,26] 
since, in the absence of an electron acceptor, each protomer 
requires three electrons for full reduction of the two prosthetic 
groups [15]. The rate constant for this process is approximately 
20-fold less than for the fast phase and therefore, 
physiologically, the slow phase is considered to be kinetically 
irrelevant. Therefore, the data presented here correspond only 
to the fast phase of flavin and heme reduction. Figures 2.9 and 2.10 
show Michaelis-Menten and Lineweaver-Burk plots for some of the 
stopped-flow kinetic data. 
The stopped-flow kinetic studies show that there are several 
major differences between the WT and Y143F enzymes. From Table 2.5 
it can be seen that the kcat for reduction of the WT-b2 heme is 
445s-1 whereas this value has dropped substantially to 21st in 
Y143F-h2. This is all the more pronounced as the kcat for flavin 
reduction in the mutant enzyme is somewhat higher than with WT-b2, 
735s 1 compared to 604s 1 . Not surprisingly there have also been 
changes in the KIE values for flavin and heme reduction. The 
respective values for the WT enzyme are 8.1 and 6.3, consistent with 
the previously reported values for the intact enzyme of 8 and 5.9 
(obtained at 5 ° C in 0.1M phosphate buffer pHi [151). The abstraction 
of the lactate C2-H is therefore rate limiting for flavin 
reduction. There is a small decline in the rate of heme reduction 
compared to that of the flavin (604s' to 445s 1 ) and this is 
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FIGURE 2.8 
STOPPED-FLOW KINETIC TRACES FOR THE REDUCTION OF THE FLAVIN AND HEME 
PROSTHETIC GROUPS OF Y143F-b2 AT A SATURATING LACTATE CONCENTRATION. 
(A) FLAVIN REDUCTION (438.3nm) 
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TABLE 2.5 
STOPPED-FLOW KINETIC PARAMETERS AND DEUTERIUM KINETIC ISOTOPE EFFECT 
VALUES FOR THE RAPID PHASE REDUCTION OF FLAVIN AND HEME IN THE WT 
AND Y143F ENZYMES, 
ENZYME 	PROSTHETIC 	kcat(s 1 ) 
	
KN(]M) 	 HE 
GROUP 	['lILAC 	[ 2 11]LAC 
	
['lILAC 	[ 2 HILAC 
REDUCTION 
WT 	FLAVIN 	604 ± 60 	15 ± 5 
	
0.84 + 0.20 	1.33 ± 0.28 	8.1 ± 1.4 
WT 	115MB 	445 ± 50 	11 ± 5 
	
0.53 ± 0.05 	0.68 ± 0.05 	6.3 ± 1.2 
Y143F 	FLAVIN 	735 ±80 	111 + 10 	2.81 ± 0.30 	3.81 ±0.4 	4.3 ±0,8 
Y143F 	115MB 	21±2 	13±2 	0.19 ± 0.02 	0.37 ± 0.04 	1.6 ± 0.5 
Abbreviations 
['H]LAC, L-[2- 1H]lactate; [ 2 H]LAC, L-[2- 2 H]lactate. 
ExperiRental conditions 
All experiments were carried out at 25 ° C in Tris/HC1 buffer pH 7.50, 
I = 0.1M. kcat values are expressed as the number of prosthetic 
groups reduced per second. 
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reflected in the slight erosion of the KIE for heme reduction. In 
Y143F-b2 however the KIE values have been lowered to 4.3 and 1.6 
for flavin and heme reduction respectively. Although abstraction of 
the C2-H of lactate is still the main rate-limiting step for the 
former, this is clearly not the case for heme reduction. 
In general, there are only small differences in the values of Ku 
for the WT and Y143F enzymes (see Table 2.5). The values evaluated 
by the stopped-flow reduction of flavin are perhaps more realistic 
determinations of Ku than those obtained through steady-state 
kinetics as the number of dependent kinetic steps are minimised. 
This L- [2 -'H] lactate Ku value for Y143F-b2 is 3.3-fold greater 
than that for WT-b2 but corresponds to a loss in binding energy of 
only 3kJmol 1 . It would appear from this result that Tyr143 has an 
inconsequential role in formation of the Michaelis complex. 
2.3.3 	DISCUSSION OF THE COMBINED KINETIC RESULTS 
Rate constants obtained from the steady-state and stopped-flow 
kinetic experiments are given, for both the WT and Y143F enzymes, in 
Figure 2.11 which is a linear representation of the physiologically 
relevant steps in the catalytic cycle of b2. It can be seen that in 
the WT enzyme the rate of electron transfer declines with each 
catalytic step. By the time an electron is conveyed to cytochrome c, 
the rate of reduction is approximately one third of the initial 
flavin reduction rate. These downturns in rate are mirrored in the 
KIE values which drop from 8.1 to 6.3 to 3.0 on flavin, heme and 
cytochrome c reduction respectively (Figure 2.12). The main rate-
limiting step throughout remains abstraction of the lactate C2-H. 
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FIGURE 2.11 
A LINEAR REPRESENTATION OF THE PHYSIOLOGICALLy RELEVANT CATALYTIC 
CYCLE IN b2 SHOWING THE RATE CONSTANTS FOR THE WT AND Y143F ENZYMES. 
LACTATE PYRUVATE 	 CYT c ox CYT c Ito 	 CYT c ox 	CYT c RID 
F01 Hot 	 Fito Hot 	 FsøHi.o F5 Hot 	 FoxH. FozHo i 
VT = 604 ± 60 sI 
Y143F = 735 ± 80 s - I 
WT = 445 ± 50 
Y143F = 21 ± 2 s - I 
© 
VT = 207 ± 10s 1 
Y143F = 22 ± 29' 
Abbreviations 
F, flavin; H, heme; Fsq, flavin-semjqujnone; CYT c, cytochrome c; 
WT, WT-b2; Y143F, Y143F-b. 
67 
FIGURE 2.12 
A COMPARISON OF KIE VALUES FOR THE WT AND Y143F ENZYMES IN THE 
PHYSIOLOGICALLY RELEVANT OATALYT1C CYCLE OF lii. 
WT-i 	 81 ± 14 	63 ± 12 	 3•0 0•5 
LACTATE 	FLAVIN UUØIPHEMEUI.I.I.ØII.CYTOCHROME c 
Y143F-i 	 43 ± 0•8 	1•6 ± 0•5 	17 ± 0•3 
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With the Y143F enzyme the situation is very different. It appears 
that by changing Tyr143 to a phenylalanine the rate of electron 
transfer between the flavin and heme has been disrupted to such an 
extent that this step now becomes the main rate-limiting step in 
catalysis. The first step in the catalytic cycle, electron transfer 
from lactate to flavin is - 22% faster in the mutant enzyme than in 
WT-b2. Although it has already been demonstrated that Tyr143 play s 
no significant role in Michaelis complex formation, this does not 
preclude a contribution from the residue to transition stat. 
stabilisation. It is worth considering at this stage a mechanism 
proposed by Ghisla and Massey [27] for the related enzyme 
L(+)lactate oxidase where Tyr44, the analogous residue to Tyr143 in 
b2, is considered capable of stabilising the carbanion intermediate 
formed after abstraction of the lactate C2-H (Figure 2.13). It 
is thought feasible that the electron pair is delocalised onto the 
carboxylate (as originally suggested in [281) and then relocated to 
the phenolic hydroxyl of the tyrosine. If, as has occurred in the 
Y143F enzyme, the tyrosine was substituted by a phenylalanine, no 
such stabilisation could take place, possibly resulting in an 
alteration of the transition state. For Y143F-b2 the KIE value, 
the magnitude of which reflects the extent of cleavage in the 
lactate C2-H bond during the transition state, for flavin 
reduction is only 4.3 compared with the value of 8.1 obtained for 
the corresponding step in the WT enzyme. 
The transfer of electrons from the flavin to the heme is the step 
which has been most radically altered in the mutant enzyme. The rate 
of heme reduction is 97% lower than that obtained for flavin 
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The carbanion, formed after abstraction of the substrate C 2-H, is 
delocalised to the substrate carboxylate and then relocated to the 
phenolic hydroxyl of Tyr44. 
(1he equivalent residues in b2 are given in parentheses.) 
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is only 1.6 ± 0.5 indicating that flavin to heme electron 
transfer is the predominant rate-limiting step. 
It is as a consequence of the decrease in rate of henie reduction 
that cytochrome c reduction has been affected so much. As cytochrome 
c can only accept an electron from the b2 heme [14] its rate of 
reduction is entirely dependent upon that of the latter. In 
contrast to the WF enzyme, cytochrome c reduction does not 
contribute to rate limitation in the Y143F enzyme. The observed rate 
constants for heme and cytochrome c reduction are identical within 
experimental error as are the corresponding KIE values. 
The elucidation that flavin to heme electron transfer is rate 
limiting in the Y143F enzyme clarifies the origin of the 
ferricyanide concentration dependence seen in the steady state. 
Iwatsubo et al. [22] found a dependence on ferricyanide 
concentration with de-henio b2, the apparent KM for ferricyanide 
being 100-fold greater than that for the WT enzyme. In the absence 
of any heme, which in WT-b2 can donate electrons to ferricyanide, it 
was suggested [221 that the acceptor would take an electron from 
both the flavin-hydroquinone and flavin-semiquinone (electron 
transfer from the latter being 20-fold faster than from the former). 
As a result, the KM for ferricyanide would arise from a contribution 
of the rate constants for electron transfer from lactate to flavin, 
flavin-hydroquinone to ferricyanide and flavin-semiquinone to 
ferricyanide. With Y143F-b2, the scenario is believed to be much the 
same. While the steady-state kcat value for ferricyanide reduction 
is in the region of 400s 1 , that for heme redUction is only 21s 1 . 
It follows then that ferricyanide must be accepting an electron from 
moieties other than the heme. It seems likely that at high 
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concentrations of ferricyanide the heme is completely bypassed. 
Instead, the acceptor takes an electron directly from the flavin-
hydroquinone with subsequent formation of the flavin-semiquinone. 
The latter can then reduce another molecule of ferricyanide as 
illustrated in the scheme of Figure 2.14. 
If one postulates the existence of different electron pathways 
for ferricyanide at high and low concentrations in the Y143F 
enzyme, the biphasic plots of 1/rate against 1/ferricyanide 
concentration observed with some data sets (see Figure 2.7) can be 
rationalised. At high concentrations (when electron transfer is 
unlikely to proceed via the heme) a I(ii of 3.3mM was obtained. At 
low ferricyanide concentrations there is a greater possibility of 
heme reduction occurring so the Kn obtained, which is in the region 
of 0.65mM, would arise from a combination of rate constants 
including that of electron transfer from heme to ferricyanide. It is 
worth noting that 1(xi values which are wholly dependent upon electron 
transfer through the heme, ie. those obtained for cytochrome c and 
In heme reduction, are always lower than the corresponding values 
for flavin and ferricyanide reduction (see Tables 2.1 and 2.4). 
It has been demonstrated in this chapter that as a consequence of 
changing Tyr143 to phenylalanine the rate of electron transfer 
between the flavin and heme prosthetic groups in In has been 
severely curtailed. In determining why the mutation should have such 
a profound effect on catalysis, it is necessary to consider the 
factors which control rates of electron transfer. Of prime 
consideration are: 	(i) the distance between, 	and relative 
orientations of, the participating electron carriers (ii) the 
difference in their redox potentials and (iii) the nature of the 
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FIGURE 2.14 
A SCHEMATIC REPRESENTATION OF THE ELECTRON TRANSFER PATHWAYS FROM 
LACTATE TO FERRICYANIDE AS CATALYSED BY THE WT (ROUTE 1) AND Y143F 
(ROUTE 2) ENZYMES. 
Fox H02 
Fe(C,)/?1  
Fe(CN)8 4 - 
Fsq Ho2 
LACTATE PYRUVATE 
F02 Ho F liD H01 
s H liD 
Fe (CM) e 	 Fe (CM) .3- 
Fe(CN)e 4 - 	
Fe (CN) 4- 
FozH02 
WT-bz (Route 1) : After reduction of the flavjn by lactate, one 
electron is passed to the heme, generating the flavin-semiquinone 
and reduced heme which are both oxidjged by ferricyanjde. 
Y143F-b2 (Route 2) : Electrons are transferred directly from the 
reduced flavin to ferricyanide, bypassing electron transfer to the 
heme. The resulting semiquinone form of the flavin is then oxidised 
by electron transfer to a second ferricyanjde ion. 
(F, flavin; FSQ, flavin-semjqujnone; H, heme) 
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intervening medium. 
The b2 prosthetic groups are almost coplanar, the plane of the 
flavin being inclined by approximately 17 ° to that of the heme [6]. 
The closest distance between the two ring systems is 9.7A. 
Reorganisation energies appear to be minimal in the WT enzyme as no 
change in conformation was observed at 3.OA resolution when crystals 
of the protein were oxidised [6]. 
As the link between residues 100 and 101 is the only covalent 
bonding between the two domains it was assumed [6] that part of the 
electron transfer pathway is through space. Studies on ruthenated 
myoglobin led Mayo et al. [29] to conclude the following order of 
importance for the ease of electron transfer, as governed by the 
intervening medium: aromatic amino acids > non polar amino acids > 
aliphatic amino acids > polar amino acids > water. In 172 there is 
only one aromatic residue bridging the two prosthetic groups, 
namely Tyr143, and it was postulated that this could provide a 
"hopping" pathway for the electrons [6]. It has also been a long 
held belief that aromatic residues may be important in electron 
transfer, acting as "7r-ways". However, the results obtained here 
indicate that there must be some other factor dominant in electron 
transfer between the two domains of b2 other than aromaticity. 
Through computer simulation studies on the WT enzyme [26,30] 
rates of between 500s' and 600s 1 have been estimated for electron 
transfer from flavin to heme. Moser et al. [31] have recently 
established a linear dependence of the free energy optimised rate on 
edge to edge distance. If this was the only factor controlling the 
rate of electron transfer in in, estimates of flavin to heme 
electron transfer would be orders of magnitude greater than those 
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proposed. However, as mentioned previously, the b2 heme domain 
exhibits some degree of mobility [32,61. This implies that the 
closest edge to edge distance of 9.7A between the flavin and heme is 
not fixed. It may well be that a major factor influencing the rate 
of electron transfer in b2 is the recognition process between the 
two domains. 
With the Y143F enzyme it is proposed that the loss of an 
important interdomain interaction has led to an increased mobility 
of the heme domain resulting in inefficient overlap of the 
acceptor/donor orbitals and a general impairment of domain/domain 
recognition. Figure 2.15 shows the relationship of Tyr143 to the 
hydrogen and ionic bonding network in subunit 1 of the b2 crystal 
structure. It is easy to visualise the "knock on" effects to the 
system following the loss of the hydrogen bond from residue 143. It 
is not inconceivable that electron transfer from the flavin could 
occur via the heme propionate. In subunit 1 it lies only 5.7A from 
the flavin N5, connected by a bridging water molecule [6]. Loss of 
the interaction with Tyr143 would most likely result in increased 
mobility of this propionate. The effect could also be transmitted 
through water 685 to the second heme propionate and hence to Lys296. 
The latter two moieties form the only salt bridge between the two 
domains. The significance of this is not yet understood but is in 
the process of being investigated through site-directed mutagenesis 
[33]. 
Another strong possibility to account for the drop in rate of 
flavin to heme electron transfer in Y143F-b2 is that the redox 
potentials of the prosthetic groups have been affected by the 
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and heme in various forms of b2 are listed in Table 2.6. 
The enhanced rate of electron transfer from lactate to flavin and 
the decreased rate between flavin and heme in the Y143F enzyme might 
be compatible with an increase in the flavin redox potential. As the 
flavin and heme potentials are close it would not require much of 
a rise in the former to restrict the driving force for electron 
flow to the heme. Although the redox potential for the Y143F-b2 
flavin group has not yet been evaluated, that of the heme was 
determined in this study. 
Figure 2.16 shows the oxidative titration of the Y143F-b2 heine 
group at 557nm. The Nernst plots for both the oxidation and 
reduction of the enzyme are shown in Figure 2.17. The redox 
potential of -17.3mV obtained from the former is identical within 
experimental error to the potential of the WT-b2 heme, -19mV [35], 
obtained under the same conditions. Determination of the Y143F-b2 
flavin redox potential was attempted but the results were 
inconclusive. Difficulties were encountered as the flavin 
chromophore is obscured by that of the heme and data interpretation 
is hampered as the flavin-semiquinone also contributes ie. it is not 
a straightforward one electron oxidation/reduction as observed for 
the heme. It should be measurable once the ideal conditions have 
been achieved. 
2.4 	CONCLUSIONS 
To conclude, the function of Tyr143 has been probed by generating 
the Y143F mutant enzyme, in which the hydrogen bonding capability 
of the residue has been removed. As a result of kinetic 
77 
TABLE 2.6 
REDUCTION POTENTIALS (mV) FOR FLAVIN AND HEME IN VARIOUS FORMS OF b2 
ENZYME 	Hox/HEED 	Fox/FsQ 	FSQ/FRED 	Fox/FRED 	REF 
Si 10 -94 -34 -64 [341 
Si -19 - - -  
Si 	L12 CORE -28 - - -  
Sx 0±3 - - -  
Sx 6 -50 - - [24] 
Sx 6±2 -44±8 -57 ± 9 -51±16  
Sx in CORE -28 - - -  
Hi -19 ± 5 -23 ± 10 -45 ± 12 -34 ± 10 [38] 
Hi -16 ± 5 -16 -60 -54 ± 10  
Hi 	in CORE -10 ± 5 - - -  
Other potentials 
Lactate/Pyruvate = -190mV 	[421 
Ferri/Ferrocytochrome'c = 273mV [43] 
Abbreviations 
Si, Intact b2 from S.cerevisiae 
Sx, Cleaved in from S.cerevisiae 
Hi, Intact in from H.anomala 
in core, The isolated heme domain 
H,Heme; F,FMN; SQ, semiquinone. 
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FIGURE 2.16 
THE DECREASE IN ABSORBANCE AT 557nm AS THE HEME GROUP OF Y143F—b2 IS 












i1NST PLOTS FOR THE REDUCTION (A) AND OXIDATION (B) OF THE HEME 
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characterisation of this enzyme several conclusions have been 
reached as to the role of the residue in catalysis:- 
Tyr143 is a crucial residue in facilitating the transfer of 
electrons from the flavin to the heme. 
Through substituting Tyr143 with phenylalanine the rate-
limiting step of the reaction has been changed from 
the abstraction of the lactate C2-H, as observed in the WT 
enzyme, to the transfer of electrons between the flavin and 
heme. 
At saturating concentrations, 	ferricyanide only removes 
electrons from the flavin. This contrasts with the WT enzyme 
where ferricyanide can accept electrons from both the flavin 
and heme. 
Tyr143, contrary to the proposed catalytic mechanism, does not 
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CHAPTER 3 
I NTERDOMAI N COMMUNI CATION 
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Li 	INTRODUCTION 
The study of the Y143F mutant enzyme reported in the preceeding 
chapter has demonstrated the importance of interdomain contacts in 
the recognition process between the flavin and cytochrome domains of 
b2 and subsequent electron transfer between the two. In the present 
chapter, further investigations of the interactions of interdomain 
residues through site-directed mutagenesis are reported. 
The cytochrome and flavin binding domains, residues 1-100 and 
101-511 respectively, are covalently linked between the two backbone 
residues 100 and 101 [1]. Local interactions between the two domains 
are formed through a three turn structure composed of residues 98-
101. Twenty four amino acids are involved in long range 
interactions, fifteen from the flavin binding domain and nine from 
the cytochrome domain. Three of these amino-acid residues Tyr97, 
Tyr143 and Phe325 (Figure 3.1) have been substituted with 
phenylalanine, glutamine and alanine respectively (Figure 3.2). 
Although the role of Tyr143 has already been studied through the 
construction and characterisation of Y143F-b2, a different mutation 
was made at position 143 in which the tyrosine was changed to 
glutamine. In contrast to the original mutation, the aromatic 
character of the amino-acid residue has been removed but its 
hydrogen bonding ability has been retained. 
Phe325 is an interface residue in the flavin binding domain. It 
forms hydrophobic contacts with Phe39, Asp42, Pro44 and Tyr74, all 
from the cytochrome domain [1]. A mutant enzyme, F325A-b2 has been 
constructed in which the phenylalanine has been replaced by the non-
aromatic alanine. Initial steady-state kinetic studies on F325A-b2 
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FIGURE 3.1 
THE PO5[TIIONS OF INTERDOMAIN RESIDUES TYR97, TYR143 AND PHE325 IN 
RELATION TO THE FLAVIN AND HEME PROSTHETIC GROUPS OF b2. 
FIGURE 3.2 
THE SUBSTITUTION OF TYR143, PHE325 AND TYR97 WITH GLN, ALA AND PIlE 
RESPECTIVELY TO GENERATE 1143Q-b2, F325A-b2 and Y97F-b2. 
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[2] 	showed 	that 	kcat 	and Kn (L(+)lactate) values, using 
ferricyanide as the electron acceptor, were approximately half and 
double respectively those obtained for the WT enzyme. This was 
attributed to small conformational changes in the enzyme which had 
been transmitted to the active site. 
Tyr97 is a residue in the cytochrome domain and is therefore only 
ordered in subunit 1 of the crystal structure [1]. It forms a 
hydrogen bond (2.4A) to one of the heme propionates (see Figure 
2.15) and also makes a hydrophobic interaction with G1u139 in the 
flavin binding domain. The tyrosine was mutated to a phenylalanine 
to generate Y97F-I2. A preliminary kinetic characterisation [2] 
showed that kcat and Kti (L(+)lactate) values, obtained with 
ferricyanide as the electron acceptor, were identical to those 
obtained for the WT enzyme. The only difference observed between 
the two enzymes was with their inhibition by excess L(+)lactate. 
With WT-b2, saturation occurs at around 10mM L(+)lactate, with 
inhibition by excess substrate occurring after 20mM. With Y97F-b2, 
Vmax was obtained at approximately 6mM L(+)lactate, above which 
inhibition occurred. It was suggested that the mutation had enhanced 
a second, low affinity substrate binding site on in. 
3.2 
3.2.1 CONSTRUCTION OF Y97F-I2, Y143Q-in AND F325A-L2 	(DR. 
M.T.BLACK AND DR. F.D.C.MANSON) 
Y97F-l2, F325A-in (Dr.M.T.Black) and Y143Q-b2 (Dr. F.D.C.Manson) 
were generated by site-directed mutagenesis using the double primer 
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method [3] as described in [4]. The oligonucleotides used were 
synthesised on an Applied Biosystems model 380B DNA synthesiser and 
are listed in parentheses after the corresponding enzyme: Y97F-b2 
(TCCTCCTTTTGCTCCTG), Y143Q- b2 (GCGTGGGCCCAATATTCCTCC) and F325A-b2 
(TATCAAAGGCTATTGACC). All three enzymes were expressed in E.coli 
as reported in [5]. Growth conditions were as described in Section 
7.1.4. 
3.2.2 ENZYME PREPARATION 
The WT, Y97F, Y143F, Y143Q and F325A enzymes were isolated from 
E.coli and purified as described in Section 7.6.3. 
3.2.3 KINETIC ANALYSIS 
All kinetic experiments, unless otherwise stated, were carried 
out at 25 ° C in Tris/HC1 buffer pH 7.50, I = 0.1M. 
Steady-state kinetic experiments were carried out for all three 
enzymes as described in Section 7.9, with both ferricyanide and 
cytochrome c as electron acceptors. Stopped-flow kinetic studies 
were carried out on the F325A enzyme as described in Section 7.10. 
Kinetic isotope effects were measured using L-[2- 1 H] and L-[2- 2 H] 
lactate, the former synthesised and purified as described in Section 
7.8.2.1. 
3.2.4 CIRCULAR DICHROISM 
The WT, Y143F Y143Q and F325A enzymes were analysed by circular 
dichroism as described in Section 7.12. Spectra were recorded in 
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0.1M phosphate buffer pH 7.50 at 25 °C on a Jasco J-600 
spectropolarimeter. The secondary structure content was determined 
(S.Kelly) by applying the CONTIN procedure at mm intervals over 
the range 190nm - 240nm [6]. 
3.3 	THE CIIARACTERISATION OF Y143Q-lx 
3.3.1 RESULTS 
The steady-state kinetic results for the Y143Q enzyme are 
presented in Table 3.1. Corresponding values for the WT and Y143F 
enzymes are also given for comparison. 
Saturation kinetics were only observed at L(+)lactate 
concentrations higher than 400mM with the Y143Q mutant enzyme 
(Figure 3.3). Consistent kcat values were not obtained, 
indicating that the enzyme exhibits some degree of instability. 
With ferricyanide as the electron acceptor the highest observed 
value of Vmax at 400mM lactate was 18s1 but in most data sets 
this value was closer to 3s 1 . The average lactate KM value 
obtained was 65 ± 10mM. The Y143Q enzyme exhibits no significant 
ferricyanide concentration dependence up to acceptor concentrations 
of 8mM (the KM for ferricyanide was < 0.1mM as observed for the WT 
enzyme). When cytochrome c was used as the electron acceptor the 
KM for lactate was very similar to that obtained with ferricyanide 
as the acceptor (Table 3.1). On average, the ratio of the rates of 
ferricyanide and cytochrome c reduction was 1.9 : 1, much the same 
as with the WT enzyme. The KM for cytochrome c (6.8 ± 2.0,uM) was 
also close to that seen with WT-b2 (10 ± 1pM). 
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TABLE 3.1 
STEADY-STATE KINETIC PARAMETERS FOR THE WT. Y143F AND Y143Q ENZYMES 
WITH L-[2-'HlLACTATE AS SUBSTRATE. 
ENZYME 	ELECTRON 
	
L- II 2-' HI LACTATE 
	
ACCEPTOR 
ACCEPTOR kcat(s 1 ) 	Kn(mM) KM 
WT 	FERRICYANIDE 
	
400 ± 10 
	
0.49 ± 0.05 
	
<< 0.1mM 
WT 	CYTOCHROME c 
	207 ± 10 
	
0.24 ± 0.04 
	





400 ± 30 
	
2.90 ± 0.23 
	





22 ± 2 
	
0.23 ± 0.03 
	





* 18 (7.1) 
	







* 95 (3.7) 
	
68 ± 20 
	
6.8 ± 21uM 
* These represent the highest kcat values obtained. Average values 
are given in parentheses. 
All kinetic data were evaluated at 25 ° C in Tris/HC1 buffer, pH 7.50, 
I = 0.1M. For the determination of lactate kcat and KM values the 
concentration of cytochrome c used was 50MM. Ferricyanide 
concentrations were 1mM (WT-ln and Y143Q-b2) and 8mM (Y143F-b2). 
Acceptor KM values were determined at 10mM lactate (WT-b2 and Y143F-
b2) and 400mM lactate (Y143Q-l2). 
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FIGURE 3.3 
(4). PLOT OF RATE AGAINST THE CONCENTRATION OF L-[2-'H]LACTATE FOR 
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It is obvious from these results that the Y143Q enzyme exhibits 
markedly different kinetic behaviour from Y143F-b2. In the latter 
enzyme, flavin to heme electron transfer is the step most affected 
by the mutation. With Y143Q-b however the drop in the value of 
kcat (with ferricyanide as the acceptor) from 400s 1 , in both the WT 
and Y143F enzymes, to a maximum of 18s1 appears to be due to a low 
rate of electron transfer between lactate and the flavin. The 
evidence for this is as follows. Firstly, the ratio of the rates of 
ferricyanide and cytochromé c reduction is the same as for WT-b2. As 
cytochrome c only accepts an electron from the in heme [7] the 
implication is that there is no significant drop in rate as 
electrons flow through the latter. Secondly, there is no significant 
ferricyanide concentration dependence as observed with the Y143F 
enzyme. Ferricyanide must therefore be accepting electrons from the 
flavin-semiquinone and the in heme as in WT-b2. 
These two results suggest that, in contrast to Y143F-I2, there is 
no significant rate limitation in electron transfer between the 
flavin and heme in the Y143Q mutant enzyme (this would of course 
have to be confirmed by stopped-flow kinetic analysis). It would 
seem likely then that in the Y143Q enzyme the glutamine, unlike the 
corresponding phenylalanine residue in Y143F-l2, is able to form an 
interdomain hydrogen bond similar to that formed by Tyr143 in the WT 
enzyme thereby facilitating electron transfer from the flavin to 
the heme. This emphasizes the importance of the hydrogen bonding 
network between the two domains. 
If the Y143Q mutant enzyme had been generated prior to Y143F-l2, 
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one might have considered that the 143 residue played an 
important role in Michaelis complex formation. The lactate KM of 
65mM is over 100-fold greater than the 0.49mM observed for the WT 
enzyme and represents a loss in free energy of 12kJmol 1 . The 
fact that kcat is so low however suggests that there are other 
factors to consider. 
Changing Tyr143 to phenylalanine was a mutation in which 
possible conformational changes at the enzyme active site were 
minimised. This assumption appeared to be justified as there were 
only minor changes in the values of the lactate Ku (increased from 
0.49mM to 2.90mM) and the rate of electron transfer to the flavin 
(increased from 604s' to 735s 1 ) compared to the WT enzyme. With 
Y143Q-b2 there is a much greater likelihood of significant 
conformational changes having taken place as the aromatic residue 
has been replaced by the non-aromatic glutamine. Table 3.2 shows a 
comparison of some of the properties of tyrosine, phenylalanine and 
glutamine [8]. Although the relative hydrophilicity of tyrosine is 
higher than that of phenylalanine, the other parameters listed for 
the two amino acids show reasonable correlation. The volume of the 
glutamine residue is 25% less than those of the aromatic residues 
and it has a slightly lower surface area. Its relative 
hydrophobicity is considerably less than that of tyrosine and 
phenylalanine. If Tyr143 really does play a significant role in 
Michaelis complex formation, the effects should have been detected 
in the kinetics of the Y143F enzyme. The most likely factor to 
account for the high lactate Ku in Y143Q-b2 is that some 
conformational effect has occurred. 
One should also consider the possibility of changes in the 
1,1 
TABLE 3.2 
A COMPARISON OF THE PROPERTIES OF TYROSINE, PHENYLALANINE AND 
GLUTAMINE 181. 
AMINO MASS 	VOLUME ACCESSIBLE RELATIVE * 
	RELATIVE * 
ACID (DALTONS) (A3 ) SURFACE 	HYDROPHOBICITY HYDROPHILICITY 
AREA (A2 ) 	 ( kJ mol') 	(kJ mol') 
TYR 	163.18 	193.6 	230 	 9.62 	 35.6 
PHE 	47.18 	189.9 	210 	10.46 	 13.2 
GLN 	128.14 	143.9 	180 	-1.26 	 49.2 
* Values expressed relative to glycine at pH 7.0. 
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flavin redox potential, brought about by structural alterations in 
the vicinity of the flavin. To account for the low catalytic rates 
the potential of the flavin would have had to have decreased to a 
value close to that of the lactate/pyruvate couple (-190mV [9]). As 
yet, no redox potential studies have been carried out with the Y143Q 
enzyme. 
3 • 3.3 A COMPARI SON OF THE CIRCULAR DICHROI SM SPECTRA OF THE WT, 
Y143F AND Y143Q ENZYMES. 
It has been proposed here that changes in conformation may 
account for some of the kinetic parameters obtained for Y143Q-b2. In 
the absence of a crystal structure, an ideal technique for detecting 
conformational changes is circular dichroism (CD). In the present 
study, CD spectra were acquired for the WT, Y143F and Y143Q enzymes 
to enable direct comparisons of the enzymes to be made. The 
technique of circular dichroism depends on the interaction of 
polarised light with optically active molecules. Although unlikely 
to give absolute information about structure, it is extremely 
sensitive in detecting conformational changes [10]. 
The first reported CD studies on b2 were carried out on the 
cleaved enzyme [11-13]. They showed, as had prior optical rotation 
studies, that the hemè chromophore was modified by the presence 
of flavin in the protein [14]. A direct comparison of the CD spectra 
of intact and cleaved In [15] revealed that the only difference 
between the two was the lack of a dichroic signal in the Soret 
region ( - 423nm (reduced) and 413nm (oxidised)) of the intact enzyme. 
Figure 3.4 shows the CD spectra of the oxidised and reduced WT 
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FIGURE 3.4 
THE CD SPECTRA OF OXIDISED AND REDUCED WT - ba FROM 190nR - 600n. 
BLACK = OXIDISED WT-12 
BLUE = LACTATE REDUCED WT- Lr 
(A) I90n - 260n. 
rel Li 0 
too a 	 Wavelength (ne) 	
200.0 
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enzyme, obtained in the present study. The far UV region, 190nm - 
260nm (Figure 3.4A) reflects the structure of the peptide backbone. 
The spectrum, which shows a maximum at 192nm and minima at -208nm 
and 218nm, undergoes a slight change with oxidation state. The 
flavin is not considered to contribute to the region below 250nm as 
demonstrated by Tsong and Sturtevant [11] who removed the flavin 
prosthetic group from the cleaved enzyme. 
The CD spectrum between 260nm and 500nm (Figure 3.4B) is the most 
detailed region for b2. The heme group contributes from 350n. - 
600nm with the flavin contributing over 250nm. There is some 
uncertainty in the literature as to the origin of the large minimum 
at around 269nm. This band shows a small dependence on the 
oxidation state of the enzyme (it is slightly less intense when 
the enzyme is reduced) [12,13,15], but disappears when flavin is 
removed [11]. It has been variously assigned as a consequence of 
aromatic (tyrosine or tryptophan) residues [11], flavin/aromatic 
residue interactions [121 or of the flavin itself [13,16]. 
The spectra of the oxidised and reduced WT enzyme differ between 
approximately 300nm and 400nm. There is a broad maximum at - 325nm 
and minimum at 375nm in the spectrum of the oxidised enzyme whereas 
that of the reduced enzyme exhibits a broad maximum at -385nm. The 
spectrum of the reduced WT enzyme differs from that previously 
published for the intact enzyme [15,16] in that a small Cotton 
effect is observed in the Soret region (423nm). This signal, which 
occurs in the cleaved enzyme, has been ascribed to interactions 
between the flavin and heme groups as the signal becomes inverted 
when the flavin is removed [11]. Free protoheme IX is CD silent 
[11], so any signals observed must represent either heme/protein 
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interactions and/or heme/flavin interactions. 
The 500nm - 600nm region (Figure 3.4C) is relatively featureless 
when the enzyme is oxidised. When reduced however, the enzyme 
exhibits a dichroic signal with a minimum and maximum at - 550nm and 
558nm respectively. 
The CD spectra of the two 143 mutant enzymes are compared with 
those for WT-b2 in Figures 3.5 - 3.7. In the far UV, 190nm - 260nm 
(Figure 3.5), the spectra for the three enzymes appear similar, 
although that for oxidised Y143Q-b2 (Figure 3.5A) is slightly more 
intense than those for the WT and Y143F enzymes. Table 3.3 shows the 
estimations of the protein secondary structure composition as 
analysed by the Contin programme for secondary structure 
determination [6]. The values for the reduced enzymes correlate 
reasonably well, the main difference being in the percentage of 13-
sheet in the Y143F enzyme. It is uncertain as to how significant 
this result is as CD cannot always detect the various kinds of 13-
turns in a protein [10]. The data for the oxidised enzymes reveal 
that WT-b2 and Y143F-b2 contain (within experimental error) 
identical proportions of both a-helix and 13-sheet. The Y143Q enzyme 
is rather anomalous in that it appears to contain no B-sheet. The 
percentage of a-helix although slightly higher than for the WT and 
Y143F enzymes gives a reasonable correlation within experimental 
error. For all three enzymes, different batches of protein were used 
to determine the spectra of the oxidised and reduced states. It is 
possible that, in the oxidised state, the Y143Q enzyme was more 
unstable and had denatured somewhat (from the steady-state kinetic 
results this enzyme appeared rather unstable as mentioned in Section 
3.3.1). On the other hand, the value could reflect the inadequacies 
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TABLE 3.3 
SECONDARY STRUCTURE DETERMINATIONS FOR THE OXIDISED AND REDUCED WT 
Y143F AND Y143Q ENZYMES. 
ENZYME X a-HELIX % 13-SHEET % 	REMAINDER 
WT (OXIDISED) 51 ± 3 15 ± 4 34 ± 5 
NT (REDUCED) 38 ± 1 31 ± 2 31 ± 1 
Y143F (OXIDISED) 53 ± 1 16 ± 2 31 ± 2 
Y143F (REDUCED) 41 ± 2 19 ± 2 40 ± 3 
Y143Q (OXIDISED) 63 ± 6 0 37 ± 6 
Y143Q (REDUCED) 45 ± 1 27 ± 3 28 ± 2 
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FIGURE 3.5 
A COMPARISON OF THE CD SPECTRA OF THE OXIDISED AND REDUCED WT 
(BLACK)1 Y143F (GREEN) AND Y143Q (RED) ENZYMES IN TILE REGION 190n. 
- 260n.. 
(A) SPECTRA OF THE OXIDISED ENZYMES 
Ce; 
_2 OOO 9OO 
	
ave1ength (nii) 	 800.0 
(B) SPECTRA OF THE REDUCED ENZYMES 
100.0 	 weve1engtr (nm) 
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FIGURE 3.6 
A COMPARISON OF THE CD SPECTRA OF THE OXIDISED AND REDUCED WT 
(BLACK)1 Y143F (GREEN) AND Y143Q (RED) ENZYMES IN THE REGION 260n 
- 500n.. 
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FIGURE 3.7 
A COMPARISON OF THE CD SPECTRA OF THE OXIDISED AND REDUCED NT 
(BLACK) Y143F (GREEN) AND Y143Q (RED) ENZYMES IN THE 500n.-600n. 
REGION. 
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of the CD technique in accurately determining the true amount of 13-
sheet as mentioned previously. 
Figure 3.6 shows the CD spectra of the three enzymes from 260nm - 
500nm. The spectra of both the mutant enzymes exhibit deviations 
from those of WT-bz, the effects being most pronounced when the 
enzymes are in the reduced state. The spectra of oxidised Y143F-
b2 and WT-b2 (Figure 3.6A) are basically the same shape although 
some of the extrema in the former are more intense, for example at 
269nm and 325nm. (In the CD spectrum of the WT/sulphite complex the 
269nm band is also enhanced [161). Although the quality of the 
spectrum of the Y143Q enzyme is not ideal, the peak at 269nm is 
clearly much less intense than for the other two enzymes. The 
effects observed at 269nm in the oxidised spectra are mirrored in 
the spectra of the reduced enzymes for both Y143Q-b2 and Y143F-
I2. Although the origin of this band was previously uncertain, it 
can now be definitively ascribed to interactions between the flavin 
and nearby aromatic residues. In the Y143Q enzyme a tyrosine residue 
situated near the flavin has been replaced with the non-aromatic 
glutamine. This has resulted in a considerable loss of intensity in 
the band at 269nm, the same band that is lost when the flavin 
prosthetic group is removed from the cleaved enzyme [11]. The 
residual band observed in Y143Q at 269nm is most likely to be due to 
interactions of the flavin with Tyr254 and His373. 
The major difference between the WT and the two mutant enzymes 
occurs over the Soret region in the spectra of the reduced enzymes. 
The signal has been inverted and enhanced in Y143F-b2 and Y143Q-In, 
similar to that observed when flavin was removed from the cleaved 
enzyme [11]. As both enzymes still contain flavin, this effect must 
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be interpreted as being due to the loss of a flavin/heme interaction. 
The CD spectrum of H.anomala in also exhibits a positive signal in 
the Soret region, similar to that observed for the two mutant 
enzymes [12,131. It should be noted here that the main rate-limiting 
step in the H. anomala enzyme appears to be flavin reduction rather 
than abstraction of the lactate C2-H as observed in the S. 
cerevisiae enzyme. KIE values for flavin and heme reduction in the 
former were found to be 3.2 and 1.8 respectively [17] considerably 
lower than the values of 8 and 6 obtained for S.cerevisiae in [18]. 
In the region between 500nm and 600nm, the CD spectra of the 
oxidised WT, Y143F and Y143Q enzymes (Figure 3.7A) are relatively 
featureless. The spectra of the reduced enzymes are shown in Figures 
3.7B where it can be seen that that the two mutant enzymes exhibit 
a slightly different spectrum from that of the WT enzyme. In the 
spectrum of the latter, the maximum and minimum are relatively 
symmetrical whereas in the spectra of the two mutant enzymes the 
minimium is more intense than the maximum. 
In conclusion, CD has shown that the substitution of Tyr143 with 
both phenylalanine and glutamine has led to conformational changes 
in the protein. In the Y143Q enzyme, it was considered that a 
hindrance of electron transfer to the flavin was the most likely 
reason to account for the low kcat values. This conclusion is 
compatible with the CD spectrum which shows that a significant 
flavin/aromatic residue interaction has been lost, most likely 
resulting in some distortion at the active site. 
Tyr143 is considered to be an important interdomain residue and 
this is substantiated by the fact that the CD spectra for the 
reduced Y143F and Y143Q mutant enzymes show that a significant 
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flavin to heme interaction has been lost. The CD spectrum of Y143F-
i2 is almost identical (from 260nm - 400nm) to that of H43M-b2 (see 
Chapter 6) in which there is only 5% heme incorporation. This 
implies that there has been a considerable loss of recognition 
between the flavin and heme groups in the Y143F enzyme. The CD 
spectrum of Y143Q-b2 in the same region is comparable to that of the 
WT enzyme. It therefore appears that in the Y143Q enzyme the 
glutamine has been able to form a compensatory hydrogen bond 
elsewhere within the network which Phe143 in Y143F-b2 is unable to 
accomplish. 
3.4 	F325A-bz 
The steady-state kinetic results for the F325A mutant enzyme are 
compared to those for WT-bz in Table 3.4. The Ku (L(+)lactate) and 
kcat values obtained using ferricyanide as the electron acceptor are 
virtually identical to those previously reported [2]. No 
ferricyanide concentration dependence was observed up to 2mM. 
When cytochrome c was used as the electron acceptor, the kcat 
value was just under half ( - 43%) that for ferricyanide reduction. 
This is slightly less, but comparable with, the value of 52% 
obtained with the WT enzyme. The Ku for lactate obtained using 
cytochrome c as the acceptor is much lower than that with 
ferricyanide, as is also seen with WT-ln. Similarly, F325A-l2 is a 
slightly more efficient enzyme with cytochrome c as the electron 
acceptor than with ferricyanide, but is 3.5-fold less efficient as 
a lactate dehydrogenase than is WT-in. KIE values for the F325A 
enzyme determined with L-[2-'H] and L-[2-2H]lactate are slightly 
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TABLE 3.4 
STEADY-STATE KINETIC PARAMETERS AND DEUTERIUM KINETIC ISOTOPE EFFECT 
VALUES FOR THE WT AND F325A ENZYMES. 
ENZYME 	ELECTRON L-(2-'H] LACTATE EFFICIENCY 
ACCEPTOR k,t 	(s') K3 	(EM) kc1t/K(K 1 s - ') 
VT 	FERRICYANIDE 400 	+ 	10 0.49 ± 0.05 8.2 X 10 
WY 	CYTOCUROME c 201 ! 10 0.24 	± 0.04 8.6 I 10 




F325A 	FERRICYANIDE 	215 ± 15 	0.90 ± 0.05 	2.4 I 10 
	
p50+4 	4.3+0.5 
F325A 	CYTOCEROME c 	92 ± 5 	0.35 ± 0.05 	2.6 1 10 
	
$ 36±5 	2.6±0.4 
* Average Vmax values. 
All experiments were carried out at 25 °C in Tris/HC1 buffer pH 7.50, 
I = 0.1M. Ferricyanide and cytochrome c concentrations were 1mM 
and 501uM respectively. 
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lower (with both electron acceptors) than for WT-b2. From the 
steady-state results it seemed that the most likely explanation for 
the lower kcat values obtained for the F325A enzyme was that the 
rate of electron transfer to the flavin had been retarded. 
Stopped-flow kinetics were therefore employed to ascertain the rate 
of flavin reduction and, as Phe325 is an interdomain residue, to 
see if flavin to heme electron transfer had been slowed down. The 
results are presented in Table 3.5. Figure 3.8 shows stopped-f lob. 
kinetic traces for the reduction of both the flavin and heme groups 
of F325A-I2. 
The kcat value obtained for the reduction of the F325A-L72 
flavin is around 35% lower than that for WT-b- (388s' and 604s 1 
respectively). This is reflected in a small erosion of the KIE from 
8.1 to 7.0. With WT-b2, the kcat value for heme reduction is 1.3-
fold less than that of the flavin. With the F325A enzyme, this 
figure increases to 2.3, the values for flavin and heme reduction 
being 388s 1 and 124s 1 . Again, this is mirrored in the KIE for heme 
reduction which drops from 6.3 in the WT enzyme to 5.1 in the 
mutant. The main rate-limiting step in the F325A enzyme remains 
abstraction of the lactate C2-H. 
In the previous study of F325A-b2, the lower rate of ferricyanide 
reduction and the higher Kn for lactate were ascribed to small 
changes in conformation, transmitted to the active site [2]. This 
seems reasonable in view of the decreased rate of electron 
transfer to the flavin. The lower rate of flavin to heme electron 
transfer suggest that some interaction between the two prosthetic 
groups has been lost. This is hardly surprising as substituting 
phenylalanine with alanine is quite a significant change (Table 3.6). 
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FIGURE 3.8 
STOPPED-FLOW KINETIC TRACES FOR THE REDUCTION OF THE FLAVIN AND HEME 
PROSTHETIC GROUPS OF F325A-b2 AT A SATURATING LACTATE CONCENTRATION. 
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TABLE 3.5 
STOPPED-FLOW KINETIC PARAMETERS AND DEUTERIUM KINETIC ISOTOPE EFFECT 
VALUES FOR THE RAPID PHASE REDUCTION OF FLAVIN AND HEME IN THE WT 
AND F325A ENZYMES. 
ENZYME 	PROSTHETIC 	kcat (s) 
	
kcat (s') 	KIE 
GROUP 	L-[2-'H]LACTATE L-[ 2_2 H] LACTATE 
REDUCTION 
WT FLAVIN 604 ± 60 
WT HEME 445 ± 50 
F325A FLAVIN * 388 ± 10 
F325A HEME * 124 ± 3 
	
75 ± 5 	8.1±1.4 
71±5 	6.3±1.2 
* 55 ± 3 	7.0 ± 0.4 
* 24 ± 1 	5.2 ± 0.2 
* Average Viax values. 




A COMPARISON OF THE PROPERTI ES OF PHENYLALANINE AND ALANI NE [8]. 
AMINO 	MASS 	VOLUME ACCESSIBLE RELATIVE * 	RELATIVE * 
ACID (DALTONS) (A3 ) 	SURFACE 	HYDROPHOBICITY HYDROPHILICITY 
AREA (A2 ) 	 ( kJ mol') 	(kJ mol') 
PHE 	147.18 	189.9 	210 	10.6 	 13.2 
ALA 	71.08 	88.6 	115 	2.1 	 1.88 
* Values expressed relative to glycine at pH 7.0. 
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Also, Phe325 interacts with Phe39 and Pro44, residues which form 
hydrophobic interactions with the heme. 
A CD study of the F325A enzyme was carried out to determine the 
extent of any conformational changes that may have occurred as a 
result of substituting Phe325 with alanine. A comparison of the 
spectra of oxidised and reduced F325A-b2 are shown in Figure 3.9. In 
the far UV (Figure 3.9A), the spectrum does not change 
significantly with oxidation state (the estimations of secondary 
structure content are given in Table 3.7, along with the values 
obtained for the WT enzyme). The most significant difference between 
the two spectra in the region from 260nm - 500nm (Figure 3.9B) 
occurs over the soret region where a positive peak is observed with 
the reduced enzyme. As observed with the WT enzyme, the spectrum for 
oxidised F325A-b2 between 500nm and 600nin is relatively featureless 
(Figure 3.9C). When reduced, the enzyme exhibits a dichroic signal 
with a minimum at 551nm and a maximum at 558nm. 
Figure 3.10 shows a comparison of the CD spectra of the reduced WT 
and F325A enzymes over the region 260nm - 600nm. In the soret 
region of the spectrum of F325A-b2 (Figure 3.10A) a similar effect 
to that seen with the Y143 mutant enzymes is observed, that is, an 
inverted, enhanced signal at - 423nm. The spectrum also differs from 
that of WT-b2 between 300nm and 400nm where a relatively flat signal 
is observed, consistent with fairly symmetrical interactions. The 
spectrum of the reduced enzyme from 500nm - 600nm is again more 
comparable to those of the Y143F and Y143Q enzymes than to WT-b2, 
with the minimum more intense than the maximum. 
In conclusion it can be stated that the substitution of Phe325 
with alanine has resulted in the loss of a domain/domain interaction 
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FIGURE 3.9 
THE Cl) SPECTRA OF OXIDISED AND REDUCED F325A-b2 FROM 190n - 600na. 
BIAJE = OXIDISED F325A-b2  
BLACK = LACTATE REDUCED F325A-b 
(A) 190n. - 260n. 
ce 
-25000 so 	
Wavelength (na) 	 250.0 
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TABLE 3.7 
A COMPARISON OF THE SECONDARY STRUCTURE CONTENT OF THE NT AND F325A 
ENZYMES. 
ENZYME 	 % o'-HELIX 
WT (OXIDISED) 	51 ± 3 
WT (REDUCED) 	38 ± 1 
F325A (OXIDISED) 	41 ± 1 
F352A (REDUCED) 	54 ± 3 
% 13-SHEET 	% REMAINDER 






A COMPARISON OF THE CD SPECTRA OF THE REDUCED WT (BLACK) AND F325A 
(BLUE) ENZYMES IN THE REGION 260n - 600na. 
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as indicated by the CD spectra. There appears to have been some 
small conformational effect transmitted to the active site as shown 
by the increased lactate Kn values and the change in the CD 
spectrum over 300nm - 400nm, most likely due to alterations in the 
flavin environment. The aromatic ring does not seem to be too 
important in facilitating electron transfer as catalysis is still 
fairly efficient in its absence. The most probable role for Phe325 
is to contribute to domain/domain integrity and recognition. 
Ii 	Y97F-bz 
Initial characterisation of the Y97F mutant enzyme, using 
ferricyanide as the electron acceptor, revealed that the Kn value 
for lactate and the kcat value for acceptor reduction were the same 
as those obtained for the WT enzyme [2]. The work reported here 
extends the characterisation of Y97F-b2 somewhat to include studies 
with cytochrome c as the electron acceptor and the determination of 
KIE values for acceptor reduction. 
Table 3.8 shows a comparison of the steady-state kinetic results 
for the WT and Y97F enzymes. The kcat and KH values obtained with 
ferricyanide as the electron acceptor are the same for Y97F-b2 as 
for WT-b2, consistent with previously reported values [2]. With 
cytochrome c as the electron acceptor the two kinetic parameters are 
also identical, within experimental error, to those for the WT 
enzyme. There does not appear to have been a significant change in 
rate-limiting step as the KIE values for the two enzymes are very 
similar (KIE values for Y97F-l2 were an average of values at 
saturating lactate concentrations). 
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TABLE 3.8 
STEADY-STATE KINETIC PARAMETERS AND DEUTERIUM KINETIC ISOTOPE EFFECT 
VALUES FOR THE MT AND Y97F ENZYMES. 
ENZYME 	ELECTRON 	L-[2-'llJ LACTATE 
	
kctt/Ki 	L_[2_zllJ LACTATE 	KIE 
ACCEPTOR kt (r') 	K (iM) (10K 1 8' ) kt (r' ) 
WI 	FERRICYANIDE 	400 + 10 	0.49 ± 0.05 
	
8,2 ± 0,9 	86 ± 5 	4.65 	0.29 
VT 	CYTOCHROHE c 	201 +10 	0,24 ± 0.04 
	
8.6 ± 1,5 	70 ± 10 	2.96 + 0.45 
Y9IF 	FERRICYANIDE 	420 ± 20 
	
0,50 ± 0.04 
	
8.4 ± 0.8 	* 98 ± 10 	4,29 ± 0.48 
Y97F 	CYTOCHROME c 	214 48 
	
0,26 ± 0,03 
	
8.2 ± 1.0 	$ 93±9 	2.30 ± 0.24 
* Average Vax values. 
All data were collected at 25 ° C in Tris/HC1 buffer pH 7.50, I = 
0.1M. 
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A significant difference in the steady-state kinetic behaviour of 
Y97F-l2 with cytochrome c as electron acceptor was the value of Kn 
obtained for cytochrome c. This was 41 ± 10 aM, a 4-fold decrease in 
the apparent strength of cytochrome c binding as opposed to the 10 ± 
1 pM obtained with the WT enzyme. The interaction between in and 
cytochrome c is strongly dependent on electrostatic factors. 
Although electrons are only transferred to cytochrome c through the 
in heme [7], the flavin domain is considered to participate in 
cytochrome c binding [19] (stoichiometry of 1 cytochrome c molecule 
per in subunit [201). Tyr97 is hydrogen bonded to the he.e 
propionate that forms a salt bridge with Lys296 and it also makes a 
hydrophobic interaction with G1u139 [1]. The loss of the hydrogen 
bond as a result of changing the tyrosine to phenylalanine could 
have caused a local disruption in the distribution of charge leading 
to a slightly reduced affinity for cytochrome c binding to the 
protein. The flow of electrons from in to the acceptor does not 
appear, from the steady-state kinetic results, to have been affected 
(this could be confirmed by determining the rate of heme reduction 
by stopped-flow kinetics) so any effects must be small. 
From this steady-state kinetic study on the Y97F mutant enzyme, 
it appears that changing Tyr97 to a phenylalanine does not affect 
the rate of electron transfer to either ferricyanide or cytochrome 
c. It does however result in a 4-fold increase in the value of 
the Kn for cytochrome c. 
Although the amino-acid sequences of H.anomala in 	and 
S.cerevisiae in show a 60% homology, Tyr97 is not conserved [21]. In 
the S.cerevisiae enzyme, Tyr97 is contained within a surface loop 
joining the cytochrome and flavin binding domains. The cytochrome 
121 
domain is considered to move about this so called "hinge" region 
(residues 89 -103) [11, hence the disorder in the crystal structure 
and the evidence of mobility in the NMR studies [22]. In 
H.anomala b2 this region only encompasses residues 88-96. It would 
therefore appear that the Tyr97 residue is not of great functional 
significance. 
3.6 	SUMMARY 
Three interdomain residues, Tyr143, Phe325 and Tyr97 were 
investigated through the study of the following mutant enzymes; 
Y143Q, Y143F, F325A and Y97F. The main observations are as follows 
The substitution of Tyr143 with glutamine resulted in an 
enzyme with very low L(+)lactate dehydrogenase activity and a 
high Kn for L(+)lactate. Subsequent CD studies revealed that 
an important flavin/aromatic residue interaction had been 
lost. 
A comparison of the CD spectra of the Y143F and Y143Q 
mutant enzymes with thatfor WT-b2 indicates that a flavin/ 
heme interaction has been lost in the two mutant enzymes. 
Kinetic evidence and CD studies suggest that Phe325 is 
important in domain/domain integrity and recognition. 
Tyr97 does not appear to be a crucial interdomain residue. It 
may however contribute in a small way to cytochrome c binding. 
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ACTIVE SITE RESIDUES 
125 
4.1 	INTRODUcTION 
As outlined in Chapter 1, the X-ray crystal structure of 	12 
enabled the identification of the residues at the active site of the 
enzyme (Figure 4.1) [1,21. This breakthrough, coupled with results 
from solution studies, led to suggestions of possible roles for 
these individual residues in catalysis [3]. The use of site-directed 
mutagenesis as a probe to examine these proposals has been reported 
for three of the active site residues, Arg376, Lys349 and Tyr254 
[4,51. 
Arg376 appears to play a key role in the binding and orientation 
of the substrate through electrostatic interactions and a hydrogen 
bond (3.05A) between the NE moiety of the guanidinium side chain and 
one of the substrate carboxylate oxygens [3]. Replacement of this 
arginine with lysine (to generate R376K-b2) resulted in an enzyme 
seemingly devoid of all lactate dehydrogenase activity [4,6]. 
Although the substrate binding ability of this modified enzyme was 
expected to have been impaired, the total lack of activity was 
surprising. A possible explanation for this was later proposed after 
an investigation of the structure via molecular modelling studies 
[7]. Arg376 is involved in hydrogen bonding, not only to the 
substrate carboxylate but also to the peptide carbonyls of several 
amino-acid residues, Tyr143, Tyr144 and Ser146. It seemed likely 
that the lysine residue would, in attempting to maintain these 
bonds, be unable to interact with the substrate. 
The total lack of lactate dehydrogenase activity exhibited by the 
enzyme in which Lys349 was changed to an arginine (to generate 
K349R-b) [4,6] was not unexpected bearing in mind the proposed 
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FIGURE 4.1 
THE ACTIVE SITE OF SUBUNIT 2 IN Liz, SHOWING BOUND PYRUVATE AND THE 
KEY ACTIVE SITE RESIDUES. 
function of Lys349 [3]. It was considered that after His373 had 
abstracted the lactate C2-H, Lys349 would contribute to the 
stabilisation of the resulting anionic form of the flavin-
semiquinone and hydroquinone. The introduction of the arginine at 
position 349 was thought to have resulted in a repositioning of the 
positive charge, a possible consequence being a change in the flavin 
redox potential. There was concern that the arginine would cause 
overcrowding and change the conformation in the region to such an 
extent that binding of flavin would be restricted. It was however 
confirmed that the enzyme contained its full complement of flavin 
[6]. 
The mutation of Tyr254 proved very fruitful in defining its 
mechanistic role [4,5]. It was originally proposed that the residue 
formed a hydrogen bond to the lactate hydroxyl and facilitated 
electron transfer to the flavin by deprotonation of the former. The 
tyrosine was mutated to a phenylalanine (to generate Y254F-l2) 
thereby removing the hydrogen bonding capability of the side chain. 
Initial studies implied that the tyrosine did not bind to the 
substrate hydroxyl in the Michaelis complex, the lactate I(ii for the 
mutant enzyme being the same as that for WT-ln [4]. However a 
comparison of the Ki value for propionate obtained with WT-b2 
(28mM) [8] and the Ki for lactate obtained with the mutant enzyme 
(0.5mM) suggested that a hydrogen bond was still being formed with 
the substrate carboxyl in the latter. H1s373 was ruled out as a 
possible bonding partner as this might have resulted in lactate 
dehydrogenation via a hydride mechanism, no evidence of which was 
found [5]. The decrease in the kcat value of approximately 40-fold 
in the mutant enzyme is seen as a direct consequence of a decrease 
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in 	transition state stabilisation. This is reflected in a slight 
increase in the steady-state KIE value relative to the WT enzyme. 
There is some doubt as to whether Tyr254 is responsible for 
the deprotonation of the substrate hydroxyl as originally proposed. 
With Y254F-b2 this function must be fulfilled by a buffer ion. A 
similar scenario cannot be ruled out for the WT enzyme [8]. The main 
function for Tyr254 therefore seems to be transition state 
stabilisation (as indicated by kcat/Ki). The phenyl ring does not 
appear to be important in electron transfer as thought prior to 
site-directed mutagenesis. 
Two active site residues which until now had not been 
investigated by site-directed mutagenesis were His373 and Asp282. 
The former is the residue considered responsible for the abstraction 
of the lactate C2-H [3]. It lies above the flavin ring in an 
approximately parallel plane [2] and, from the crystal structure of 
subunit 2, the N2 histidine atom lies within hydrogen bonding 
distance (2.6A) of the pyruvate 02. His373 also forms an important 
interaction through OD1 of Asp282 12.4A), which is responsible for 
securing the histidine in position for abstraction of the substrate 
C2-H. 
To investigate the role of His373, the residue was changed to a 
glutamine to generate H373Q-b2 (some of the properties of the two 
amino acids are compared in Table 4.1). The interaction with Asp282 
would probably be retained through hydrogen bonding of the side 
chain amino group but most importantly, glutamine was not considered 
capable of abstracting the lactate C2-H. 
The supposed role of Asp282 is to anchor His373 as described 
above and also to stabilise the imidazolium ion formed after 
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TABLE 4.1 
A COMPARISON OF SOME OF THE PROPERTIES OF ARGI NINE, LYSINE, 
HI STIDI NE, GLUTAMI NE, ASPARTIC ACID AND ASPARAGINE [9]. 
AMINO MASS 	VOLUME ACCESSIBLE RELATIVE * 	RELATIVE * 
ACID (DALTONS) (A3 ) 	SURFACE 	HYDROPHOBICITY HYDROPHILICITY 
AREA (A2 ) 	 ( kJ mol') 	(kJ mol') 
ARG 156.20 173.4 225 -46.86 93.35 
LYS 128.18 168.6 200 -17.57 49.83 
HIS 137.15 153.2 195 2.09 52.80 
GLN 128.14 143.9 180 -1.26 49.25 
ASP 115.09 111.1 150 -30.96 55.69 
ASN 114.11 117.7 160 -0.84 50.50 
* Values expressed relative to glycine at pH 7.0. 
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abstraction of the substrate C2-H [3]. By substituting the acidic 
residue with the similarly sized, neutral asparagine (to generate 
D282N-1) the stabilising ability of the residue is removed. 
The results presented in this chapter detail the reinvestigation 
of R376K-l2 and K349R-b2 along with the preliminary 
characterisation of H373Q-b2 and D282N-b2 (Figure 4.2 shows the 
relevant mutations). 
4.2 	EXPERIMENTAL 
4.2.1 CONSTRUCTION OF THE MUTANT ENZYMES (DR. M. T. BLACK AND DR. 
F.D.C. MANSON). 
R376K-b2 and K349R-b2 (Dr. M.T.Black) along with H373Q-b2 and 
D282N-b2 (Dr. F.D.C.Manson) were generated using the double primer 
method of Zoller and Smith [101 as described in [4]. The 
oligonucleotides used were synthesised on an Applied Biosystems 
model 380B DNA synthesiser and are given in parentheses after the 
corresponding enzyme: R376K-b2 (GTGGTAAACAATTAGAT), K349R-b2 (GTTATC 
AGAGGTAAA), H373Q-b2 (TCCAATCAAGGTGGTAG) and D282N-b2 (GTCACTGTGAATG 
CTCCAAG). 
All of the mutant enzymes were expressed in E.coli as described 
in [11]. 
4.2.2 ENZYME PREPARATION AND CHARACTERISATION 
The mutant enzymes were isolated and purified as described in 
Section 7.6. R376K-b2 and H373Q-b2 were fully purified, both enzymes 
exhibiting a single band on an SDS-PAGE gel in the same position as 
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FIGURE 4.2 
THE SUBSTITUTION OF ARG376 1 LYS349, H1S373 AND A8P282 WITH LYS, 
ARG, GLN AND ASN RESPECTIVELY TO GENERATE R376K-1,, K349R-b2, H373Q-
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WT-b2. D282N-b2 and K349R-b2 were partially purified up to the 
first 70% ammonium sulphate precipitation. All four mutant enzymes 
exhibited the same UV/visible absorption spectrum as the WT enzyme. 
Steady-state kinetic analyses were carried out at 25 ° C, in 
Tris/HC1 buffer pH 7.50 I = 0.1M, as described in Section 7.9. 
Where appropriate, -the data were fitted to a non-linear least mean 
squares program to determine kcat and Kn values. 
In the case of R376K-b2, the presence of dissociated flavin was 
detected after elution of the enzyme from a Sephadex G25-50 ion-
exchange column equilibrated in Tris/HC1 buffer pH 7.50, I = 0.1M. 
Two distinct bands appeared on the column. The upper, yellow band 
was identified by UV/visible spectroscopy as oxidised flavin, the 
larger, orange band as oxidised enzyme. 
Samples of R376K-b2 and H373Q-b2 were prepared for circular 
dichroism analysis as described in Section 7.12.2. Although spectra 
of the oxidised enzymes were obtained, neither protein could be 
fully reduced with lactate, at the time of spectra collection, due 




The UV/visible spectrum of purified R376K-b2 in the presence of 
lactate was identical to that of the reduced WT enzyme with 
characteristic a, B and Soret bands at 557nm, 528nm and 423nm 
respectively. This was in direct contradiction to the previously 
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reported studies on the R376K enzyme [4,6] in which there was no 
observation of heme reduction at any stage during isolation and 
purification. 
Steady-state kinetic experiments were carried out on the R376K 
enzyme with both ferricyanide and cytochrome c as electron acceptors 
to ascertain the extent of its lactate dehydrogenase activity. The 
results are shown in Tables 4.2 and 4.3. Typical saturation kinetics 
were observed for the enzyme at lactate concentrations up to 150mM 
(Figure 4.3). At higher concentrations substrate inhibition became 
evident. 
What was very apparent throughout the kinetic studies on the 
R376K enzyme was the variation in values of kcat, not only between 
individual preparations but also at different stages of purification 
within the same preparation. Some of the kcat values obtained, along 
with their corresponding Km values, are presented in Table 4.3. 
There does not appear to be any correlation between the magnitude of 
kcat and that of Ku. The highest value of Vmax obtained to date 
was 41s1 (with ferricyanide as the electron acceptor). This was 
immediately prior to elution of the enzyme from a hydroxyapatite 
column. After elution, the most dilute fractions were found to be 
completely inactive while the maximum activity obtained from the 
concentrated fractions was 3s 1 . This drop in activity (>90%) 
far exceeds that seen for the WT enzyme (<<10%) under the same 
conditions. One possible explanation is that the bound flavin is 
able to dissociate much more readily from the mutant enzyme. This 
was confirmed after elution of R376K-b2 from a Sephadex G25-50 gel-
filtration column at pH 7.50 revealed a separate band of oxidised, 
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TABLE 4.2 
A COMPARISON OF STEADY-STATE KINETIC PARAMETERS FOR THE WT AND R376K 
ENZYMES. 
ENZYME 	ACCEPTOR 	 L-[2- 1 H]LACTATE 	ACCEPTOR KM 
kcat,(s') 	K,,i(mM) 
WT 	FERRICYANIDE 	400 ± 10 	0.49 ± 0.05 	<<0.1mM 
WT 	CYTOCHROME c 	207 ± 10 	0.24 ± 0.04 	10 ± 11uM 
R376K 	FERRICYANIDE 	*41 	*56.8 ± 17.1 	<0.1mM 
R376K 	CYTOCHROME c 	*29 	 - 	 5.6 ± 0.5!uM 
*These values represent Vmax at 150mM lactate, saturating for R376K-
b2. 
#This represents an average of Kn values obtained for R376K-l2, 
individual values are presented in Table 4.3. 
All data were obtained at 25 °C in Tris/HC1 buffer, pH 7.50, I = 




kcat AND Kn VALUES FOR THE R376K ENZYME WITH L-[2-'HILACTATE AS 
THE SUBSTRATE AND FERRICYANIDE AS THE ELECTRON ACCEFIOR. 
	
kcat (s'l) 	Km(mM) 
2.46 ± 0.20 	67.3 ± 10.9 
17.60 ± 1.56 	57.3 ± 10.7 
9.10 ± 0.50 	45.7 ± 7.7 
The above data show the variation in values of kcat for R376K-b2, 
obtained at the same stage in different enzyme preparations. There 
appears to be no correlation between the value of kcat and the 
corresponding K?1. 
The results were obtained at 25 ° C in Tris/HC1 buffer pH 7.50, I = 
0.1M. The ferricyanide concentration was 1mM. 
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Control experiments with the WT enzyme at this pH did not result 
in loss of flavin. In subsequent experiments with R376K-b2, assay 
mixtures with added FMN were found to exhibit 5-6% more activity 
than those without, suggesting that flavin dissociation was being 
restricted. 
The average value of Kn obtained for lactate binding to R376K-b2 
was 56.8 ± 17.1mM. This is approximately 100-fold higher than the 
0.49mM obtained for the WT enzyme and equates to a loss in free 
energy of 11.72 ± 3.72kJmol 1 relative to the WT enzyme. Within 
experimental error, this value is more or less equivalent to the 
minimum amount of energy that could be attributed to the loss of a 
hydrogen bond between a charged amino-acid side chain and the 
substrate (normally between 14.7kJmol 1 and 25.1kJmol 1 [121). 
This is consistent with the proposed catalytic mechanism in which 
Arg376 contributes to substrate binding [3]. 
Like the WT enzyme, R376K-b2 does not exhibit a significant 
ferricyanide concentration dependence, the Kn for ferricyanide being 
< 0.1mM. From Table 4.2 it can be observed that the Kn for 
cytochrome c has been enhanced by - 2-fold in the R376K enzyme. 
An unusual feature of the steady state kinetics exhibited by the 
R376K enzyme was the increasing rate of consumption of electron 
acceptor over time seen with many of the assays (Figure 4.4). This 
feature, not observed with the WT-ln or any of the in mutant 
enzymes, was seen with both ferricyanide and cytochrome c as 
electron acceptors and tends to suggest that there is no 
significant dissociation of flavin from the enzyme during turnover. 
The effect could- be interpreted as a consequence of the enzyme 
undergoing some kind of conformational rêorganisation during 
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FIGURE 4.4 
EXAMPLES OF ASSAY TRACES OBTAINED FOR THE REDUCTION OF FERRICYANIDE 
BY R376K-b2. 
TIME 
The solid line represents the increasing rate of ferricyanide 
consumption over time, observed for many of the assays with R376K-
i2 (a similar effect was also seen when cytochrome c was used as the 
electron acceptor). 
The second type of assay trace obtained with R376K-l2 is represented 
by the dashed line, depicting a constant rate of ferricyanide 
reduction over time (as is typically observed with the WT enzyme). 
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turnover to facilitate catalysis. This could also be an example of 
positive homotropic cooperativity, where the binding of one lactate 
molecule to the enzyme increases the affinity of the enzyme for 
other lactate molecules. 
4.3.2 DISCUSSION 
In the R376K enzyme a large increase in the lactate KM value has 
been observed. Although consistent with the proposed participation 
of Arg376 in substrate binding, the KM is perhaps not as large as 
might have been expected, 	especially as Tyr143 does not appear to 
contribute to substrate binding in the Michaelis complex. 	A 
comparison can be made here with the lactate dehydrogenase enzyme 
from Bacillus stearothermophilus where, as in b2, an active site 
arginine has been mutated to a lysine [13]. In this case, the KM for 
lactate increased from 50mM to >1M and the Kit for pyruvate increased 
by 2000-fold, the latter effect accompanied by a 14-fold decrease in 
the value of kcat. It should be noted however that the mode of 
substrate binding differs from that in b2, with the arginine 
forming a planar bifurcated bond with the lactate carboxylate. 
The decreased substrate binding ability of the R376K enzyme, 
compared to that of WT-ln, could be attributed to several factors. 
Arg376 is thought to bind and orientate the substrate carboxylate 
through electrostatic interactions of the guanidinium group and 
hydrogen bonding at N. In replacing it with lysine, a shorter 
side chain has been introduced, probably resulting in a weakening of 
the charge/charge interaction. There is also a significant 
difference in the relative hydrophilicity of lysine and arginine 
i'itI 
(values of 49.83kJmol 1 and 93.35kJmol' respectively (Table 4.1)). 
The difference between the values of the lactate K}i obtained with 
WT-b2 and R376K-b2 is equivalent to a loss in energy of - 11.7kJmol 1 
in the mutant enzyme. This could theoretically be attributed to the 
loss of the hydrogen bond between the substrate carboxylate and 
the guanidinium NE.  It seems probable then that lysine 376 in the 
mutant enzyme does contribute to substrate binding in the Michaelis 
complex but to a far lesser extent than does arginine. This would 
probably mean that the lysine would not be in a position to 
maintain hydrogen bonds to residues in the protein backbone, namely 
Tyr143, Tyr144 and Ser146. These missing interactions could lead to 
conformational changes outwith the vicinity of the active site and 
account for the dissociation of the flavin. One possibility is that 
the conformational effects are transmitted to Arg433 and possibly 
Arg413, key residues which anchor the flavin through the ribose 
phosphate (Figure 4.5). 
The decrease in kcat (for ferricyanide reduction) from 400s 1 
(WT-b2) to a maximum of around 41s 1 in the R376K enzyme is most 
likely a direct consequence of poor substrate orientation. It was 
considered that such an effect could result in the substrate 
molecule being prone to rotation about the C-C axis, possibly to 
such an extent that in D(-) lactate the C2-H could be in a suitable 
position for extraction by His373. D(-)lactate however proved not to 
be a substrate for the R376K enzyme and inhibits catalysis with a 
Ki of 90 ± 15mM (this work). 
Caution should be exercised in interpreting the above results 
due to the loss of flavin from the enzyme. Although 41s 1 was the 
highest rate observed, it is not known if the enzyme contained its 
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FIGURE 4.5 
THE INTERACTIONS OF ARG433 AND AEG413 WITH THE FLAVIN RI BOSE 
PHOSPHATE. 
The substitution of Arg376 with lysine could have resulted in 
conformational effects which have been transmitted to arginines 413 
and 433. As a result, their interactions with the flavin ribose 
phosphate may have been weakened, thereby accounting for the 
dissociation of flavin from the R376K enzyae. 
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full complement of flavin at the time. The same applies for the Kn 
values listed in Table 4.3. The enzyme was not fully active when 
these results were obtained, most likely due to flavin dissociation. 
There does not however appear to be any correlation between the 
magnitude of kcat and the corresponding Kn value. 
4.3.3 CIRCULAR DICHROISM STUDIES ON R376K-I. 
In order to elicit the extent of any conformational changes as a 
result of substituting Arg376 with lysine, CD studies were carried 
out on the R376K enzyme and the spectrum compared to that of WT-b2. 
After full purification, the enzyme exhibited very little lactate 
dehydrogenase activity and could only be partially reduced. 
Therefore, only the CD spectrum of the oxidised enzyme is shown. 
The spectrum of R376K-b2 in the far UV region, 190nm - 260nL, 
(Figure 4.6A) differs slightly from that of the WT enzyme, 
reflecting some differences in the structure of the protein 
backbone. An estimation of the secondary structure content of 
oxidised R376K-b2 is compared to that of the oxidised WT enzyme in 
Table 4.4. The results are similar within experimental error apart 
from the percentage of B-sheet which is greater in the mutant. 
The CD spectra of The oxidised WT and R376K enzymes from 260nm-
500nm are shown in Figure 4.6B. Several differences between 260nm 
and 400nm are immediately apparent. The prominent minimum at 
269nm in the spectrum of the WT enzyme has been almost totally 
lost in the R376K enzyme, 	with only very residual activity 
remaining. 	This is consistent with a loss of flavin from the 
enzyme. The broad maximum at - 325nin in the NT enzyme has been 
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FIGURE 4.6 
A COMPARISON OF THE CD SPECTRA OF THE OXIDISED WT (BLACK) AND R376K 
(ORANGE) ENZYMES IN THE REGION 190n - 500na. 
190na - 260n.. 
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TABLE 4.4 
A COMPARISON OF THE SECONDARY STRUCTURE CONTENT OF THE OXIDISEI) WT 
AND R376K ENZYMES. 
ENZYME 	 %a-HELIX 	% 13-SHEET 
	
% REMAINDER 
WT (OXIDISED) 	51 ± 3 	 15 ± 4 
	
34 ± 5 
R376K (OXIDISED) 	46 ± 1 	 24 ± 2 
	
30 ± 2 
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replaced by two smaller peaks at 305nm and 335nm. 
The spectrum of the oxidised, cleaved WT-b2 in which flavin had 
been removed shows a large peak at 280nm [141 (no such peak is 
observed in the spectrum of R376K-b2). The region from 310nm - 340nm 
is almost flat with a very slight indication of two peaks as 
observed for the R376K enzyme. The soret region of the de-flavo 
enzyme shows a positive peak (inverted from that of the WT enzyme). 
If flavin had dissociated from the mutant, an inverted signal would 
have been expected in this region. It should be noted however that 
in the Y143F and Y143Q mutant enzymes where a flavin to heine 
interaction has been lost an invertion of this signal is only 
observed in the spectra of the reduced enzymes. Also, to date, no 
spectrum has been recorded for the intact de-flavo b2. A comparison 
of this with that of the R376K enzyme would really be necessary 
to draw firm conclusions as to which aspects of the R376K-l2 
spectrum are due to the mutation and which are due to the loss of 
flavin. The spectrum of oxidised R376K-b2 from 500nm - 600nm (not 
shown) is relatively featureless as is that of the WT enzyme. 
To summarise, it appears that Arg376 may play an important role in 
substrate binding in the Michaelis complex. It also appears to be an 
integral component in preserving conformational integrity as 
substitution of this residue with lysine leads to the dissociation 
of the flavin prosthetic group resulting in loss of activity. This 
could partly account for the total lack of activity reported in the 
previous study, in other words, if the flavin had dissociated 
completely, no lactate dehydrogenase activity would have been 
detected. In future it would be interesting to quantify the loss of 
flavin from the enzyme and equate it with the loss of activity. It 
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may also be possible to reincorporate the flavin to ascertain the 
maximum rate of acceptor reduction and the corresponding Ki for 
lactate. 
44 	K349R-b2 
Although this enzyme was previously reported to be completely 
inactive [4,6] the work presented here reveals that it possesses a 
residual amount of lactate dehydrogenase activity. A UV/visible 
spectrum of the fully reduced enzyme was obtained only after 
saturation with lactate under anaerobic conditions. Purification of 
the enzyme was restricted due to the inability of the enzyme to bind 
to a hydroxyapatite column under the conditions employed for the WT 
enzyme (0.1M phosphate pH 7.0, I = 0.22M). 
The maximum observed rate of ferricyanide reduction by R376K-b2 
at 20mM lactate and 1mM ferricyanide was 0.129s' (Table 4.5). This 
represents a drop in rate of - 3000-fold relative to the WT enzyme. 
Preliminary assays with cytochrome c as the electron acceptor (at a 
concentration saturating for WT-b2) showed that the rate of 
reduction was on average 12-fold slower than for ferricyanide. 
The surrounding environment of Lys349 is a tightly packed, low 
dielectric, solvent inaccessible region of the enzyme. Therefore, 
introducing the bulkier arginine into this area could result in 
gross structural changes as suggested in [4], detrimental to the 
lactate dehydrogenase capability of the enzyme. 
Reduction of the flavin primarily affects C4a, N5 and Ni of the 
isoalloxazine ring. Lys349 is assumed to stabilise the Ni anion, the 
degree of stabilisation being an important factor in governing the 
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TABLE 4.5 
A COMPARISON OF STEADY-STATE KINETIC RATES FOR THE WT, K349R AND 
H373Q ENZYMES. 
ENZYME 	ELECTRON 	kcat(S 1 ) 	FERRICYANIDE CYTOCHROME 
ACCEPTOR c REDUCTION RATES 
WT FERRICYANIDE 400 ± 10 
{ 	 1.93 	1.00 
WT CYTOCHROME c 207 ± 10 
K349R FERRICYANIDE *0.130 
{ 	 11.8 	1.00 
K349R CYTOCHROME c *0.011 
H373Q FERRICYANIDE 
{ 	 2.50 	: 	1.00 
H373Q CYTOCHROME c * - 0.04 
* These values represent the highest rate at 20mM lactate. 
* These values represent the highest rate at 10mM lactate. 
Ferricyanide and cytochrome c concentrations were 1mM and 50 1uM 
respectively. All data were acquired at 25 ° C in Tris/HC1 buffer, 
pH 7.50, I = 0.1M. 
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flavin redox potential. In changing Lys349 to an arginine, a 
decrease in this value might be expected as it is unlikely that the 
arginine would be as well positioned as the lysine to stabilise the 
flavin Ni anion. As a result the rate of flavin reduction would be 
lowered, consistent with the very low rates of acceptor reduction 
observed for the K349R enzyme. This scenario does not however 
account for the decrease in the rate of cytochrome c reduction, 
relative to ferricyanide, by the mutant enzyme (Table 4.5). By the 
same reckoning the rate of electron transfer to the heme and hence 
to cytochrome c should be enhanced, contrary to what is observed. 
One possibility is that cytochrome c binding is somehow restricted 
in the mutant enzyme resulting in inefficient electron transfer to 
the acceptor. 
4.5 	H373Q-bz 
Removing the active site histidine and replacing it with a 
glutamine resulted in an enzyme devoid of all but residual lactate 
dehydrogenase activity. This is consistent with the crucial role 
ascribed to the residue in catalysis where it is considered to act 
as an active site base, abstracting the substrate C2-H [3]. 
The maximum rate obtained with 1mM ferricyanide and 10mM lactate 
was in the region of 0.1s 1 (Table 4.5), a 4000-fold decrease 
compared to the kcat of the WT enzyme. The ratio of the rates of 
ferricyanide and cytochrome c reduction was 2.5 : 1, similar to that 
obtained for the WT enzyme (1.93 : 1). 
Although glutamine was chosen to replace histidine so as to 
minimise any possible conformational effects (Table 4.1), CD studies 
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of H373Q-b (Figure 4.7) show that there have been significant 
changes in the vicinity of the flavin (as with R376K-b2 only the 
CD spectrum of the oxidised enzyme was acquired). In the region from 
260nm - 500nm (Figure 4.7B), the prominent peak observed at 270nm 
in the WT enzyme, ascribed to flavin/aromatic residue interactions, 
has been all but lost. In fact the spectrum of oxidised H373Q-b2 
over this region closely resembles that of Y143Q-b2 and shows 
certain similarities to the spectrum of the oxidised R376K enzyme 
(Figure 4.6B). The CD spectrum from 190nm-260nm is practically 
identical to that of oxidised WT-b2 as shown in Figure 4.7A. The 
composition of secondary structure in the mutant enzyme is given in 
Table 4.6. 
The above results have substantiated the proposition that His373 
is a crucial active site residue. Replacement with glutamine, which 
is considered to be unable to abstract the lactate C2-H, results in 
an enzyme with only residual activity. The lack of this histidine 
residue, which lies above the flavin in almost the same plane, has 
resulted in the loss of flavin interactions as indicated by the CD 
spectrum. The presence of a full stoichiometric complement of flavin 
in the mutant enzyme was not established. This would have to be 
checked before the results could be unequivocally attributed to the 
loss of the histidine and consequential conformational effects. 
j 	D282N-1 
As with K349R-b2 and H373Q-b, the D282N mutant enzyme retains 
only residual lactate dehydrogenase activity. No saturation kinetics 
were observed during assays at lactate concentrations of up to 400mM 
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FIGURE 4.7 
A COMPARISON OF THE CD SPECTRA OF THE OXIDISED WT (BLACK) AND H373Q 
(DASHED) ENZYMES IN THE REGION 190n - 500nR. 
190n. - 260n. 
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A COMPARISON OF THE SECONDARY STRUCTURE CONTENT OF THE OXIDISED WT 
AND H373Q ENZYMES. 
ENZYME 	 %a-HELIX 
	
% B-SHEET 	% REMAINDER 
WT (OXIDISED) 	51 ± 3 
	
15±4 	 34±5 
H373Q (OXIDISED) 	64 ± 2 
	
13±2. 	 23±3 
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(Figure 4.8), the reaction effectively being second order. At 400mM 
lactate the rate with 1mM ferricyanide as the electron acceptor was 
- 0.3s' and, with cytochrome c, 0.25s 1 . 
Although aspartic acid and asparagine are of similar steric bulk 
(Table 4.1), the former, negatively charged residue, has been 
replaced by a neutral one. This loss of charge effectively means 
that the imnidazolium ion formed at His373 after abstraction of the 
substrate C2-H cannot be stabilised by charge relay to the 
asparagine. The most likely explanation for the lack of activity of 
D282N-b2 is that the pKa of the histidine has shifted resulting in a 
lack of abstraction of the lactate C2-H. 
£1 	CONCLUSIONS 
Results from these studies on four site-directed mutant enzymes 
are consistent with the roles proposed for the residues Arg376, 
His373, Lys349 and Asp282 in the catalytic mechanism. From the 
results presented here, Arg376 seems to plays an important role 
in substrate binding and orientation in the Michaelis complex. It 
also appears to be necessary for conserving conformational 
integrity as mutation of this residue to lysine results in 
the dissociation of flavin from the enzyme. 
It has been shown that the substitution of three key active site 
residues Lys349, His373 and Asp282 results, in each case, in 
enzymes which are almost totally catalytically inactive. This 
underlines the importance of these residues. 
Although attempts were made to minimise the effects of 
substituting an amino acid residue, it would be rather naive not to 
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FIGURE 4.8 
PLOT OF RATE AGAINST THE CONCENTRATION OF L-[2-'jI]LACTATE FOR THE 
REDUCTION OF FERRICYANIDE BY D282N-l2. 




84 	 168 	252 	336 




expect any conformational effects in a region as sensitive as the 
active site. CD studies have shown that some conformational changes 
have occurred in the H373Q enzyme including the loss of a 
flavin/aromatic residue interaction. Conformational effects are also 
considered to account for the loss of flavin in R376K-b2. It is 
assumed however that the majority of the kinetic results for the 
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SUBSTRATE SPECIFICITY AND INHIBITION 
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5.1 	INTRODUCTION 
Prior to the elucidation of the In crystal structure, studies of 
possible substrates and inhibitors of catalysis were useful aids iii 
acquiring information about substrate specificity and the active 
site of the enzyme. With the advent of site-directed mutagenesiR, 
these studies can be carried out to detect any changes iii 
specificity at the enzyme active site as a result of mutating a 
specific amino-acid residue. 
Enzyme specificity studies are typically carried out by using 
compounds whose structures are based on that of the physiological 
substrate but with differing structural or functional features. The 
degree of substrate specificity depends on three main factors: (a) 
the chemical structure of the compound, (b) the reaction type and 
(c) the stereochemistry. As regards the latter point, enzymes are, 
on the whole, very specific towards a particular stereoisomer [1]. 
This is perfectly illustrated in the case of in where the 
physiological substrate is L(+)lactate. D(-)lactate on the other 
hand is a competitive inhibitor and is completely inactive as a 
substrate [2-5]. 
It was established by Dikstein [6] that the basic structural 
requirements for a substrate of In were an a-hydrogen, an a-hydroxy 








THE BASIC STRUCTURAL REQUIREMENTS FOR A SUBSTRATE OF in. 
159 
further, steric, requirement was noted after it was discovered 
that a-hydroxy-iso-valerate (Figure 5.2) was a strong inhibitor of 




'.7\ o 	CH 2CH,cjH 
C H3 
-HYDROXY- I SO-VALERATE 
Although the first three criteria for a substrate are fulfilled, the 
bulky methyl groups prevent catalysis. A further example of steric 
interference is with mandelate (Figure 5.3A). This is an inhibitor 
of lactate oxidation [6] whereas f3-phenyllactate (Figure 5.3B) which 
has a CH2 group between the aromatic ring and the ar-carbon is a 
substrate [4]. 
FIGURE 5.3 






MANDELATE 	 L3-PHENYLLACTATE 
Overall, in exhibits a broad substrate specificity as shown in Table 
5.1 [6,7,8,9]. 
In the work presented in the first part of this chapter, a number 
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SUBSTRATES OF 1,2 
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of substrates of varied a-carbon chain length, as illustrated in 
Figure 5.4, were used to probe the specificity of several b2 mutant 
enzymes namely Y97F, Y143F, Y254F and F325A. (Some data with DL-
glycerate as a substrate (R = CH20H) is also included for Y143F-b2 
and F325A-b2). Part of this study was carried out in conjunction 
with a final year honours project submitted by S.Pealing [101. 
The second part of the chapter consists of a study of the Y97F, 
Y143F and F325A mutant enzymes with the inhibitors D(-)lactate and 
oxalate. Inhibition by excess substrate (L(+)lactate) is also 
discussed. 
5.2 	EXPERIMENTAL 
5.2.1 CONSTRUCTION OF THE POINT MUTANTS (DR. M. T. BLACK) 
The Y97F, Y143F and F325A mutant enzymes were generated by 
Dr.M.T.Black as described in Sections 2.2.1 and 3.2.1. Y254-b2 was 
similarly constructed using the oligonucleotide (CCAACTATTTGTTAACTC) 
as reported in [111. All the above enzymes and WT-b2 were expressed 
in E.coli as described in [12]. 
5.2.2 ENZYME PREPARATION 
All enzymes were fully purified as described in Section 7.6.3. 
Immediately prior to use, the protein was fully oxidised by elution 
from a Sephadex G25-50 gel filtration column equilibrated with Tris/ 
HC1 buffer, pH 7.50, I = 0.1M. All substrates used were 50:50 
racemic mixtures as described in Section 7.8. The inhibitors used 
are as listed in Section 7.8.3. 
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FIGURE 5.4 
b2 SUBSTRATES OF VARIED p-CARBON CHAIN LENGTH. 
O 	 0 
L(+) 	 D(-) 
H O 
/ e ' c ci_uuhb0H 	 e 
I
C_C..IIII H 4? 	\ 
O R 
R 	 SUBSTRATE 	 n (NUMBER OF CARBON 
ATOMS IN R) 
H 	 GLYCOLATE 	 0 
CH3 	LACTATE 	 1 
CH2CH3 	2-HYDROXYBUTYRATE 	2 
(CH2 ) CH3 	2-HYDROXYCAPROATE 	4 
(CH2 )s CH3 	2-HYDROXYOCTANOATE 	6 
All substrates were 50:50 racemic mixtures. 
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5.2.3 KINETIC ANALYSIS 
Steady-state kinetic analyses were carried out at 25 ° C in 
Tris/HC1 buffer pH 7.50, I = 0.1M, as described in Section 7.9. 
In the substrate study, the concentration of ferricyanide used 
as the electron acceptor for the WT, Y97F, Y254F and F325A enzymes 
was 1mM and for Y143F-b2, 8mM. Typical saturation curves were 
observed in all cases. Kinetic parameters were either obtained 
graphically or else the data were fitted to a non-linear least mean 
squares program. 
The inhibition studies were carried out with 1mM ferricyanide as 
the electron acceptor for the WT, Y97F, Y143F and F325A enzymes. The 
one exception was inhibition of Y143F-b2 by excess L(+)lactate where 
8mM ferricyanide was used. Inhibition with D(-)lactate and oxalate 
was accomplished either by varying inhibitor concentrations at fixed 
non-saturating lactate concentrations, or by varying the lactate 
concentration at set inhibitor concentrations. Ki values were 
evaluated graphically where appropriate. 
5.2.4 CIRCULAR DICUROISM 
The WT and Y143F enzymes were prepared for circular dichroism 
analysis as described in Section 7.12. Spectra were recorded at 
25 °C, in 0.1M phosphate buffer, pH 7.50, on a Jasco J-600 
spectropolarimeter. Spectra of the WT and Y143F enzymes with 
oxalate were obtained by adding a concentrated, buffered solution of 
oxalate to a final concentration of 0.8mM and 18mM (estimated Ki 




Values of kcat and Ki obtained with the various substrates are 
presented in Tables 5.2 - 5.6 for the WT, Y97F, Y254F, Y143F and 
F325A enzymes. Although there are minor differences within each 
enzyme, the overall trends with increasing ci-carbon chain length are 
very similar. This is best represented in Figure 5.5 which shows how 
the efficiency, as expressed by kcat/Kn (see also Tables 5.2 - 5.6) 
of each enzyme varies with the number of carbon atoms in R. 
Glycolate, with simply a hydrogen replacing the lactate methyl 
group, is a very poor substrate for all the enzymes. Efficiency 
rises to a maximum with lactate and then falls off to 2-
hydroxybutyrate and 2-hydroxycaproate. There then follows a sharp 
rise in the efficiency of the enzymes with 2-hydroxyoctanoate as 
substrate. This rise is mainly as a consequence of the low K?1 
values. 
The kcat value for WT-b2 is at a minimum for glycolate (n = 0) 
and a maximum for lactate (n = 1). It then falls off as n increases 
until 2-hydroxyoctanoate (n = 6) where there is a slight rise (Table 
5.2). This is consistent with previously reported values for 
glycolate, lactate, 2-hydroxybutyrate and 2-hydroxycaproate as 
listed in Table 5.1 [6,7,8,9]. The KM for lactate (0.79mM) is higher 
than for all the other substrates apart from 2-hydroxybutyrate 
(1.51mM). 
Overall, the results obtained with the Y97F and Y254F enzymes 
(Tables 5.3 and 5.4 respectively) are very much as expected, based 
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FIGURE 5.5 
PLOT OF EFFICIENCY (kcat/K) OF THE WT Y97F, F325A Y143F AND Y254F 
ENZYMES AGAINST THE NUMBER OF CARBON ATOMS IN THE SUBSTRATE R GROUP. 
iO kcat/Kn 
(M's') 
NUMBER OF CARBON ATOMS IN R 
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TABLE 5.2 
STEADY-STATE KINETIC PARAMETERS FOR WT-b2 WITH VARIOUS SUBSTRATES 
SUBSTRATE 	 kcat 	 KM 	10 3 kcat/KM 
(s') (mM) (M 1 s 1 ) 
L(+)LACTATE 400 ± 10 0.49 ± 0.05 816 ± 85 
GLYCOLATE 6.89 ± 1.00 0.34 ± 0.05 20.3 ± 4.2 
DL-LACTATE 325 ± 20 0.79 ± 0.10 411 ± 56 
DL-2-HYDROXYBUTYRATE 79.1 ± 4.0 1.51 ± 0.15 52.4 ± 5.8 
DL-2-HYDROXYCAPROATE 19.4 ± 3.0 0.31 ± 0.05 62.6 ± 14 
DL-2-HYDROXYOCTANOATE 46.4 ± 3.0 0.22 ± 0.05 211 ± 50 
DL-GLYCERATE 40.4 ± 5.0 13.43 ± 1.00 3.0 ± 0.4 
All results were obtained at 25 ° C in Tris/HC1 buffer, 	pH 7.50, I = 
0.1M. The electron acceptor was 1mM ferricyanide. 
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TABLE 5.3 
STEADY-STATE KINETIC PARAMETERS FOR Y97F-b2 WITH VARIOUS SUBSTRATES 
SUBSTRATE kcat Ki 
(s') (mM) 
L(+)LACTATE 400 ± 20 0.50 ± 0.04 
GLYCOLATE 7.4 ± 0.3 0.48 ± 0.10 
DL-LACTATE 325 ± 5 0.68 ± 0.10 
DL-2-HYDROXYBUTYRATE 86.8 ± 3.0 1.16 ± 0.25 
DL-2-HYDROXYCAPROATE 19.1 ± 1.0 0.25 ± 0.04 
DL-2-HYDROXYOCTANOATE 49.5 ± 2.0 0.18 ± 0.04 
10 3 kcat/K 
(M's 1 ) 
800 ± 75 
15.4 ± 3.3 
478 ± 71 
74.8 ± 16.3 
76.4 ± 12.9 
275 ± 62.1 
All results were obtained at 25 ° C in Tris/HC1 buffer, pH 7.50, I = 
0.1M. The electron acceptor was 1mM ferricyanide. 
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TABLE 5.4 
STEADY-STATE KINETIC PARAMETERS FOR Y254F-b2 WITH VARIOUS SUBSTRATES 
SUBSTRATE 
	
k a t 
	 Kn 
	10 k at 
(s') (mM) (M- 's- ') 
L(+)LACTATE 
	
13.5 ± 1.0 
	
0.53 ± 0.03 
	
25.5 ± 2.4 
GLYCOLATE 	 0.17 ± 0.02 
DL-LACTATE 	 11.0 ± 0.5 
DL-2-HYDROXYBUTYRATE 2.62 ± 0.10 
DL-2-HYDROXYCAPROATE 0.51 ± 0.02 
DL-2-HYDROXYOCTANOATE 1.43 ± 0.05 
0.25 ± 0.03 
1.28 ± 0.50 
1.02 ± 0.11 
0.34 ± 0.04 
0.30 ± 0.06 
0.68 ± 0.11 
8.59 ± 3.38 
2.57 ± 0.29 
1.50 ± 0.19 
4.77 ± 0.97 
All results were obtained at 25 ° C in Tris/HC1 buffer, pH 7.50, I = 
0.1M. The electron acceptor was 1mM ferricyanide. 
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TABLE 5.5 
STEADY-STATE KINETIC PARAMETERS FOR Y143F-b2 WITH VARIOUS SUBSTRATES 
SUBSTRATE kcat Kn 10 3 kcat/Kn 
(s-i) (mM) (M's) 
L(+)LACTATE 400 ± 30 2.90 ± 0.23 138 ± 15 
GLYCOLATE 18.3 ± 0.5 1.91 ± 0.14 9.58 ± 0.75 
DL-LACTATE 357 ± 11 4.41 ± 0.36 81.0 ± 7.1 
DL-2-HYDROXYBUTYRATE 111 ± 6 7.21 ± 0.71 15.4 ± 1.73 
DL-2-HYDROXYCAPROATE 37 ± 2 3.01 ± 0.28 12.3 ± 1.32 
DL-2-HYDROXYOCTANOATE 54 ± 3 1.92 ± 0.27 28.1 ± 4.25 
DL-GLYCERATE 104 ± 10 45.5 ± 11.0 2.29 ± 0.60 
All results were obtained at 25 °C in Tris/HC1 buffer, pH 7.50, I = 
0.1M. The electron acceptor was 8mM ferricyanide. 
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TABLE 5.6 
STEADY-STATE KINETIC PARAMETERS FOR F325A-b2 WITH VARIOUS SUBSTRATES 
SUBSTRATE kcat KM 10 3 kcat/KM 
(s') (mM) (M's') 
L(+)LACTATE 220 ± 10 0.92 ± 0.05 239 ± 17 
GLYCOLATE 7.26 ± 0.51 1.15 ± 0.06 6.31 ± 0.55 
DL-LACTATE 184 ± 8 1.43 ± 0.05 128 ± 7 
DL-2-HYDROXYBUTYRATE 49.8 ± 2.0 1.92 ± 0.10 25.9 ± 1.7 
DL-2-HYDROXYCAPROATE 19.4 ± 2.2 0.48 ± 0.03 40.4 ± 5.2 
DL-2-HYDROXYOCTANOATE 48.2 ± 3.1 0.39 ± 0.04 123 ± 15 
DL-GLYCERATE 3.50 ± 0.20 5.75 ± 1.00 0.61 ± 0.11 
All results were obtained at 25 ° C in Tris/HC1 buffer, pH 7.50, I = 
0.1M. The electron acceptor was 1mM ferricyanide. 
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on a comparison of their KM and kcat values (L(+)lactate) with those 
for WT-b2. For the Y97F enzyme these values are identical to those 
for WT-b2 (kcat = 400s 1 , KM = 0.49mM, see also [131). A comparison 
of the values in Tables 5.2 and 5.3 reveals that, with all the 
substrates listed, kcat and KM for both enzymes are identical within 
experimental error. With Y254F-b2, the Kii for L(+)lactate is 
identical to that with WT-bz while the kt value is approximately 
30-fold less (see also [9,111). A comparison of Tables 5.4 and 5.2 
reveals that there are no major differences between the KM values of 
Y254F-b2 and WT-b2 for the substrates listed. Values of kcat are 
proportionally lower than for lactate in both enzymes. 
With the Y143F and F325A enzymes there are many differences in 
the substrate Kn and kcat values as compared to WT-b2 (Tables 5.5, 
5.6 and 5.2). For the sake of clarity a direct comparison of 
values for the three enzymes is made in the form of a bar chart 
(Figure 5.6). KM values for the Y143F enzyme are higher than those 
for WT-ln with all substrates tested, consistent with the higher 
value obtained for L(+)lactate (2.90mM versus 0.49mM). In all cases 
kcat values are also higher than in WT-fr2. It was shown in Chapter 2 
that electron transfer from lactate to flavin is faster in the 
Y143F enzyme than in WT-b2 (735s 1 versus 604s 1 ) so the higher kcat 
values are consistent with this observation. When glycolate is 
used as the substrate, the Y143F enzyme exhibits no ferricyanide 
concentration dependence. The rate of ferricyanide reduction is 
18.3s 1 , lower than that of the Y143F heme (21s 1 )(see Chapter 2) so 
presumably with this substrate the electron transfer pathway is the 




BAR CHART COMPARING kcat AND Kn VALUES, OBTAINED WITH VARIOUS 




For the F325A enzyme, the kcat values obtained with glycolate, 2-
hydroxycaproate and 2-hydroxyoctanoate are the same (within 
experimental error) as those for WT-b2. KM values for these three 
substrates are all lower than for lactate. The kcat of 48.2s1 
obtained with 2-hydroxyoctanoate, combined with a KM of 0.39mM 
(Table 5.6) means that the F325A enzyme is almost as efficient a 
2-hydroxyoctanoate dehydrogenase as it is a lactate dehydrogenase. 
The Km for glycerate with F325A-b2 is considerably lower than for 
WT-b2 (5.75mM versus 13.43mM) as illustrated in Figure 5.5. The 
enzyme turnover number suffers as a consequence, the kcat value of 
3•51 being approximately li-fold less than that for the WT 
enzyme. The overall efficiency of F325A-b2 with glycerate as the 
substrate is 5-fold less than for WT-b2 (Tables 5.2 and 5.6). 
5.3.2 DISCUSSION 
What is apparent from these studies is that although lactate 
generates the best kcat value it does not bind as well to the 
enzymes, in the Michaelis complex, as some of the other substrates. 
If the theory of Fischer, the so called "lock and key" analogy of 
the protein and substrate, was applied, one would expect lactate to 
be bound most strongly, that is, enzyme/substrate complementarity 
[141. Nowadays the suggestion of complementarity between the enzyme 
and the transition state, first conceived by Haldan€ and later 
developed by Pauling, is the most adhered to theory [15,16]. The 
substrate, on binding, changes to the transition state and then to 
products. If the enzyme retains its structure throughout, it cannot 
be complementary to all forms of the substrate. If the enzyme is 
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complementary to the substrate, binding will be strong in the 
Michaelis complex (low Ki) but will decrease as the transition state 
is formed. This results in an increase in the activation energy and 
therefore a low kcat value. On the other hand, if the strength of 
binding increases in the transition state, the activation energy 
will be lower as a consequence. It therefore appears that high 
values of Kn are necessary for the maximisation of turnover, that 
is, it is kinetically more favourable to have a high Kn as kcat 
is maximised [17]. 
Glycolate (n = 0), 	2-hydroxycaproate 	(n = 4) and 	2- 
hydroxyoctanoate (n = 6) bind better to WT-b2 and the mutant 
enzymes than does lactate. Their kcat values however are very much 
lower. This could be a reflection of non-transition state 
complementarity or it might be due to physical factors such as 
redox potentials higher than the lactate/pyruvate couple of -190mV 
[18]. For example, glycolate, which has the lowest kcat values, has 
a redox potential of only -90mV [19] so the driving force for 
electron transfer is lowered. 2-hydroxybutyrate does not bind 
strongly to the enzymes but has a reasonable kcat value. This 
suggests that its transition state shows a greater resemblance to 
that of lactate than do the transition states of the other 
substrates. 
Why is it then that the two longer chain 2-hydroxyacids, 2-
hydroxycaproate and 2-hydroxyoctanoate, bind so well to the mutant 
and WT enzymes? A study of b2 using molecular graphics revealed that 
there is a hydrophobic channel running below the active site [101 
This extends from Tyr254 along to Tyr97 as shown in Figure 5.7 and 
encompasses Leu230, Ala198, Leu199 and Leu202. It was suggested that 
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FIGURE 5.7 
THE HYDROPHOBIC CHANNEL BELOW THE bz ACTIVE SITE. 
The channel extends from Tyr254 
A1a198, Leu199 and Leu202. 
to Tyr97, encompassing LeuZ30, 
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this could be where the long chain 2-hydroxyacids were interacting 
[101. It also appears that the propionate groups of the heme occupy 
part of this channel at some stage during catalysis. It was proposed 
that the lower kcat values obtained for these larger substrates 
could be due to product dissociation and subsequent orientation of 
the heme for electron transport. Table 5.7 shows the steady-state 
kinetic parameters for the WT enzyme with 2-hydroxyoctanoate as 
substrate and cytochrome c as the electron acceptor. The ratio of 
the kcat values obtained for ferricyanide and cytochrome c reduction 
is 1.35 : 1 with 2-hydroxyoctanoate as the substrate. This is less 
than the ratio of - 2 : 1 as observed with L(+)lactate and implies 
that there is no significant rate limitation in transferring 
electrons to the heme when 2-hydroxyoctanoate is used as the 
substrate. 
5.3.3 	SUMMARY 
To summarise, this study was carried out with substrates of 
varied ac-carbon chain length to investigate their interactions 
with various site-directed mutant forms of b2. The main 
observations are given below. (For simplicity, 2-hydroxyoctanoate, 
2-hydroxybutyrate and 2-hydroxycaproate are referred to simply as 
octanoate, butyrate and caproate). 
For all 5 enzymes kcat increased as shown: 
glycolate < caproate < octanoate < butyrate < lactate 
(n0) 	(n=4) 	(n6) 	(n2) 	(n1) 
As regards Kn values, the general trend was 
butyrate > lactate > glycolate > caproate > octanoate 
(n=2) 	(n1) 	(n0) 	(n=4) 	(n=6) 
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TABLE 5.7 
STEADY-STATE KINETIC PARAMETERS FOR THE NT ENZYME WITH DL-2-HYDROXY-
OCTANOATE AS SUBSTRATE AND CYTOCHROME c AS THE ELECTRON ACCEPTOR, 
SUBSTRATE 
	
kcat (s'') 	kcat (s 1 ) 
(FERRICYANIDE) (CYTOCHROME c) (CYTOCHROME c) 
L(+)LACTATE 
	
400 ± 10 	207 ± 10 	10 ± 1 
DL-LACTATE 
	
325±20 	 - 	 - 
DL- 2 -HYDROXYOCTANOATE 
	
46.4 ± 3.0 	34.1 ± 3.4 	1.5 ± 0.6 
All results were obtained at 25 ° C in Tris/HC1 buffer, pH 7.50, I = 
[IWIP 
Ferricyanide and cytochrome c concentrations were 1mM and 501uM 
respectively. 
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With the Y143F enzyme however, Kn decreased as 
butyrate > lactate > caproate > glycolate = octanoate 
(n=2) 	(n1) 	(n=4) 	(n0) 	(n=6) 
The Y97F enzyme behaves as WT-b2 with all the substrates tested. 
Ki values for Y254F-b2 are the same as for the WT enzyme with 
all substrates tested. 
The substrate specificity of F325A-b2 has altered somewhat 
as the 	enzyme is almost as efficient an octanoate 
dehydrogenase as it is a lactate dehydrogenase. 	With 
glycerate, the F325A enzyme is more complementary to the 
substrate than to its transition state as both the glycerate 




A preliminary study was carried out to examine the effects of 
inhibitors on the catalysis of lactate by the Y97F, Y143F, and 
F325A mutant enzymes. The inhibitors used were D(-) lactate 
and oxalate. With the WT enzyme, high concentrations of 
L(+)lactate, the physiological substrate, inhibits catalysis [2]. 
Inhibition by the substrate at high concentrations was also 
investigated for the three mutant enzymes. 
There are four modes of inhibition; competitive, non-competitive, 
uncompetitive and mixed [20]. These are illustrated graphically in 
Figure 5.8, either as 1/rate versus 1/substrate plots in which 
inhibitor concentration is varied at set substrate concentrations, 
or 1/rate versus the concentration of inhibitor plots in which 
substrate concentration is varied at set inhibitor concentrations. 
A competitive inhibitor is one which competes with the substrate 
for the active site. Only Kn is affected by competitive inhibition, 
apparently increased by a factor of (1 + [I]/Ki) (see Appendix 1). 
With non-competitive inhibition, substrate and inhibitor bind to the 
enzyme at the same time but do not compete for the active site. Kn 
is unaffected but kcat decreases by (1 + [I]/Kx). In cases where 
both Ki and kcat are altered, the inhibition is termed mixed. 
Uncompetitive inhibition occurs when the inhibitor binds, not to 
the enzyme, but to the enzyme-substrate complex. 
A number of inhibitors of in are known, the vast majority being 






GRAPHICAL REPRESENTATIONS OF THE VARIOUS MODES OF INHIBITION. 
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p-toluenesulphonate [6] and sulphite, the latter being the 
strongest known inhibitor of hz, with a Ki of 0.0014mM [22]. It 
inhibits competitively by forming a reversible covalent adduct with 
the flavin N5. High concentrations of L(+)lactate inhibit the 
intact S.cerevisiae (Ki = 130mM [21) and H.anomala (Ki = 45mM [231) 
enzymes but not the cleaved form of the former. It has been 
suggested that this inhibition arises from a second, lower affinity 
substrate binding site or different substrate binding modes at the 
active site [2,21,24]. As a result of a study concerning the 
inhibition of H.anomala in by pyruvate [25], it was suggested that 
substrate inhibition was due to the binding of excess substrate, not 
only to the oxidised enzyme but also to a second, transient, form 
involved in turnover, probably the flavin-semiquinone. Pyruvate 
inhibits catalysis by binding to the semiquinone, thereby changing 
the redox potential and preventing electron transfer to acceptors 
[25]. 
D(-)lactate has been shown to be a competitive inhibitor of in in 
all reported studies [2-5]. The inhibition is independent of pH [5] 
and it has been proposed that D(-)lactate binds independently of the 
Tyr254 hydroxyl group [21]. With L(+)lactate, this moiety is 
considered to anchor the lactate molecule, ensuring that the C2-H 
is correctly orientated for abstraction by His373 [9]. It is thought 
that with D(-)lactate, the inhibitor hydroxyl group is positioned 
within hydrogen bonding distance of the flavin N5 and 04 [21]. 
Oxalate is one of the strongest inhibitors of in [261 and is a 
well established inhibitor of enzymes that oxidise lactate [19]. 
Early work suggested that inhibition was competitive [2,3] and 
showed that the strength of oxalate binding was pH dependent, for 
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example the Ki was 2mM at pH 7.6 and 0.022mM at pH 5.5 [3]. However, 
subsequent, more detailed studies revealed that the inhibition was 
mixed [22,26]. 
5.4.2 	INHIBITION BY EXCESS L(+)LACTATE 
The results of inhibition by excess substrate, L(+)lactate, are 
shown in Table 5.8. Ki values (the amount of inhibitor bound at 
which the rate is half of the maximum) are quoted along with Sopt 
(the concentration of substrate at which the maximum rate is 
obtained). Graphical representations of the inhibition of the WT 
enzyme are shown in Figure 5.9. 
As would be expected, Sopt varies in proportion to Ki. The Ki 
is lowest for the Y97F enzyme (141 ± 15mM) and highest for Y143F-b2 
(324 ± 14mM). The WT-b2 value of 175 ± 7 is slightly higher than 
the previously reported value of 130mM [2]. Excluding Y97F-b2, Ki 
values with the various enzymes increase as follows; WT-b2 < F325A-
i2 ( Y143F-b2. Superficially, the observed trends are that Ki is 
proportional to the Kn for L(+)lactate and inversely proportional to 
the rate of heme reduction. A comparison of the rates of heme 
reduction with the Ki for L(+)lactate is made for the WT, F325A, 
Y143F and Y254F enzymes in Table 5.9. 
The most straightforward way of interpreting these results would 
be in terms of a second, lower affinity substrate binding site. It 
has already been suggested that mutating Tyr97 to a 
phenylalanine could have caused a slight enhancement of this site 
[13]. Similarly, it could be postulated that the substitution of 
Phe325 by alanine and Tyr143 by phenylalanine might have resulted in 
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TABLE 5.8 
Ki AND Soit VALUES FOR INHIBITION OF THE NT, Y97F Y143F AND F325A 
ENZYMES BY EXCESS L(+)LACTATE. 
ENZYME Ki(m14) Sopt 	(mM) 
WT 174±8 10 
Y97F 141 ± 15 6.9 
Y143F 324 ± 15 15-18 
F325A 216 ± 10 12 
All results were obtained at 25 °C in Tris/HC1 buffer, pH 7.50, I = 
0. 1M. 
The electron acceptor was 1mM ferricyanide for the WT, Y97F and 
F325A enzymes and 8mM ferricyanide for Y143F-b2. 
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FIGURE 5.9 
INHIBITION OF THE WT ENZYME BY EXCESS L(+)LACTATE 
PLOT OF RATE AGAINST THE CONCENTRATION OF L-[2-'HJLACTATE. 
SpRATE (s- ') 
0 	 42 	 81 	 126 	 168 
(L(+)LAcmTE) (1034) 
PLOT OF 1/RATE AGAINST THE CONCENTRATION OF L-[2--'H]LACTATE. 
1/R'iTE (10s) 
5 
1 Kir  
D 




A COMPARISON OF THE RATE OF HEME REDUCTION WITH THE Ki FOR 
L(+)LACTATEII FOR THE NT, Y143F, Y254F AND F325A ENZYMES. 
ENZYME 	 RATE OF HEME REDUCTION 
(s') 
WT 	 *445 ± 50 
F325A 	 124 ± 3 
Y143F 	 * 21±2 
Y254F 	 12.9 ± 0.8 
L(+)LACTATE 
Ki (mM) 
174 ± 8 
216 ± 10 
324 ± 15 
NO INHIBITION[21] 
All results were obtained at 25 ° C in Tris/HC1 buffer, pH 7.50, I = 
0.1M except [21]. 
*k t values. 
The rates of heme reduction for the F325A and Y254F enzymes were 
obtained at 10mM lactate. 
The electron acceptor for the evaluation of Sopt was 1mM 
ferricyanide for WT-bz and F325A-b2 and 8mM ferricyanide for Y143F-
b2. 
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restricted access of lactate to this site or lowered its affinity as 
attested by the Ki values being higher than that for WT-!n (216mM 
and 325mM respectively for the two mutant enzymes). 
As previously mentioned, it has also been suggested that 
substrate inhibition may be due to complexation of excess substrate 
with the flavin-semiquinone [25]. This would require that after 
lactate is oxidised, the resultant pyruvate molecule must dissociate 
from the active site and another molecule of lactate bind before the 
flavin-semiquinone donates its electron to ferricyanide. The 
observation that the Y254F enzyme does not exhibit inhibition by 
excess L(+)lactate [21] was explained in terms of this latter 
theory, with the suggestion that the phenolic hydroxyl of the 
Tyr254 residue is necessary for the preferential binding of lactate 
to the flavin-semiquinone [21]. 
5.4.3 	INHIBITION BY D(-)LAcTATE 
The results for D(-)lactate inhibition of the WT, Y97F, Y143F and 
F325A enzymes are presented in Table 5.10. The mode of inhibition 
was determined graphically through plots of 1/rate versus D(-) 
lactate concentration. Ki values were evaluated by non-linear least 
mean squares analysis. 
The inhibition of WT-b2 and the three mutant enzymes is 
competitive as shown for Y143F-b2 in Figure 5.10. The Ki value for 
D(-) lactate of 1.80 ± 0.05mM, obtained with the WT enzyme is 
slightly higher than the previously reported value of 1.4mM [2]. In 
general, the Ki values mirror the trend in the Ki for L(+)lactate of 
each enzyme. For example the Ki values for D(-)lactate obtained with 
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TABLE 5.10 
A COMPARISON OF THE Ki VALUES FOR D(-)LACTATE WITH THE KM VALUES IOk 
L(+)LACTATE OBTAINED WITH THE WT, Y97F, Y143F AND F325A ENZYMES. 
ENZYME 	 D(-)LACTATE 
Ki (mM) 
WT 	 1.8 ± 0.1 
Y97F 	 1.8 ± 0.1 
Y143F 	 19.7 ± 3.0 
F325A 	 4.1 ± 0.2 
L(+)LACTATE 
KH(mM) 
0.49 ± 0.05 
0.50 ± 0.04 
*290 ± 0.23 
0.90 ± 0.05 
All results were obtained at 25 ° C in Tris/HC1 buffer, pH 7.50, I = 
0.1M. 1mM ferricyanide was used as the electron acceptor. 
(*Value obtained using 8mM ferricyanide as the electron acceptor.) 
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FIGURE 5.10 
THE COMPETITIVE INHIBITION OF Y143F-b BY D(-)LACTATE: 
PLOTS OF 1/RATE AGAINST THE CONCENTRATION OF D(-)LACTATE AT VARIOUS, 
NON SATURATING, L(+)LACTATE CONCENTRATIONS. 
Sp 
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[D(-)LACTATE (10 3 14) 
= 2mM L(+)Jactate 
• = 1mM L(+)lactate 
0= 0.5mM L(+)lactate 
Fm- 
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the WT and Y97F enzymes are identical while that with F325A-b2 
(4.1mM) is roughly double the value for WT-ln. D(-)lactate was 
tested as a substrate for all the above enzymes but results proved 
negative in all cases. 
5.4.4 	INHIBITIONBY OXALATE 
Plots of 1/rate against 1/L(+)lactate concentration, for oxalate 
inhibition of the WT, Y97F, Y143F and F325A enzymes are presented in 
Figures 5.11 - 5.14. Inhibition, as previously reported for WT-b2 
[22,26], is mixed for all the above enzymes. It is obvious from 
these Figures that inhibition of Y143F-b2 by oxalate (Figure 5.13) 
is considerably weaker than for the other three enzymes as indicated 
by the amount of oxalate used to obtain significant inhibition. 
Oxalate is considered to be analogous to the transient carbanion 
of lactate [27] (Figure 5.15) and would therefore be expected to 
bind strongly to WT-b2, as is observed (from the KD of 0.5mM [22] 
the binding energy is calculated as 8.2kJmol 1 ). In studies on 
oxalate inhibition of L(+)lactate oxidase [19] it was proposed that 
the inhibitor was bound at the enzyme active site, as shown in 
Figure 5.16, with interactions to the b2 enzyme equivalents of 
Arg376, Tyr143 and Tyr254. It was concluded in Chapter 2 that Tyr143 
was important in transition state stabilisation. The decreased 
affinity of the Y143F enzyme for oxalate indicates that Tyr143 
forms a hydrogen bond interaction with oxalate, a transition state 
analogue for In. 
CD spectra, of the WT and Y143F enzymes with added oxalate, were 
acquired to investigate any changes in the conformation of the 
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FIGURE 5.11 
THE MIXED INIIIBITION OF WT-ln BY OXALATE: 
SP 







A = 0mM Oxalate 
0= 0.5mM Oxalate 
= 1mM Oxalate 
• = 2mM Oxalate 
0 	 800 
1/[L(+)LACTATE] (14 -1 ) 
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FIGURE 5.12 
THE MIXED INhIBITION OF Y97F-b2 BY OXALATE: 
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A = 4mM Oxalate 
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FIGURE 5.13 
THE MIXED INHIBITION OF Y143F-bz BY OXALATE: 
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FIGURE 5.14 
THE MIXED INHIBITION OF F325A-bz BY OXALATE: 
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FIGURE 5.15 
THE ANALOGY BETWEEN OXALATE AND THE TRANSIENT CARBANION OF LACTATE, 
00 	 0 	OH '\ 	 'I' 
ec— :'e ec—c 'e 
f 	 ' I  a. 0 	 o 
OXALATE 	 THE LACTATE CARBAN ION 
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FIGURE 5.16 
THE PROPOSED INTERACTiONS OF OXALATE AT THE ACTIVE SITE OF L(+) 
LACTATE OXIDASE [191. 
(K34 9) 
(H373) 	K266 	(D282) ri_i 
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Oxalate is bound by Arg293 and Tyr44, with interactions to Tyr152. 
His290 is considered to stabilise the second negative charge of 
oxalate. 
The equivalent residues in in are given in parentheses. 
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enzymes upon binding oxalate. The effects of oxalate addition to 
oxidised and reduced WT-b2 are shown in Figures 5.17 and 5.18. In 
the far UV region, 190nm - 260nm, only minor changes are observed 
upon oxalate addition to the oxidised enzyme (Figure 5.17A). In the 
range 260nm - 500nm the only significant difference is a decrease in 
the intensity of the 269nm band (Figure 5.17B). This decrease is 
similar to that observed when lactate is added to the reduced WT 
enzyme (see Figure 3.4B). 
When oxalate was added to the lactate reduced enzyme, slight 
increases in intensity were observed from - 200nm - 240nm (not 
shown). In the range 260nm - 500nm (Figure 5.18A) there are several 
differences between the spectrum of the reduced enzyme and that with 
added oxalate. As observed with the oxidised enzyme, the intensity 
of the 269nm band decreases upon oxalate addition. The most 
significant difference is an inversion of the Soret band (423nm) 
when oxalate is present. In the 500nm - 600nm region (Figure 5.18B) 
the minimum at - 548nm has increased in intensity upon oxalate 
addition. 
The spectrum of oxidised Y143F-I2 is compared to that with added 
oxalate in Figure 5.19. The spectrum of the latter in the far UV 
region, 190nm - 260nm, is essentially the same as for the former 
apart from an unexplained decrease in intensity between 190nm and 
200nm. From 260nm - 500nm the spectra have the same shape, with 
minor differences in peak intensity. 
The spectrum of lactate reduced Y143F-l2 is compared to that with 
added oxalate in Figure 5.20. The spectra in the region from 190nm - 
260nm (not shown) are essentially the same as those shown in Figure 
5.19 for the oxidised Y143F enzyme, with and without added oxalate. 
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FIGURE 5.17 
A COMPARI SON OF THE CI) SPECTRA (1 9Ona - 500na) OF THE OXI DI BED WT 
ENZYME BEFORE (BLACK) AND AFFER (GREEN) THE ADDITION OF OXALATE. 
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A COMPARI SON OF THE CD SPECTRA (260n. - 600n.) OF THE LACTATE 
REDUCED WT ENZYME BEFORE (BLUE) AND AFTER (BLACK) THE ADDITION OF 
OXALATE. 
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FIGURE 5.19 
A COMPARISON OF THE CD SPECTRA (1 9Ona - 500n.) OF THE OXI DI SKI) 
Y143F ENZYME BEFORE (BLACK) AND AFTER (GREEN) THE ADDITION OF 
OXALATE. 
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A COMPARISON OF THE CD SPECTRA (260n - 600na) OF THE LACTATE 
REDUCED Y143F ENZYME BEFORE (GREEN) AND AFTER (RED) THE ADDITION OF 
OXALATE. 
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Over the entire region (190nm - 600nm) the two spectra have the same 
shape, the only significant difference being that the spectrum of 
the enzyme with added oxalate is less intense from 260nm - 500nm. 
The most significant differences observed in this CD study occur 
upon oxalate addition to the reduced WT-b2. The inversion of 
the Soret peak and the increase in intensity of the band at - 548nm 
are identical to the effects observed for reduced Y143F-b2 and 
Y143Q-&2 (without added oxalate), discussed in Section 3.3.3. In 
contrast, there is no change in the spectrum of the reduced Y143F 
enzyme at these positions when oxalate is added. This implies that, 
in the WT enzyme, Tyr143 binds to oxalate, preventing interaction 
with the heme propionate. The CD spectrum therefore reflects the 
loss of a domain/domain interaction, the same effect that is 
observed when Tyr143 is mutated to a phenylalanine. Upon 
consideration of the fact that Tyr143 seems to bind to oxalate in. 
the complex with the WT enzyme, it is not surprising that in Y143F-
l2, where the hydrogen bonding ability of the residue has been 
removed, the inhibitor is not bound as strongly. This explains the 
lack of perturbation to the CD spectrum of the Y143F enzyme when 
oxalate is added and the weaker binding of oxalate as indicated from 
the steady-state kinetic results discussed previously. 
5.4.5 	SUMMARY OF THE INHIBITION RESULTS 
The Y97F, Y143F and F325A enzymes all exhibit inhibition by 
excess L(+)lactate. 
D(-)lactate inhibition, as previously reported for WT-b2 is 
competitive with the three mutant enzymes. The trend in 
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values of Ki is similar to that observed with Kti values for 
L(+)lactate. 
(4) 	Oxalate inhibition, as for WT-b2, is mixed for the three 
mutant enzymes. Inhibition of Y143F-L is weaker than for the 
other enzymes indicating that Tyr143 is involved in the 
binding of oxalate. 
5.5 	CONCLUSIONS 
Overall, this substrate/inhibitor study has shown that the active 
site specificity of the Y97F enzyme is the same as for WT-b. The 
only difference between the two enzymes in this respect is the 
enhanced inhibition of the mutant enzyme by excess L(+)lactate as 
previously observed. The differences between the WT and F325A 
enzymes are consistent with a small change in conformation 
transmitted to the active site in the latter. The specificity of 
this enzyme has altered somewhat to become almost as efficient a 
2-hydroxyoctanoate dehydrogenase as it is a lactate dehydrogenase. 
The most significant feature of this study is the weakened binding 
of oxalate by the Y143F enzyme. As oxalate is a transition state 
analogue for liz, this result is consistent with Tyr143 being 
involved in transition state stabilisation. 
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CHAPTER 6 
SUBSTITUTION OF A HEME AXIAL LIGAND 
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6.1 	INTRODUCTION 
Bis-axial-coordinated, low spin heme centres in proteins are 
generally found to participate in rapid electron transfer due to 
their minimal structural rearrangements upon redox changes [1]. 
Without axial ligands, porphyrins, although strong field ligands, 
are not capable of generating low spin iron [2]. However, with 
histidine, methionine, cysteine or lysine, the only amino acids 
with side chains of ligand field strength greater than the energy 
required to pair the electrons, this can be achieved [1]. All 
cytochromes contain at least one histidine [3] 	and in b type 
cytochromes bis-histidine is the most common ligation. 	Two 
exceptions of the latter are E.coli cytochrome b562 [4] and 
cellobiose oxidase from Phanerochaete crysosporium [5] which have 
been shown to contain a histidine/methionine coordination scheme. 
The heme of flavocytochrome b2 is low spin, as shown by EPR 
spectroscopy [6] and the iron is axially ligated by two histidine 
residues, 43 and 66 [7,8] (Figure 6.1). The heme group is located in 
the cytochrome domain, close to the interface with the 
flavodehydrogenase domain, where it is positioned in a hydrophobic 
pocket formed by two pairs of helices and a 6-stranded mixed - 
sheet. The two heme propionates project towards the flavin and 
form hydrogen bond interactions with two tyrosine residues, 97 and 
143. The orientation of the porphyrin has been shown to be slightly 
non-planar. 
In order to investigate the effects on heme coordination and the 
enzymic activity, His 43 was mutated to a methionine to generate the 
H43M mutant enzyme (Figure 6.2). A similar mutation has been 
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FIGURE 6.1 
THE CYTOCHEOME DOMAIN OF bz SHOWING THE AXIAL LIGANDS OF THE HEME 
GROUP I H1S43 AND HIS 66. 
FIGURE 6.2 
THE SUBSTITUTION OF 111343 WITH MET TO GENERATE 1143M-b2. 
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H 2 N -CH -CO2H 
CH 3 
S 
(C H 2 )2 





reported for cytochrome bs [9] a protein homologous to the b2 
cytochrome domain [10]. The b5 heme is located in a hydrophobic 
pocket similar to that containing the In heme (Figure 6.3) and 
is axially ligated by histidines 39 and 63 [11]. The orientation of 
the helices in the two enzymes is slightly different and an extra 
helix in b5 replaces some of the B-sheet found in l2. Unlike in, 
only one of the bs heme propionates extends into the solvent. The 
other is buried, forming hydrogen bonds to Ser64. Overall, the 172 
heme is rather more exposed. 
When His63 of l,s (the opposite histidine to that changed in 172) 
was mutated to a methionine, the apo form of the enzyme was 
produced. Once reconstituted, the protein was found to contain a 
high spin, 5 coordinate heme which could bind exogenous ligands such 
as CO [9]. This chapter describes the effects on the heme 
coordination and enzymic activity of in following a similar mutation 
to generate H43M-l2. 
6.2 	EXPERIMENTAL 
6.2.1 GENERATION OF H43M-l2 (DR.F.D.C.MANSON) 
H43M-in was generated by site-directed mutagenesis using the 
double primer method [12] as described in [13]. The oligonucicotide 
used (CTACCAAATATGCCAGGTGGG) was synthesised on an Applied 
Biosystems model synthesiser. The enzyne was expressed in E.coli, 
with growth conditions as deribed in Section 7.1.4. 
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FIGURE 6.3 
ACOMPARISON OF THE CYTOCUROME DOMAIN OF b2 WITH CYTOCHROME bs 171 
THE CYTOCIIROME DOMAIN OF liz CYTOCHROME b5 
The cylinders and arrows 	represent helices 	and 13-strands 
respectively. X indicates the extra helix found in cytochrome b5. 
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6.2.2 	ISOLATION AND PURIFICATION OF H43M-lx 
Unlike the WT-b2 and other mutant enzymes discussed, E.coli cells 
containing H43M-b2 were pale green. As this colour was not easy to 
detect on growth plates, single colonies were selected at random and 
grown up as described in Section 7.1.4. After harvesting, the cells 
from each starter culture were frozen in liquid nitrogen before 
being lysed (Section 7.6.2). After centrifugation (39000g, 10 
minutes, 0-4 °C) the crude supernatant was assayed for lactate 
dehydrogenase activity (Section 7.9) using ferricyanide as the 
electron acceptor. Bulk quantities of cells were then grown after 
innoculation of flasks from, starter cultures which exhibited 
activity. 
H43M-l2 was purified as described in Section 7.6.3. The procedure 
was modified slightly in that only a very short hydroxyapatite 
column was used (to minimise heme dissociation). The purified, green 
coloured, H43M enzyme was stored as a 70% ammonium sulphate 
precipitate under nitrogen at 0-4 ° C. The protein was only stored for 
short periods due to heme dissociation. 
6.2.3 STEADY-STATE KINETICS 
Steady-state kinetic analyses were carried out, as described in 
Section 7.9, at 25 °C in Tris/HC1 buffer, pH 7.50, I = 0.1M. 0.2cm 
pathlength cuvettes were used for all assays involving ferricyanide. 
As no extinction coefficients have been evaluated for the H43M 
enzyme, no actual kcat values were determined. 
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6.2.4 METALLOIVRPHYRIN INCORPORATION 
Small amounts of metalloporphyrins were dissolved in a minimum 
amount of 1M NaOH and buffered with Tris/HC1 buffer, pH 7.50, I = 
0.1M. Excess of this solution was then added to H43M-b2, dissolved 
in Tris/HC1 buffer, and the mixture incubated at 0-4°C for 
approximately one hour. 
6.2.5 CIRCULAR DICHROISM 
H43M-b2 was prepared for analysis by circular dichroism as 
described in Section 7.12.2. Prior to use, the protein was dissolved 
in 0.1M phosphate buffer and dialysed against the same buffer to 
remove lactate and ammonium sulphate. 
6.2.6 EPR SPETROScOPY 
H43M-b2 was fully purified for analysis using EPR spectroscopy as 
described in Section 7.14. The protein was dissolved in HEPES 
buffer, pH 7.50 and dialysed against the same buffer. Spectra were 
obtained at 12K using a Bruker electron spin resonance ER 200D 
spectrometer. 
6.3 	RESULTS AND DISCUSSION 
6.3.1 THE IN/VISIBLE ABSORFION SPECTRUM OF H43M- Liz. 
The UV/visible absorption spectrum of H43M-b2 (pH 7.50) is 
shown in Figure 6.4. That of the oxidised enzyme is dominated by 
the absorbance of the flavin which exhibits characteristic peaks at 
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FIGURE 6.4 
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391m and 449nm. There is evidence of a small amount of heme 
(estimated from the spectrum to be around 5%) with absorbances at 
419nm (the Soret band), 534nm and 643nm. Upon the addition of sodium 
dithionite the flavin becomes reduced, resulting in the loss of the 
chromophores at 391m and 449nm. The three heme bands however barely 
change position, with maxima at 414.5nm, 533.5nm and 650.5nm, the 
last peak being better resolved rather than shifted from its 
position of 643nm. There is no evidence of a band at 695nm in 
either spectrum, the presence of which is usually indicative of 
methionine ligation [14] (as in cytochrome c for example). The broad 
band at 650nm in both spectra suggests that the heme of H43M-b2 is 
high spin. Such a band, usually observed at 600nm - 640nm, is 
associated with high spin ferric-heme proteins, either with water 
as the sixth ligand or, as in cytochrome c', five coordinate [14]. 
The fact that this band does not alter position on the addition of 
dithionite implies that the heme remains oxi.dised and may therefore 
have a redox potential lower than that of dithionite. 
The UV/visible absorption spectrum of the H43M-b2 heme was also 
studied at pH 11. At this pH, the flavin prosthetic group 
dissociates from the protein [15] and can be removed by elution from 
a Sephadex G25-50 gel filtration column equilibrated in O.1M CAPS 
buffer, pH 11. Although poorly resolved, two small peaks could be 
observed at - 526nm and 552nm in the spectrum with added 
dithionite. At pH 7.50 only one band, at 534nm, was observed. 
This suggests that some reduction of the heme occurs at high pH. 
Both the Soret band and 650nm band at pH 11 were slightly shifted to 
a longer wavelength on the addition of dithionite. 
It appears then that H43M-b2 has a high spin heme with a ferric 
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resting state. Bands at 600nm - 640nm and 500nm are normally 
associated with such a system. The UV/visible absorption spectrum of 
the enzyme appears very similar to that of Rhodospirillum 
molischianum ferricytochrome c' [16]. In this protein (pH 6.2) peaks 
are observed at 638nm and 500nm. At pH 10.7, two peaks are 
observed at 505nm and - 530nm. This is accompanied by an increase 
in the absorbance of the 638nm band. 
6.3.2 	THE STEADY-STATE KINETICS OF H43M-fr2 
The H43M enzyme appears to be a fairly efficient L(+)lactate 
dehydrogenase when ferricyanide is used as the electron acceptor. 
However, the enzyme is a very inefficient cytochrome c reductase as 
shown in Table 6.1. With WT-b2, the ratio of the rates of 
ferricyanide and cytochrome c reduction is - 2 1. With the H43M 
enzyme the rate of cytochrome c reduction is so slow that the best 
ratio obtained was 1012 : 1. 
The deuterium kinetic isotope effect values for H43M-b2, 
determined with L-[2- 1 H]lactate and L-[2- 2 H]lactate are compared 
with those for the WT enzyme in Table 6.1. Although the KIE value 
for ferricyanide reduction has been lowered slightly from 4.5 in the 
WT enzyme to 3.6 in H43M-b2, the main rate-limiting step remains 
abstraction of the lactate C2-H. Cytochrome c reduction by H43M-b 
is considerably more rate limiting in the overall reaction 
than that by the WT enzyme, as is evident from the drop in the KIE 
value from 3.0 to 1.4. 
It was estimated from the UV/visible absorption spectrum that 
the H43M enzyme contains only 5% of its full stoichiometric 
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TABLE 6.1 
A COMPARISON OF THE STEADY-STATE KINETIC PARAMETERS OF THE MT AND 
H43M ENZYMES. 
THE RATIO OF 
FERRICYANIDE 
CYTOCHROME c DEUTERIUM KIE KM(mM) 
ENZYME REDUCTION RATES 
	
FERRICYANIDE CYTOCHROME c 
	
L(+)LACTATE 
WT 	 -2:1 
	
4.7 ± 0.3 	3.0 ± 0.5 
	
0.49 ± 0.05 
H43M 	1012 : 1 
	
3.6 ± 0.3 	1.4 ± 0.2 
	
0.61 ± 0.06 
All results were obtained at 25 ° C in Tris/HC1 buffer, pH 7.50, I = 
0.1M. 
Ferricyanide concentrations were 1mM and 8mM for the MT and H43M 
enzymes respectively. The concentration of cytochrome c was 50 MM. 
KIE values for the MT enzyme were evaluated from kcat parameters 
whereas those for H43M-b2 were evaluated from Vmax obtained at 
4mM lactate. 
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complement of heme. The low rate of cytochrome c reduction and the 
KIE of only 1.4 are hardly surpristhgsince this electron acceptor 
can only be reduced by the b2 heme [17]. It must also be taken into 
consideration that evidence suggests that the H43M-b2 heme has a 
low redox potential. Assuming that the flavin redox potential is 
approximately the same as in the WT enzyme there will be very little 
driving force for heme reduction. The fact that cytochrome c can be 
reduced signifies that the heme is suitably orientated for electron 
transfer. 
The L(+)lactate Kn for H43M-b2 is the same within experimental 
error as that for the WT enzyme (Table 6.1). This implies that there 
is no significant difference in the Michaelis complex of the two 
enzymes. Any conformational effects that may have occurred in the 
vicinity of the heme upon changing the histidine to methionine do 
not appear to have been transmitted to the active site. 
As with Y143F-b2 but unlike the WT enzyme, H43M-b2 exhibits a 
significant ferricyanide concentration dependence (Table 6.2). This 
can be explained in terms of ferricyanide accepting electrons from 
the flavin-hydroquinone and semiquinone, thereby bypassing the heme 
(see also Section 2.3.3). 
The Km value for cytochrome c binding to the protein is 3-fold 
higher than that for WT-bz. A similar result was observed with the 
Y97F enzyme in which a hydrogen bond to one of the heme propionates 
had been removed. It is quite conceivable that an equivalent effect 
has occurred in the H43M enzyme due to a change in orientation of 
the heme brought about by the loss of the histidine ligand. 
As with WT-In, excess L(+)lactate is found to inhibit the H43M 
enzyme (Figure 6.5). The Ki value obtained is lower than for any 
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TABLE 6.2 
KM VALUES FOR THE ELECTRON ACCEPTORS FERRICYANIDE AND CYTOCHROME c 
OBTAINED WITH THE WT AND H43M ENZYMES. 
ENZYME 	 ELECTRON ACCEPTOR 
FERRICYANIDE 	CYTOCHROME c 
KM(InM) Kii(pM) 
WT 	 << 0.1 	 10 ± 1 
H43M 	 2.40 ± 0.19 	30 ± 5 
All results were obtained at 25 °C in Tris/HC1 buffer, pH 7.50, I = 
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of the enzymes discussed in Chapter 5 as shown in 
result contradicts the trend (Section 5.4.2) in 
increased with decreasing rate of heme reduction. 
favoured here is that the mutation at His43 
enhancement of a secondary substrate binding site, 
to that observed in Y97F-b2. 
Table 6.3. This 
which Kr values 
The explanation 
has led to an 
a similar effect 
To summarise these steady-state kinetic results, it is evident 
that the H43M enzyme exhibits reasonable ferricyanide reductase 
activity but is a very poor cytochroine c reductase. The latter 
effect is due to a combination of poor heme incorporation, an 
assumed low heme redox potential and possibly an altered orientation 
of the heme. It also accounts for the significant ferricyanide 
concentration dependence exhibited by H43M-I2 as this acceptor is 
only taking electrons from the flavin-hydroguinone and semiquinone. 
The H43M enzyme also exhibits similar behaviour to the Y97F enzyme 
in some respects. For example both have increased Kn values for 
cytochrome c and stronger L(+)lactate inhibiton than WT-b2. The 
latter effect could be due to the similar enhancement of a secondary 
substrate binding site. 
6.3.3 	HEME INCORPORATION 
At best, it is estimated from the UV/visible absoprtion spectrum 
that fully-purified H43M-b2 has around 5% heme occupancy. It is also 
observed that the enzyme loses heme during purification and storage. 
This is illustrated in Figure 6.6 which shows the spectrum of H43M-
i2 after the enzyme had been stored for several weeks. It is 
essentially that of a flavoprotein, with little evidence of heine. 
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TABLE 6.3 
A COMPARISON OF THE STEADY-STATE KINETIC BEHAVIOUR OF THE NT AND 
MUTANT ENZYMES TOWARDS L C + ) LACTATE. 
ENZYME Sopt 	(mM) Ki(mM) Kn(mM) 
H43M 4 100 ± 4 0.61 ± 0.06 
Y97F 6.9 141 ± 5 0.50 ± 0.04 
WT 10 174 ± 8 0.49 ± 0.05 
F325A 12 216 ± 10 0.90 ± 0.05 
Y143F 15-18 324 ± 15 2.92 ± 0.23 
All results were obtained at 25 ° C in Tris/HC1 buffer, pH 7.50, I = 
0.1M. The concentrations of ferricyanide used as the electron 
acceptor were 1mM for the NT, Y97F and F325A enzymes, 8mM for Y143F-
b2 and H43M-b2. 
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FIGURE 6.6 
THE UV/VISIBLE ABSORPTION SPECTRUM OF H43M-b2 AFTER THE ENZYME HAD 

















400 	 500 	 600 vv,.i'pu'ru t....i 
The spectrum is essentially that of. a flavoprotejn, with little 
evidence of heme. (The enzyme was stored, in the presence of 
lactate, under nitrogen at 0-4 ° C) 
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Crude studies were carried out to ascertain if heme could be 
reincorporated. This involved adding small quantities of hematin and 
hemin to H43M-b2 and monitoring any increase in the rate of 
cytochrome c reduction. Similar experiments were also carried out 
with cobalt porphyrin. 
As seen in Table 6.4, the addition of both hematin and hemin 
increased the rate of cytochrome c reduction indicating that 
successful heme reincorporation had taken place. The addition of 
cobalt porphyrin to H43M-b2 resulted in a 2.5-fold increase in the 
rate of cytochrome c reduction showing that it is physiologically 
capable of accepting electrons from the flavin and transferring them 
to cytochrome c. This result is consistent with that of Naismith 
[18] who replaced the heme of WT-bz with cobalt porphyrin and found 
the Co-tn capable of reducing cytochrome c. The heme iron of 
cytochrome c has also been replaced with cobalt resulting in a 
biologically active enzyme [19,20]. 
6.3.4 	THE BINDING OF CARBON MONOXIDE TO H43M-tn 
CO binding depends on several factors: the nature of the in 
plane ligand, the number and type of axial ligand, the amount of 
steric interaction and the solvent medium [21]. Neither WT-b2 nor 
cytochrome b5, with their two histidine axial ligands, are 
susceptible to CO binding [15,22]. Under normal conditions, 
cytochrome c (His/Met ligation) does not combine with CO [23], but 
the five coordinate ferricytochrome c' binds CO with a 1:1 
stoichiometry per subunit [24]. CO generally has a stronger 
propensity to bind to and stabilise ferrous rather than ferric 
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TABLE 6.4 
H43M-fr2 : THE EFFECT ON CYTOCHROME c REDUCTION FOLLOWING THE 
ADDITION OF VARIOUS PORPIIYRINS. 
MOIETY ADDED 	INCREASE IN RATE OF CYTOCHROME c REDUCTION 
TO H43M-I2 (FOLD) 
HEMATIN 	 8 
HEMIN 	 4-5 
Co PORPHYRIN 	 2.5 
PROTOPORPHYRIN IX 	 NO CHANGE 
Steady-state kinetic determinations of the increase in rate of 
cytochrome c reduction were carried out at 25 °C in Tris/HC1 buffer, 
pH 7.50, I = 0.1M. The concentration of cytochrome c was 100uM. 
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complexes as it is a strong 7T acceptor. 
Since H43M-b2 has a 5-coordinate heme (or 6-coordinate with 
water) it was expected that the H43M-b2 heme might bind CO. CO 
gas was bubbled through a solution of H43M-b2 and dithionite in 
Tris/HC1 buffer, pH 7.50 and a UV/visible absorption spectrum 
obtained (Figure 6.7). There are several differences between the 
spectrum of H43M-b2 before and after CO addition. The most 
significant feature is a 35nm shifting of the 650nm band to 615nm. 
The 533nm band does not change position but the Soret peak is 
sharpened and moves from 413.5nm to 419nm. Further evidence for 
CO binding was obtained by monitoring the rate of cytochrome c 
reduction before and after CO addition. Although the latter was 
not carried out under strictly anaerobic conditions, the rate of 
cytochrome c reduction by H43M-b2 dropped by almost 10-fold to 
become barely detectable. CO binding had no effect on the reduction 
of ferricyanide as would be expected considering that this acceptor 
bypasses the heme. 
6.3.5 EPR SPECTROSOOPY 
EPR experiments were carried out on H43M-b2 in an attempt to gain 
corroborating evidence of the high spin nature of the heme. 
The EPR spectrum of the WT enzyme, run at 12K, yielded almost 
identical g values (2.99, 2.23 and 1.47) to those previously 
reported [25]. Unfortunately, the spectrum obtained of H43M-b2 was 
dominated by an intense signal at g = 4.3, the result of an iron 
impurity in the buffer. There was however no evidence of low spin 
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A COMPARISON OF THE EPR SPECTRA OF THE WT AND H43M ENZYMES, OBTAINED 
AT 12K. 
(A) THE EPR SIGNALS OF THE LOW SPIN WT-ln HEME, AT g = 2.99 and g = 
2.23. 
g:299 
(B) THE CORRESPONDING REGION IN THE SPECTRUM OF H43M-b2. 
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spectrum were hampered by the almost complete dissociation of heme 
from the enzyme during purification and concentration. Although by 
no means conclusive, minute amounts of high spin heme have been 
detected whereas no low spin signals have been observed. 
6.3.6 	THE CD SPECIRUM OF H43M-L. 
The CD spectrum of H43M-l2 was acquired to see what, if any, 
conformational changes had occurred in the enzyme and if any heme 
chromophores could be detected. 
Figure 6.9 shows the spectrum of oxidised and reduced 1143M-b2 
over the region 300nm - 600nm. The spectrum of the oxidised protein 
exhibits a maximum at 322nm and a minimum at '375nm. These bands 
are essentially the same as those observed for the oxidised WT 
enzyme, those of the mutant enzyme being rather more symmetrical. 
Between 400nm and 425nm (the Soret region) no signal is observed. 
Otherwise, the spectrum is as for the WT enzyme up to 600nm. 
The spectrum of reduced H43M-b2 between 300nm and 400nm shows two 
broad maxima, one centred at 320nm and the other at - 370nm. This 
is in contrast to the spectrum of WT-b2 which shows a shallow, broad 
minimum between 300 and 340nm and a broad maximum at 385nm. In fact 
the spectrum of H43M-b2 in this region is almost identical to that 
of the Y143F mutant enzyme. There is a very small positive peak 
centered at - 415 nm corresponding to the Soret band. From 430nm to 
500nm the spectrum is the same as seen for the WT enzyme. The region 
between 500nm and 600nm is featureless. In contrast, this region in 
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A small amount of hematin was added to reduced H43M-b2 to see if 
any changes could be detected in the CD spectrum. Compared to the 
spectrum of reduced H43M-b2, the bands at - 320nm and - 415nm have 
undergone a slight decrease in intensity. In the former region, the 
WT enzyme exhibits a negative band. The small amount of hematin 
added could be binding and causing a slight shift towards the 
spectrum observed in WT-b2. 
The main contributions to the CD spectrum of the H43M enzy.e 
appear to be due to flavin/protein interactions. There is very 
little evidence of heme over the regions studied. The spectrum of 
reduced H43M-b2 is similar to that of the Y143F mutant enzyme. In 
both enzymes a flavin to heme interaction has been lost, resulting 
in impaired domain/domain recognition. In the Y143F enzyme this Was 
due to the loss of a crucial hydrogen bond to one of the hese 
propionates. In H43M-b2, it is as a result of poor heme 
incorporation. 
6.4 	SUMMARY 
The mutation of one of the b2-heme axial ligands, His43, to a 
methionine has resulted in an enzyme with a very low heme occupancy. 
What little heme there was had a tendency to dissociate during 
purification and storage but could be reincorporated on incubation 
with hematin and hemin. Successful reincorporation with cobalt-
porphyrin gives further evidience that Co-b2 is physiologically 
capable of being reduced by the flavin and reducing cytochrome c. 
From the UV/visible absorption spectrum, it would appear that 
methionine does not ligate to the heme. The presence of the 
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absorbance band at - 650nm points to the presence of a high spin 
ferric-heme, either five coordinate, or six coordinate with water 
forming the second axial ligand. The predicted coordination of the 
}143M-b2 heme is substantiated by the observation that it binds CO. 
As a result, the 650nm band in the UV/visible absorption spectrum 
undergoes a 35nm blue shift. Also, on CO binding, the rate of 
cytochrome c reduction by H43M-b2 decreases by 10-fold to become 
barely detectable. 
Although the H43M enzyme is a very poor cytochrome c reductase it 
is a reasonable ferricyanide reductase. No extinction coefficients 
have as yet been evaluated for the enzyme so accurate concentration 
measurements and rate determinations could not be made. It is 
considered however that the rate of ferricyanide reduction by H43M-
172 may be very similar to that of the WT enzyme. The integrity of 
the active site appears to have been preserved in H43M-b2 as the 
lactate Kn value is the same as that for the WT enzyme. 
Obviously, further work is required for complete characterisation 
of this mutant enzyme. Clear EPR spectra need to be collected to 
define the heme as high spin. Further attempts should also be made 
to fully reincorporate the heme and hence determine the maximum 
rate of cytochrome c reduction. Similarly, it would be interesting 
to fully characterise, both kinetically and spectroscopically, the 
enzyme with incorporated Co porphyrin. 
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CHAPTER 7 
METHODS AND MATERIALS 
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7.1 	GROWTH OF E.coii 
7.1.1 GENERAL 
E.coii strains MN294 [1] or HB101 [2] were used for plasmid 
propagation and expression of b2 as described in [3]. All media used 
for the growth of E.coii were autoclaved, prior to use, in a Denley 
Sovereign autoclave (20 minutes, 122 ° C, 16 p.s.i.). 
7.1.2 	PREPARATION OF GROWTH MEDIUM : 	LURIA BROTH (LB) 
Tryptone (Difco / Oxoid) 	lOg/Litre 
Yeast extract (Difco) 	5g/Litre 
Sodium chloride (May & Baker) 5g/Litre 
Prior to innoculation, LB was supplemented with carbenicillin 
(501ug/ml) (Sigma). This was first dissolved in a small volume of 
deionised water and added to the broth via a sterile Millex-GS 
0.22uM filter unit (Millipore). 
7.1.3 CULTURE PLATES FOR THE MAINTENANCE OF E. coil STRAINS 
Equal volumes of agar (3%) (Difco) and double concentrated LB 
were mixed after autoclaving to give a final agar concentration of 
1.5%. Carbenicillin (50,ug/ml) was added as described in Section 
7.1.2. 
7.1.4 GROWTh CONDITIONS 
Plasmid bearing E.coii cells were grown aerobically in LB plus 
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carbenicillin at 37 ° C on an orbital shaker (Gallenkamp incubator) at 
250 r.p.m. for approximately 12 hours. 
7.1.5 	HARVESTING OF CELLS 
Cells were harvested from the growth medium by centrifuging for 4 
minutes at 15000g and 0-4 ° C (Sorval RC-5B refrigerated .superspeed 
centrifuge). On average, 5g (wet weight) of cells were obtained per 
litre of liquid culture innoculated with a single Ecoli colony. 
Cells were stored at -20 ° C until required. 
7.2 	PREPARATION OF BUFFER SOLUTIONS 
7.2.1 	GENERAL 
All buffers were prepared with deionised water purified by 
reverse osmosis and ion-exchange to a resistivity of 18.3fM 
(Millipore Mill-QSP reagent water system). pH measurements were made 
with a WPA CD620 digital pH meter fitted with a WPA glass electrode. 
Calibration of the assembly was carried out first at pH 7.00 then at 
either pH 4.00 or pH 10.00 using standard colourkey buffer solutions 
(BDH, electrochemically checked, ± 0.02 at 20 ° C). 
7.2.2 	TRIS/HC1 BULvR 
Trizma base (Tris (hydroxymethyl) aminoethane) (Sigma, Reagent 
Grade), here referred to as Tris, was used in conjunction with 
HC1 (Fisons, SLR) for the preparation of Tris/HC1 buffer at pH 7.50. 
lOmi of 1M HC1 was added to 500ml of deionised water and the 
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solution titrated to pH 7.50 by the addition of Tris. Sodium 
chloride (May & Baker) was then added to give, after dilution, the 
required ionic strength. Finally, the volume of the solution was 
adjusted to one litre. As solutions of Tris absorb carbon dioxide 
from the air [4], they were kept covered wherever possible and the pH 
monitored regularly. 
The ionic strength of Tris/HC1 buffer was calculated using the 
following equation: - 
I = 1/2 	CjZ1 2 	 (1) 
where Ci is the molar concentration of an ion and Zj represents its 
charge. If, for example, the required ionic strenght of the Tris/HCI 
buffer was 0.1M, 10mM HC1 and 0.09M sodium chloride (5.265g) would 
be used. 
	
7.2.3 	HEPES/NaDH BUFFt 
N-2-hydroxymethylpiperazine-N ' ethanesuiphonicacid (Sigma), here 
referred to as HEPES, was used with NaOH to provide a buffer of pH 
7.50 suitable for use in EPR experiments. lOml of 1M NaOH was added 
to 500m1 of deionised water and the solution titrated to pH 7.50 by 
the addition of solid HEPES. The ionic strength was adjusted to the 
required value with the addition of sodium chloride as described in 
Section 7.2.2 and the solution made up to one litre with deionised 
water. 
7.2.4 	CAPS BUFFER 
3-(cyclohexylainino)-1-propanesulphonic acid (Sigma), here referred 
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to as CAPS, was used to provide a buffer of pH 11 for use in the 
removal of FMN from b2. The solution was made up as described in 
Section 7.2.3 with CAPS substituted for HEPES. 
7.2.5 PHOSPHATE BUFFERS 
Dibasic (Na2HPO4) and monobasic (NaH2PO4) phosphates were used in 
the preparation of phosphate buffers in the pH range 5.8 to 8.0. An 
appropriate volume and concentration of NaH2PO4 was titrated against 
an appropriate amount of Na2HPO4 [5] to give a buffer of required 
concentration and pH. Phosphate buffers were mainly used in the 
isolation and purification of b2. 
7.3 	AMMONIUM SULPHATE FRACTIONATION 
The precipitation of b2 at high concentrations of ammonium 
sulphate is based on the salting out principle [6]. In polar 
solvents, macromolecules are solvated and become soluble. If a high 
concentration of salt, for example ammonium sulphate, is added, 
solvent molecules bind to the salt thereby causing precipitation 
of the macromolecules. As different proteins exhibit varying 
solubility in concentrated salt solutions, this technique can be 
used as an aid towards protein purification. Ammonium sulphate is 
the most widely used salt as it is very soluble, does not 
significantly alter pH and does not destabilise the protein. 
Solutions of impure in were first of all adjusted to 30% ammonium 
sulphate saturation and centrifuged for 10 minutes. L2 is not 
precipitated at this concentration but some of the unwanted 
proteins are. The supernatant was then brought to 70% ammonium 
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sulphate saturation, at which point l,z precipitates. This was then 
collected after centrifugation for 15 minutes and stored under 
nitrogen at 0-4 ° C until required. Normally &, in the presence of 
lactate, can be stored in this fashion for up to two months without 
any significant loss of activity. 
Unless otherwise stated, all centrifugations were carried out at 
0-4 ° C, 39000g. 
	
7.4 	DIALYSIS PROCEDURES 
Buffer exchange involves the separation of dissolved molecules of 
different molecular dimensions by using a semi-permeable membrane. 
In this case it was mainly used to remove ammonium sulphate from a 
solution of 1,2. 
A length of seamless dialysis tubing (Sigma) was soaked in 
deionised water for approximately 30 minutes then thoroughly washed 
with the appropriate buffer. An ammonium sulphate precipitation of 
b2 was dissolved in the minimum amount of the same buffer. This was 
then pipetted into the dialysis tube which had been knotted at one 
end. After sealing the other end, the tube was placed in buffer, the 
volume of which was at least 200-fold that in the dialysis tube. To 
ensure efficient removal of ammonium sulphate the external buffer 
was changed at least twice over the 20 hour dialysis period. 
7.5 	COLUMN ChROMATOGRAPhY 
7.5.1 COLUMN PREPARATION 
In preparing a column, care was taken to ensure that it was 
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mounted vertically. A small amount of glass wool was then placed in 
the bottom of the column. After suspension of the column material in 
the appropriate solution, the slurry was poured into the column, 
with the tap open, until the desired length was obtained. The column 
was then fully equilibrated by washing with several column volumes 
of solution. Care was taken to ensure that the column did not run 
dry. 
7.5.2 HYDROXYAPATITE COLUMNS 
Hydroxyapatite is a crystalline form of Calo(PO4)6(OH)2. Binding 
is considered to take place through the phosphate groups of the 
binding material [7] and proteins are purified by varying the ionic 
strength of the eluting buffer. The normal hydroxyapatite column 
dimensions used were 12cm x 2.5cm. After use, column material was 
recovered by washing with 1M sodium chloride and stored, with the 
addition of 0.02% azide, as a slurry. 
7.5.3 GEL FILTRATION COLUMNS 
Sephadex G25-50 (beads for gel filtration) (Sigma) was used 
primarily to remove lactate from solutions of b2. The basis of gel 
filtration is the separation of molecules of different molecular 
weight. A gel is a 3-dimensional network of an inert substance with 
a random structure. The material contains small pores, the size of 
which is controlled by the degree of polymer cross-linking [7]. If a 
solution comprising molecules of different dimensions is passed 
through such a column, molecules which are larger than the pores 
will only move between the particles and will not be slowed down by 
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the column material. On the other hand, those molecules which are 
smaller than the pores diffuse in and out of the particles. As the 
probability of this occurring increases with decreasing molecular 
size, the smallest molecules in a solution are retarded the most 
and will be the last to be eluted. 
Sephadex (dextran cross-linked with epichlorohydrin) was prepared 
by swelling in excess buffer (2.5 ± 0.2g of water is taken up by ig 
of dry gel). The column was poured and equilibrated as described in 
Section 7.5.1. 
7.5.4 	ION EXCHANGE COLUMNS 
Ion exchange columns are cross-linked polymer matrices with 
covalently attached ionized or ionizable groups [8] and are used in 
column chromatography to separate molecules according to charge. As 
with the gels, the degree of cross-linking determines the size of 
molecule which can diffuse into the resin pores. Charged molecules 
can reversibly adsorb to the material and can be bound or eluted by 
changing the ionic environment. Small molecules are best separated 
on matrices with small pore size. 
Dowex 1 X 8-200 strongly basic anion exchange resin, chloride 
form, (Sigma) was used to separate lactate from pyruvate during the 
purification of L-[2- 2H]lactate. The Dowex was mixed with 
deionised water and poured as described in Section 7.5.1. Prior to 
use, the column was washed with large quantities of deionised water 
until the eluent appeared clear. 
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7.6 	ISOLATION AND PURIFICATION OF in FROM K. coil. 
7.6.1 	BUFFERS 
The composition of buffer A, used throughout the purification, was 
as follows:- 
Phosphate buffer pH 7.00 	 (100mM) 
L(+)lactic acid (lithium salt) (Sigma) 	 (5mM) 
Ethylenediaminetetraacetic acid (EDTA) (Fisons SLR Grade) 	(1mM) 
7.6.2 ISOLATION OF in 
Frozen Ecoli cells were allowed to defrost and then resuspended 
in buffer A. Lysozyme (Grade III from chicken egg white) (Sigma) was 
added to approximately 0.2mg/mi and the mixture incubated with 
stirring at 0-4 ° C for 40 minutes. The solution was then centrifuged 
for 15 minutes. The resultant pellet, consisting mainly of cell 
debris, was discarded and the red supernatant of impure b2 retained. 
7.6.3 	PURIFICATION OF in 
The red supernatant described in Section 7.6.2 was brought to 30% 
followed by 70% ammonium sulphate saturation as described in Section 
7.3. The 70% ammonium sulphate precipitate of in was redissolved in 
the minimum volume of buffer A and dialysed overnight against the 
same buffer at 0-4 °C. After dialysis, the solution was centrifuged 
for 4 minutes to remove any insoluble material. The protein was then 
loaded onto a hydroxyapatite column, previously equilibrated with 
buffer A, and the column washed to remove any proteins which did not 
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bind. l,z was eluted using a gradient from 0-10% ammonium sulphate. 
Fractions were either collected manually or using a Biorad 2110 
fraction collector. Their purity was evaluated by measuring the 
ratio of their absorptions at 269nm and 423nm (275nm and 413nm if 
the protein was oxidised). In general, fractions with A269/A423 
ratios of approximately 0.5 were considered sufficiently pure. These 
fractions were then pooled and precipitated at 70% ammonium 
sulphate saturation. After centrifuging for 15 minutes, the 
precipitate was stored under nitrogen at 0-4 ° C. 
7.7 	SODIUM DODECYL SULPHATE-POLYACRYLAMIDE GEL ELECTROPHORESIS 
(SDS-PAGE). 
7.7.1 GENERAL 
The molecular weight of most proteins can be evaluated by 
measuring their mobility in polyacrylamide gels which contain sodium 
dodecyl sulphate (SDS) [9]. At pH 7, in 1% SDS and 0.1M 
mercaptoethanol (which cleaves disulphide linkages), the majority of 
proteins bind SDS and dissociate with the loss of secondary 
structure. For all proteins subjected to this treatment, the amount 
of SDS bound/unit weight of protein is the same (1.4g SDS/lg 
protein) and as a consequence they behave as if they have identical 
charge to mass ratios and uniform shape. This means that the 
effective mobility on a gel in an electric field is related only to 
the molecular weight of the protein. This latter property can then 
be calculated as the log of the molecular weight is directly 
proportional to the distance migrated. 
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SDS-PAGE was carried out using a vertical gel box system (BRL). 
The potential applied across the gel was controlled by either a LKB 
2103 or a Biorad 200/2.0 power supply. 
7.7.2 	ELECTROPIJORESI S BUFFERS 
7.7.2.1 RESOLVING BUFFER 	(Stored as a 2-fold concentrate) 
Tris/HC1 pH 8.8 	 0.375M 
SDS (Sigma) 	 0.1% 
7.7.2.2 STACKING BUFFER 	(Stored as a 2-fold concentrate) 
Tris/HC1 pH 6.8 	 0.125M 
SDS (Sigma) 	 0.1% 
7.7.2.3 SAMPLE BUyyiai 
Tris/HC1 pH 6.8 	 0.125M 
SDS (Sigma) 	 2% 
Glycerol (Fisons AR Grade) 	10% 
B-Mercaptoethanol (Sigma) 	10% 
Bromophenol blue (BDH) 	 0.01% 
7.7.2.4 RESERVOIR BUFFER 	(Stored as a 5-fold concentrate) 
Tris/HC1 pH 8.8 	 0.025M 
Glycine (Sigma) 	 0.19M 
SDS (Sigma) 	 0.1% 
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7.7.2.5 STAIN 
Isopropanol (v/v) (Fisons) 	25% 
Acetic acid (v/v) (May & Baker) 	10% 
Coomassie brilliant blue (Sigma) 0.1% 
7.7.2.6 DESTAINS 
Three successive solutions were used as indicated: 
SOLUTION 	ISOPROPANOL 	ACETIC ACID 
1 	 25% 	 10% 
2 	 10% 	 10% 
3 	 - 	 10% 
7.7.3 	FREPARATION OF THE RESOLVING GEL 
The resolving gel, 12% acrylamide (Sigma) in resolving buffer and 
deionised water, was mixed with a 10% ammonium persuiphate (Sigma) 
solution (2.5,ul/ml) and filtered. After degassing, N,N,N'N'-
tetramethylethylenediamine, here referred to as TEMED, (1 1u1/ml) 
(Sigma) was added to initiate cross-linking. 
7.7.4 	PREPARATION OF THE STACKING GEL 
Stacking gel was prepared as in Section 7.7.3, using stacking 
buffer, deionised water, 6% acrylainide and TEMED (1 1u1/ml). 
7.7.5 	PREPARATION OF SAMPLES 
Protein samples were prepared by dissolving the protein in sample 
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buffer and heating in boiling water for 2 minutes. After cooling, 5-
15ul volumes of each were loaded onto the gel. 
7.7.6 THE RUNNING OF THE GEL 
Reservoir buffer was poured into both top and bottom sections of 
the gel trough, care being taken to exclude air bubbles. A current 
flow of 0.02A was then applied until the dye front reached the 
bottom of the gel (approximately 5 hours). After the gel had been 
removed from the apparatus it was stained overnight followed by 
destaining with isopropanol and acetic acid. 
7.8 	PREPARATION OF SUBSTRATES AND INHIBITORS 
7.8.1 GENERAL 
Substrate and inhibitor solutions of appropriate concentrations 
were prepared in Tris/HC1 buffer pH 7.50, I = 0.1M. The pH of each 
solution was checked and where necessary titrated up to pH 7.50 with 
1M NaOH. 
7.8.2 SUBSTRATES 
L(+)lactic acid (Lithium salt, 98-100%) (Sigma) 
DL-lactic acid (prepared as a 50/50 mixture of L(+) and D(-) 
lactic acid (Lithium salt, 98% D-isomer, 0.01% L-isomer) (Sigma)). 
DL-Glyceric acid (Hemicalcium salt) (Sigma) 
DL-2-Hydroxybutyric acid (Sodium salt, 98% ) (Aldrich) 
DL-2-Hydroxycaproic acid (99%) (Aldrich) 
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DL-2-Hydroxyoctanoic acid (Lancaster synthesis) 
Glycolic acid (96%) (Aldrich) 
7.8.2.1 SYNTHESIS OF L-[2- 2H]LACTATE 
L-[2- 2H]lactate was synthesised by a coupled enzyme procedure, 
essentially as described in [101. 
2mg of yeast alcohol dehydrogenase (Sigma) and 12mg of beef heart 
lactate dehydrogenase (Sigma) were added to 50m1 of 90mM 
hexadeuteroethanol (Sigma), 70mM pyruvic acid (sodium salt) (Fluka) 
and 1.8mM Nicotinamide Adenine Dinucleotide (NAD) (Sigma) in 10mM 
sodium phosphate buffer pH 8. The reaction was incubated at 37 ° C for 
18 hours and curtailed by boiling for 3 minutes. The labelled 
lactate was filtered and then purified on a Dowex 1 X 8-200 ion 
exchange column by eluting with a linear gradient of deionised water 
and 3.6M formic acid (Sigma). Fractions were analysed to detect any 
pyruvate present using a pyruvate diagnostic kit (Sigma). All 
pyruvate free fractions were pooled and concentrated down to 
approximately 2m1 on a rotary evaporator. The concentrated L-[2- 2 H] 
lactate was then diluted with Tris/HC1 buffer, pH 7.50, I = 0.1M. 
The pH of the solution was checked and if necessary 1M NaOH was 
added to bring the pH to 7.50. The isotopic purity of the lactate 
was verified by means of NMR spectroscopy. The concentration of 
L-[2- 2H]lactate was determined spectrophotometrically at 420nm 
by measuring the amount of ferricyanide reduced by a limiting amount 
of lactate in the presence of a catalytic amount of Zn. 
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7.8.3 INHIBITORS 
Pyruvic acid (Sodium salt) (Fluka) 
D(-)lactic acid (Lithium salt, 98% D-isomer: 0.01% L) (Sigma) 
Sodium oxalate (Fisons) 
7.9 	STEADY-STATE KINETICS 
7.9.1 GENERAL 
b2 catalyses the two electron oxidation of L(+)lactate to 
pyruvate [11]. The rate of electron turnover can be determined by 
monitoring the rate of reduction of excess electron acceptor in the 
presence of excess substrate and a known quantity of enzyme. 
Although cytochrome c is the physiological electron acceptor of in, 
ferricyanide is commonly used in steady-state kinetic experiments. 
The rate of reduction of the acceptor is determined by following 
the change in absorbance over time at 550nm (cytochrome c) or 
420nm (ferricyanide). With the WT-b2 and most of the site-directed 
mutant enzymes, the reaction exhibits saturation kinetics over a 
range of increasing substrate concentrations. 
Experimental data can be analysed using the Michaelis-Menten 
equation [121:- 
[Eo][sl kcpt 	 (2) 
Kn + [S] 
(For derivation and definitions see Appendix 1). This equation can 
also be transformed into linear form, useful for analysing data 
graphically and in detecting data points which deviate from ideal 
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behaviour. The most frequently used method is the Lineweaver-
Burk [13] or double reciprocal plot (see Appendix 1). The Lineweaver 
-Burk equation is shown below: 
1= 	KM 	+ 
V Vmax[S] 	Viax 	(3) 
and along with Equation 2, is represented graphically in Figure 7.1. 
The two kinetic parameters that can be evaluated from the 
Michaelis-Menten equation are KM and kcat. The latter is the 
velocity of the reaction at infinite substrate concentration and 
represents the number of times that the enzyme turns over per unit 
time. KM is the Michaelis-Menten constant and, in the case of b2, is 
approximately equal to Ks, the dissociation constant of the enzyme-
substrate complex. 
Unless otherwise stated, all steady-state kinetic experiments 
were carried out at 25 ° C in Tris/HC1 buffer pH 7.50 I = 0.1M, using 
3ml quartz cuvettes of 1cm pathlength. All absorbance and assay 
measurements were made on either Pye Unicam SP8-400 or Beckman 
DU-62 UV/visible spectrometers, thermally equilibrated at 25.0 ± 
0.1 ° C. Assay solutions were kept in a similarly equilibrated water 
bath for the duration of the experiment. Protein solutions were kept 
on ice. 
For substrate KM measurements the concentration of substrate was 
varied and that of the electron acceptor kept constant. When the 
acceptor KM was measured, the procedure was reversed. 
7.9.2 	PROTEI N CONCENTRATION DETERMI NATON 
Protein concentration was measured spectrophotometrically using 
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FIGURE 7.1 
GRAPHICAL REPRESENTATIONS OF THE MICHAELJS-MEN'FEN AND LINEWEAVER-
BURR EQUATIONS. 
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published extinction coefficients [14]. 	The most accurate 
concentration measurements were determined at 557nm (AXED - Aox) 
where LE(RED - OX) is equal to 21500M 1 cm 1 . 
7.9.3 FERRICYANIDE AS THE ELECTRON ACCEPTOR 
Stock solutions of 3mM and 12mM potassium ferricyanide (Fisons) 
were made up with Tris/HC1 buffer, pH 7.50, I = 0.1M, unless 
otherwise stated. The reduction of ferricyanide was 
monitored at 420nm, with L\E(ox - RED) equal to 1010 M 1 cm 1 . For 
the determination of ferricyanide Kt.t values, assays were carried out 
in cuvettes of 0.2cm path length to enable the use of ferricyanide 
concentrations of up to 8mM. With enzymes which did not exhibit a 
significant ferricyanide concentration dependence, the acceptor 
concentration was usually 1mM. 
7.9.4 CYTOCHEOME c AS THE ELECTRON ACCEPTOR 
Solutions of cytochrome c (horse heart, type VI) (Sigma) were 
prepared with Tris/HC1 buffer, pH 7.50, I = 0.1M. Concentrations 
were determined spectrophotometrically at 550nm (€ox = 8160M 1 cm 1 ). 
A typical saturating concentration used in assays was 50 M. The 
reduction of cytochrome c was monitored by the increase in 
absorbance at 550nm with L\€(RED - OX) equal to 22640 M 1 cm 1 . 
7.10 	STOPPED-FLOW KINETICS 
7.10.1. GENERAL 
Stopped-flow kinetics were employed to directly monitor the rate 
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of reduction of either the flavin or heme prosthetic groups of b2. 
This was accomplished by the rapid mixing of oxidised enzyme and 
lactate in the absence of an electron acceptor, allowing only a 
single turnover of the enzyme. 
Stopped-flow measurements were accomplished using an Applied 
Photophysics SF.17MV microvolume stopped-flow spectrophotometer with 
• dead time of < ims. Temperature was maintained at 25.0 ± 0.1C by 
• thermostated water bath. 
7.10.2 PREPARATION OF PROTEIN FOR STOPPED-FLOW ANALYSIS 
b2 was fully purified as described in Section 7.6.3. Immediately 
prior to use, the protein was oxidised by elution down a Sephadex G-
25-50 gel filtration column. This removed ammonium sulphate as well 
as lactate. 
7.10.3 PROCEDURE FOR STOPPED-FLOW KINETIC ANALYSIS 
The syringes and sample flow circuit of the stopped-flow 
spectrophotometer were initially flushed with a small amount of 
deionised water, to displace any air, before being flushed with Tris/ 
HC1 buffer, pH 7.50, I = 0.1M. Each syringe was then flushed with 
either protein or substrate solutions before being filled. Care was 
taken to ensure that air bubbles were excluded. Mixing of reaction 
solutions was initiated by a gas drive unit under a pressure of 
approximately 70 p.s.i.. The volume of protein and substrate used 
per run was 50,til. Flavin reduction was monitored by the decrease in 
absorbance at 438.3nm, a heme isosbestic point, while heme reduction 
was monitored by the increase in absorbance at 557nm. Data were 
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collected in the software absorbance mode and were automatically 
converted and displayed in absorbance units. Data analysis was 
performed with the SF.17 MV spectrophotoineter software which allows 
non-linear regression analysis of traces to analytical equations. Kn 
and kcat parameters were determined by analysing the experimental 
data, obtained at varying L-[2-'H] and L-[2- 2 H]lactate 
concentrations, using non-linear regression analysis. 
7.11 	REDOX POTENTIAL DETERMINATION 
7.11.1 GENERAL 
The midpoint potential of the Y143F-b2 heme group was determined 
spectrophotometrically using the redox potentiometry method 
published in [15]. The reaction was carried out under anaerobic 
conditions in a 3m1 pyrex cuvette with adaptor fused on. Platinum 
was used as the working electrode, with a reference electrode of 
Ag/AgC1. 
7.11.2 PREPARATION OF REDOX SOLUTIONS 
7.11.2.1 IRON (III)! EDTA SOLUTION 
EDTA (40mM) was dissolved in deionised water and the pH adjusted 
to 7.00. Anunonium iron (III) sulphate (Aldrich) (2mM) was dissolved 
in the EDTA solution, with gentle heating if necessary. 
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7.11.2.2 IRON (II) STANDARD SOLUTION 
Ammonium iron (II) sulphate (Aldrich) (100mM) was dissolved in 
deionised water degassed with argon. The solution was then 
thoroughly degassed. 
7.11.2.3 CALIBRATION SOLUTION 
Ammonium iron (III) sulphate (0.5mM) and acetate buffer pH 5.0 
(0.25M) were dissolved in deionised, degassed water. 
7.11.2.4 DITHIONITE SOLUTION 
Sodium dithionite (Fisons) (30mg) was dissolved in 0.1M phosphate 
buffer pH 7.0 (5m1) immediately prior to use. The solution was 
thoroughly degassed and kept in an anaerobic vial fitted with a 
rubber septum. 
7.11.2.5 FERRI CYANIDE SOLUTION 
Potassium ferricyanide (30mg) was dissolved in 0.1M phosphate pH 
7.0 (5ml). 
7.11.3 REDOX MEDIATORS 
In proteins such as b2, the redox centre is shielded by the 
protein and does not therefore make proper contact with the 
electrode surface. Mediators, usually small organic or inorganic 
redox agents, are used to act as go-betweens and must be able to 
react efficiently with both the electrode and the protein redox 
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centre. 
The mediators used are listed belOw, along with their midpoint 
potentials (Em) at pH 7. 5mM stock solutions were made up with 
deionised water (20% ethanol with DAD and HNQ). 
MEDIATOR 
	
Em (mV) [151 
2-Hydroxy-1 , 4-napthaquinone 	(HNQ) 	-145 
N-Ethylphenazoniumethosulphate 	(PES) 	 +55 
N-Methylphenazoniummethosulphate 	(PMS) 	 +80 
2,3,5, 6-tetramethylphenylenediamine (DAD) 	+260 
These mediators are best suited for monitoring the oxidation and 
reduction of the heme a-band as this region is essentially free of 
mediator absorbance changes. 
7.11.4 ELECTRODE STANDARDISATION 
The platinum electrode was first polished with a small amount of 
aluminium oxide. Iron (II) solution (101ul) was injected into the 
calibration solution and the potential recorded. A further 15 1ul 
were added to give a concentration of 0.5mM and the potential 
re-recorded. A Nernst plot of these two points was drawn to obtain 
the slope and intercept (ideal values 59mV and 108mV respectively). 
7.11.5 HEME REDUCTION AND OXIDATION 
The reaction mixture (in, PES, PMS, DAD, HNQ (all 141uM) and iron 
(III)/EDTA solution (20 1uM) in 0.1M phosphate buffer) was 
thoroughly degassed and stirred continuously during the reaction. 
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The heme was reduced by titrating with sodium dithionite under 
anaerobic conditions and oxidised by titrating with potassium 
ferricyanide. The visible absorption spectrum was monitored between 
530nm and 575nm with absorbance changes at 557nm (the heme a'-band) 
measured 	with changing 	electrode 	potential. 	Sufficient 
reductant/oxidant was added to elicit a change in potential of 
around 20mV per titration until the protein was fully 
reduced/oxidised. All potentials were corrected for Ag/AgC1 (Em 
+196mV) and Nernst plots, Eh versus log [OX]/[RED], were plotted for 
both oxidative and reductive sequences. 
7.12 	CIRCULAR DICHROISM 
7.12.1 GENERAL 
The technique of circular dichroism (CD) enables the detection of 
features of chirality in molecules, as the former absorb left and 
right circularly polarised light to different extents. This 
difference in absorbance (the circular dichroism) is normally 
expressed in terms of the extinction coefficients as shown in 
Equation 4: 
LiE = EL - ER 	 (4) 
As a consequence of the differential absorption of left and right 
polarised light, the amplitudes of the transmitted waves will be 
different, resulting in elliptically polarised light. The 
ellipticity, 0, is related to the circular dichroism as shown in 
Equation 5 
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0 = 3300 LE 	 (5) 
A CD spectrum is a plot of the dependence of 0 on wavelength. 
The CD spectrum of proteins results primarily from the asymmetry 
of the constituent amino acids. The composition of the protein 
secondary structure can be determined from analysis of the CD 
spectrum in the far UV region. In a protein such as b2, interactions 
of the flavin and heme prosthetic groups, both with the protein and 
each other, contribute to the CD spectrum. 
7.12.2 ENZYME PREPARATION 
b2 was fully purified to give absorbance ratios of < 0.5, as 
described in Section 7.6.3, and stored as an ammonium sulphate 
precipitate. If the sample was required reduced, the precipitate 
was dissolved in 0.1M phosphate buffer pH 7.0 containing L(+)iactate 
(5mM) and dialysed overnight (0-4 °C, under nitrogen) against the 
same buffer. If the sample was required oxidised, lactate was 
omitted from the buffer. Typical protein concentrations used were 
0.4mg/mi (190nm - 260nm), 0.8mg/mi (260nm - 500nm) and 2.5mg/mi 
(500nm - 600nm). 
7.12.3 SPECTRA COLLECTION 
CD spectra were recorded in 0.1M phosphate buffer, pH 7.50, on a 
Jasco J-600 spectropolarimeter, equilibrated at 25 °C. Quartz 
cuvettes of pathlength 0.2cm (190nm - 260nm) and 1cm (260nm - 600nm) 
were used. Secondary structure content was determined (S.Keily) by 
applying the CONTIN procedure at mm intervals over the range 190nm 
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- 240nm [161. 
7.13 	UV/VISIBLE ABSORPTION SPECTROSCOPY 
7.13.1 GENERAL 
Radiation in the UV/visible regions of the electromagnetic 
spectrum is of sufficient energy to bring about transitions of the 
outermost electrons in molecules from a lower to a higher level. 
The degree to which this radiation is absorbed by a substance 
depends on several factors: (i) the substrate concentration, (ii) 
the path length (the distance the radiation travels through the 
sample) and (iii) the wavelength. At a fixed wavelength, dilute 
solutions obey the Beer-Lambert law, Equation 6. lo and I 
logio lo/l = Ed 	 (6) 
represent the intensities of the incident and transmitted radiation 
respectively (logio lo/l denotes the absorbance). 1, c and E are the 
path length (m), concentration (mol nr 3 ) and molar extinction 
coefficient (m 2 mol' )respectively. 
7.13.2 EXPERIMENTAL 
UV/visible absorption spectroscopy was carried out on either Pye 
Unicam SP8-400 or Beckman DU-62 UV/visible spectrometers, 
thermally equilibrated at 25 ° C. Spectra were recorded between the 
wavelengths of 230nm and 750nm. Assays were carried out at fixed 
wavelengths, either 420nm or 550nm. 
'.14?] 
7.14 	ELECTRON PARAMAGNETI C RESONANCE (EPR) SPECTROSCOPY 
7.14.1 GENERAL 
EPR spectroscopy is a microwave technique which enables the 
study of the properties of molecules containing unpaired electrons. 
An electron possesses spin angular momentum and therefore a spin 
magnetic moment. If a molecule or ion contains an unpaired electron, 
energy levels are produced from the interaction of the electron's 
magnetic moment with an applied magnetic field (Equation 7). 
E = gI3BM8 	(7) 
g is a proportionality factor (2.00232 for a free electron), 13 is 
the Bohr magneton, B is the magnetic field and M8 is the electron 
spin quantum number (+1/2 or -1/2). 
The frequency scale used in EPR is normally calibrated in g as 
shown in Equation 8, where v is the operating frequency of the 
v = gI3B/h 	(8) 
spectrometer and h is Planck's constant. An EPR spectrum is obtained 
by monitoring the absorption of microwave radiation as the field is 
swept. 
7.14.2 SPECTRA cOLLECTION 
In the present study, EPR experiments were carried out using a 
Brucker Electron Spin Resonance ER 200D spectrometer. Spectra 
(displayed as first derivatives) were acquired at 12K, using a 
microwave frequency of 9.45GHz. 
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7.14.3 PREPARATION OF PROTEI N SAMPLES 
Samples of WT-b2 were prepared as described in Section 7.6. H43M-
I2 was similarly prepared although only a very short hydroxyapatite 
column was used during purification, to minimise the loss of the heme 
prosthetic group from the enzyme. The purified enzymes (in the form 
of ammonium sulphate precipitates) were dissolved in HEPES/NaOH 
buffer, pH 7.50, I = 0.1M and dialysed (as described in Section 7.4) 
against the same buffer to remove lactate and ammonium sulphate. The 




7 • 15 	REFERENCES 
Backman , K., Ptashne ,M., and Gilbert ,W., Proc. Nati .Acad. Sci • USA 
73, 4174-4178 (1976). 
Maniatis,T., 	Fritsch,E.F., and Sambrook,J., in "Molecular 
Cloning: A Laboratory Manual", Cold Spring Harbour Press, Cold 
Spring Harbour, New York. 
Black,M.T., White,S.A., Reid,G.A., and Chapman,S.K., Biochem.J. 
258, 255-259 (1988). 
Bates,R.G. and Heitzer,H.B., Analytical Chemistry 33, 1285 
(1961). 
Goniori,G., Methods. Enzymol. 1, 138-146 (1955). 
[61 Freifelfer,D., in "Physical Biochemistry : Applications to 
Biochemistry and Molecular Biology" p.526, W.H.Freeman and Co. 
(1976). 
Freifelder,D., in "Physical Biochemistry : Applications to 
Biochemistry and Molecular Biology" p.203, W.H.Freeman and Co. 
(1976). 
Dawson,R.M.C., Elliot,D.C., Elliot,W.H., and Jones,K.M., in 
"Data for Biochemical Research" Third edition, p.503, Oxford 
Science Publications, Clarendon Press, Oxford. 
Weber,K. and Osborn,M., J.Biol.Chem. 244, 4406-4412 (1969). 
[101 Shapiro,S.S. and Dennis,D., Biochemistry 4, 2283-2288 (1965). 
Appleby,C.A. and Morton,R.K., Nature 173, 749-752 (1954). 
Michaelis,M. and Menten,M.L., Biochem.Z. 49, 333 (1913). 
[131 Lineweaver,H. and Burk,D., J.Am.Chem.Soc. 56, 658-666 (1934). 
[141 Labeyrie,F., Baudras,A., and Lederer,F., 	Methods. Enzymol. 
53, 238-256 (1978). 
262 
Dutton,P.L., Methods. Enzymol. 54, 411-435 (1978). 





THE DERIVATION OF KINETIC EQUATIONS. 
1. THE MICHAELIS-MENTEN EQUATION [1] 
The Michaelis-Menten equation is derived from the following 
scheme: - 
Ks 	kcat 
E + S ES - 	EP 	(1) 
where E, 5, ES and P are the enzyme, substrate, enzyme-substrate 
complex and product respectively. The catalytic reaction consists of 
two processes. The first, the combination of the enzyme and 
substrate to form the enzyme-substrate complex, is assumed to be 
rapid and reversible. No chemical changes take place at this 
stage but occur in the second step, with a first- order rate 
constant termed k8t. 
From Equation 1, 
Ks = [E][S] 	 (2) 
[ES] 
The initial rate (v) can be represented as in Equation 3:- 
v = kcat[ES] 	 (3) 
The total concentration of enzyme present, EEc], is equal to the sum 
of the concentration of free enzyme, [E], and the bound enzyme, [ES] 
[E] can therefore be represented as shown in Equation 4:- 
[E] = [Eo] - [ES] 	 (4) 
Equation 4 can then be substituted into equation 2 as shown:- 
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Ks = ([Eo1-[ES1)[S] 	 (5) 
[ES] 
Ks[ES] = [Eo][S] - [ES}[S] 	 (6) 
[ES](Ks + [SI) = [Eo][S] 	 (7) 
[ES] = [Eo][S] 	 (8) 
Ks + [S] 
Equation 3 can then be substituted into Equation 8 to give the 
Michaelis-Menten equation: - 
v = [Eo][Slkcat 	 (9) 
Ks + [S] 
THE LINEWEAVER-BURK EQUATION [2] 
To analyse data graphically, the Michaelis-Menten equation is 
transformed into Linear form. The most common method is the double-
reciprocal or Lineweaver-Burk plot (Equation 10). This is obtained 
by inverting both sides of Equation 9 and substituting Vmax for 
kcat[Eo], where Vmax is the limiting initial velocity. 
1= 	Ku 	+ 	1 	 (10) 
V 	 Vinax[S] V.ax 
One disadvantage of this method is that data points at low 
concentrations are emphasized, whereas those at high concentrations 
are compressed. 
COMPETITIVE INHIBITION 
A competitive inhibitor competes with the substrate for the same 
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active site. In terms of the Michaelis-Menten mechanism (Equation 
1), another equilibrium must be taken into account:- 
S,Ki 	kcat 
E 	ES -- E + P 	(11) 
I,KIJ[ 
EI 
I is the inhibitor, Ki is the dissociation constant for the reaction 
between E and I and KH, the Michaelis constant, is equal to Ks. 
Therefore: - 
Ki = [ E][I] 	 (12) 
[El] 
and, 	 K?1 = [ E]ISI 	 (13) 
[ES] 
In this case, the total concentration of enzyme is as shown in 
Equation 14:- 
[Eol = [E] + [ES] + [El] 	(14) 
Expressing Equation 12 in terms of [El] and substituting into 
Equation 14 gives:- 
[Eo] = [El + [ES] + [ElfIl 	(15) 
Ki 
[El = [Epi-EESI 	 (16) 
(1 + [I]/Ki) 
Expressing Equation 13 in [E] and substituting into Equation 16 
gives: - 
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Kn(1 + [I]/Ki) = ([ Eo]-[ES])[S] 
[ES] 	 (17) 
Finally, substituting [ES] = V/kcat into Equation 17 gives 
Equation 18:- 
V = 	[ Eo][Slkcat 	 (18) 
[S] + Kn(1 +[I]/Ki) 
Equation 18 is expressed in the same form as the Michaelis-Menten 
equation and shows that for competitive inhibition v is unchanged 
but Km is apparently increased by (1 + [ IJ/Ki). 
4. NON-COMPETITIVE INHIBITION 
With non-competitive inhibition, the inhibitor and substrate bind 
to the enzyme at the same time but do not compete for the same 
binding site. The following scheme must therefore be considered:- 
S,Ku 




If it is assumed that Ku, = Ku' ie. the dissociation constant of S 
from ESI is the same as that from ES and that ESI does not react, it 
can be shown that: 
	
V = kcat/(1 + [ Il/Ki) 	(19) 
[5] + Ku 
Therefore, with non-competitive inhibition Ku is unaffected (since 
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neither the inhibitor or substrate affect the binding of the 
other) but kcat decreases by (1 + [I]/Kj). 
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